ACG 2023 Meeting News

Page 1


MEETING NEWS Your information source for daily convention events




All ACG 2023 courses will offer MOC points.

Endoscopy School Hands-On Workshop Center sessions run from Sunday through Tuesday.

Learn about the GI Jeopardy Finals and other Fellowsfocused events.








Seven members earn the distinction of MACG.

Opens at 3:00 pm on Sunday. The Exhibit Hall Opening Reception begins at 5:30 pm.

WiFi Network


WiFi Password DUPIXENT

Interview with ACG President:

A Conversation with ACG’s Next President:





As your term as ACG President is winding down, how do you feel about your service to the organization and are there any memorable experiences you wish share? It has been an honor to have the opportunity to serve the College in this leadership capacity, a manner in which to make contributions at a level and tempo, with such a high functioning team, that in totality is such a unique and rewarding experience.

On On Monday evening at the 6:00 p.m. ACG Business Meeting, Jonathan A. Leighton, M.D., FACG, will become the next President of the ACG. We asked Dr. Leighton to share with us some of his experiences as well as his ideas and aspirations for the coming year.

You have been a proponent of integrated care and the use of innovative patient management and diagnostic tools such as genetic testing and counseling among others, especially through GIonDEMAND. Can you share with the membership what drives you to engage on these issues? The genesis of my drive is the belief that we as a collective can advance the science and clinical application of gastroenterology to improve the lives of the patients we serve. The College embodies this mission and goal. The College has long had a proud commitment to providing leadership opportunities for all clinicians, regardless of practice setting. How did your decades of experience as a private practitioner inform your year as ACG President? We all share degrees of compulsion to be healers, albeit bench or clinical researchers, or clinicians. I subscribe to the educational adage that we all should be participants in “bench to the bedside” patient care. I personally have gone from academics to practice and established a clinical research site and participated in endoscopy, sedation, and pharmacology trials. Since the vast majority of GI fellows become private practice clinicians, on the front lines of providing care to most patients, with the tools of scientific advancement, my quest has been to broaden, deepen, and strengthen that relationship. The College has allowed me to represent most of our members in that unique milieu. As President, you attended the ACG Board of Governors Fly-In in Washington, DC, in April. This year we were able to hold the event in full force with hundreds of in-person meetings on Capitol Hill. Talk about that experience as well as your overall sense of the Board of Governors, which you led not too long ago. This year’s Fly-In was incredibly successful and I am grateful for having this opportunity to participate and witness the evolution of the impact the Board of Governors is having on our advocacy efforts. Our success has been in utilizing this meeting to provide leadership training, self-education, and discourse amongst our own congress of gastroenterologists to provide our legislators with the necessary information they need for policy making. We have been instrumental through these meetings in advancing legislative bills leading to policy changes, examples being patient access to colon cancer screening; ensuring Continued on page 6

As you begin your Presidency, what are your goals and what do you believe are the biggest challenges facing ACG this year? Having the opportunity to serve the ACG for much of my professional life has been a highlight of my career. The College has provided me so much opportunity to help advance the field of gastroenterology, network with colleagues, and provide mentoring for so many entering the field. I have so much gratitude for what the ACG has allowed me to accomplish. As far as my goals as President, the first is to ensure that all of the amazing programs we have developed continue to be effective and relevant to our membership. This is a time to strengthen what we already do very well. Specifically, I am referring to our educational, leadership, and research activities. I also hope to strengthen our innovation and technology activities, especially with regard to endoscopy and artificial intelligence, through our educational programs and stronger partnerships with industry. In addition, I want to make sure that we are always inclusive as an organization and encourage diversity of opinions which I think will make us stronger. In terms of challenges, I am very concerned about the issue of burnout in healthcare, and want to make sure that we focus on improving the well-being of our membership and provide support for those in need. We will also continue to work with our members to educate them and get their input on ways to increase environmental sustainability, minimize our carbon footprint and reduce waste in our practices. We will also look at ways that we can interact internationally with GI societies in other countries to improve the practice of gastroenterology and hepatology globally. Through the ACG Institute, we continue to look for ways to fund more clinical research and innovation that will enhance our field for years to come. Last but not least, the ACG continues to advocate for our members through our Public Policy work and our interaction with the American Board of Internal Medicine to make their process less high-stakes, easier to use for our members, and more clinically relevant. You have been extremely active in the area of clinical education within the College, including a three-year term as chair of the Educational Affairs Committee. As we sit at the biggest purely clinical meeting of the year, can you share your thoughts about the College’s role as an education-focused organization and the keys to successful educational programming and resources? Education is one of the most important aspects of the College and the Educational Affairs Committee is one of the pillars of our organization. We realize the Continued on page 10




94% of patients achieved successful* bowel cleansing with SUFLAVE 87% of patients found SUFLAVE tolerable to very easy to consume 79% of patients found the taste of SUFLAVE neutral to very pleasant




THE MAJORITY OF PATIENTS SAID SUFLAVE TASTES LIKE A SPORTS DRINK3 *Success was defined as an overall cleansing assessment of excellent or good by the blinded endoscopist; scores were assigned following completion of the colonoscopy; P<0.001 in this noninferiority clinical trial.

IMPORTANT SAFETY INFORMATION SUFLAVE™ (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution) is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults. DOSAGE AND ADMINISTRATION: A low residue breakfast may be consumed on the day before colonoscopy, followed by clear liquids up to 2 hours prior to colonoscopy. Administration of two doses of SUFLAVE are required for a complete preparation for colonoscopy. Each bottle must be reconstituted with water before ingestion. Each bottle and one flavor enhancing packet are equivalent to one dose. An additional 16 ounces of water must be consumed after each dose. Stop consumption of all fluids at least 2 hours before the colonoscopy. CONTRAINDICATIONS: Use is contraindicated in the following conditions: gastrointestinal obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, gastric retention, hypersensitivity to any ingredient in SUFLAVE. WARNINGS AND PRECAUTIONS: Risk of fluid and electrolyte abnormalities: Encourage adequate hydration, assess concurrent medications and consider laboratory assessments prior to and after each use; Cardiac arrhythmias: Consider pre-dose and post-colonoscopy ECGs in patients at increased risk; Seizures: Use caution in patients with a history of seizures and patients at increased risk of seizures, including medications that lower the seizure threshold; Colonic mucosal ulcerations: Consider potential for mucosal ulcerations when interpreting colonoscopy findings in patients with known or suspected inflammatory bowel disease; Patients with renal impairment or taking concomitant medications that affect renal function: Use caution, ensure adequate hydration and consider laboratory testing; Suspected GI obstruction or perforation: Rule out the diagnosis before administration; Patients at risk for aspiration: Observe during administration; Hypersensitivity reactions, including anaphylaxis: Inform patients to seek immediate medical care if symptoms occur. ADVERSE REACTIONS: Most common adverse reactions (≥ 2%) are: nausea, abdominal distension, vomiting, abdominal pain, and headache. DRUG INTERACTIONS: Drugs that increase risk of fluid and electrolyte imbalance. Please see Brief Summary of Prescribing Information on reverse side. See Full Prescribing Information and Medication Guide at

SUFLAVE IS NOT AVAILABLE FOR SALE IN CANADA. Scan the QR code to learn more, or visit





BRIEF SUMMARY: Before prescribing, please see Full Prescribing Information and Medication Guide for SUFLAVE™ (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution). INDICATIONS AND USAGE: An osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adults. DOSAGE AND ADMINISTRATION: Split Dose (2-Day) Recommended Dosage: The Day Prior to Colonoscopy: A low residue breakfast may be consumed. After breakfast, only consume clear liquids until after the colonoscopy. Day 1, Dose 1 - Early in the Evening Prior to Colonoscopy: Open 1 flavor enhancing packet and pour the contents into one bottle. Fill the provided container (bottle) with lukewarm water up to the fill line. After capping the bottle, gently shake the bottle until all the powder has dissolved. For best taste, refrigerate the solution for an hour before drinking. Do not freeze. Use within 24 hours. Drink 8 ounces of solution every 15 minutes until the bottle is empty. Drink an additional 16 ounces of water during the evening. If nausea, bloating, or abdominal cramping occurs, pause or slow the rate of drinking the solution and additional water until symptoms diminish. Day 2, Dose 2 – The Morning of the Colonoscopy (5 to 8 hours prior to the colonoscopy and no sooner than 4 hours from starting Dose 1): Continue to consume only clear liquids until after the colonoscopy. Repeat Step 1 to Step 3 from Day 1, Dose 1. Drink an additional 16 ounces of water during the morning. Stop drinking liquids at least 2 hours prior to colonoscopy. If nausea, bloating, or abdominal cramping occurs, pause or slow the rate of drinking the solution and additional water until symptoms diminish. CONTRAINDICATIONS: Use is contraindicated in the following conditions: gastrointestinal obstruction or ileus, bowel perforation, toxic colitis or toxic megacolon, gastric retention, hypersensitivity to any ingredient in SUFLAVE. WARNINGS AND PRECAUTIONS: Serious Fluid and Electrolyte Abnormalities: Advise all patients to hydrate adequately before, during, and after the use of SUFLAVE. If a patient develops significant vomiting or signs of dehydration after taking SUFLAVE, consider performing post-colonoscopy lab tests (electrolytes, creatinine, and BUN). Fluid and electrolyte disturbances can lead to serious adverse events including cardiac arrhythmias, seizures and renal impairment. Correct fluid and electrolyte abnormalities before treatment with SUFLAVE. Use SUFLAVE with caution in patients with conditions, or who are using medications, that increase the risk for fluid and electrolyte disturbances or may increase the risk of adverse events of seizure, arrhythmias, and renal impairment; Cardiac arrhythmias: Use caution when prescribing SUFLAVE for patients at increased risk of arrhythmias (e.g., patients with a history of prolonged QT, uncontrolled arrhythmias, recent myocardial infarction, unstable angina, congestive heart failure, or cardiomyopathy). Consider pre-dose and post-colonoscopy ECGs in patients at increased risk of serious cardiac arrhythmias; Seizures: Use caution when prescribing SUFLAVE for patients with a history of seizures and in patients at increased risk of seizure, such as patients taking medications that lower the seizure threshold (e.g., tricyclic antidepressants), patients withdrawing from alcohol or benzodiazepines, or patients with known or suspected hyponatremia; Use in Patients with Risk of Renal Injury: Use SUFLAVE with caution in patients with impaired renal function or patients taking concomitant medications that may affect renal function (such as diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, or non-steroidal anti-inflammatory drugs). These patients may be at risk for renal injury. Advise these patients of the importance of adequate hydration with SUFLAVE and consider performing baseline and post-colonoscopy laboratory tests (electrolytes, creatinine, and BUN) in these patients; Colonic Mucosal Ulcerations and Ischemic Colitis: Osmotic laxative products may produce colonic mucosal aphthous ulcerations, and there have been reports of more serious cases of ischemic colitis requiring hospitalization. Concurrent use of stimulant laxatives and SUFLAVE may increase these risks. Consider the potential for mucosal ulcerations resulting from the bowel preparation when interpreting colonoscopy findings in patients with known or suspect inflammatory bowel disease; Use in Patients with Significant Gastrointestinal Disease: If gastrointestinal obstruction or perforation is suspected, perform appropriate diagnostic studies to rule out these conditions before administering SUFLAVE. Use with caution in patients with severe active ulcerative colitis; Aspiration: Patients with impaired gag reflex or other swallowing abnormalities are at risk for regurgitation or aspiration of SUFLAVE. Do not combine SUFLAVE with starch-based thickeners. Observe these patients during administration of SUFLAVE; Hypersensitivity reactions, including anaphylaxis: SUFLAVE contains polyethylene glycol (PEG) and other ingredients that may cause serious hypersensitivity reactions including anaphylaxis, angioedema, rash, urticaria, and pruritus. Inform patients of the signs and symptoms of anaphylaxis, and instruct them to seek immediate medical care should signs and symptoms occur. ADVERSE REACTIONS: Most common adverse reactions are: nausea, abdominal distension, vomiting, abdominal pain, and headache. POTENTIAL FOR DRUG ABSORPTION: SUFLAVE can reduce the absorption of other co-administered drugs. Administer oral medications at least one hour before starting each dose of SUFLAVE. Administer tetracycline and fluoroquinolone antibiotics, iron, digoxin, chlorpromazine, and penicillamine at least 2 hours before and not less than 6 hours after administration of each dose of SUFLAVE to avoid chelation with magnesium. Pregnancy: There are no available data on the use of SUFLAVE during pregnancy to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Animal reproduction studies have not conducted with polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride (SUFLAVE). Lactation: There are no available data on the presence of SUFLAVE in human or animal milk, the effects on the breastfed child, or the effects on milk production. Pediatric Use: Safety and effectiveness in pediatric patients have not been established. Geriatric Use: Of the 460 patients who received SUFLAVE in pivotal clinical trials, 125 (27%) were 65 years of age or older. No differences in effectiveness of SUFLAVE were observed between geriatric patients and younger adult patients. In geriatric patients, decreases in blood pressure on the day of colonoscopy were reported more frequently in SUFLAVE patients than with the active comparator in Study 1 (6% vs 0%) and Study 2 (3% vs 0%). Geriatric patients are more likely to have decreased hepatic, renal or cardiac function and may be more susceptible to adverse reactions resulting from fluid and electrolyte abnormalities. STORAGE: Store SUFLAVE at room temperature between 20°C to 25°C (68°F to 77°F). Excursions permitted from 15°C to 30°C (59°F to 86°F). See USP controlled room temperature. Rx only. Manufactured by Braintree Laboratories, Inc. Braintree, MA 02185 See Full Prescribing Information and Medication Guide at References: 1. Bhandari R, Goldstein M, McGowan J, et al. A safety and efficacy comparison of new BLI4900 bowel preparation to oral sulfate solution. Poster Sa1024 presented at: Digestive Disease Week Annual Meeting; May 21-24, 2022; San Diego, California. -2022. 2. SUFLAVE [package insert]. Braintree, MA: Braintree Laboratories, Inc. 3. Bhandari R, Goldstein M, McGowan J, et al. The new flavor enhanced bowel preparation BLI4900 provides a superior patient experience. Poster Mo1024 presented at: Digestive Disease Week Annual Meeting; May 21-24, 2022; San Diego, California. 4. Data on file, Braintree, MA: Braintree Laboratories Inc.

For additional information, please call 1-800-874-6756 ©2023 Braintree Laboratories, Inc.

All rights reserved.


October 2023



this year’s POSTGRADUATE COURSE YOU WON’T WANT TO MISS THE LATEST CLINICAL UPDATES FROM THIS YEAR’S ACG POSTGRADUATE COURSE, where leading gastroenterology experts will discuss a variety of relevant and timely topics including colorectal cancer, hepatology, the microbiome, endoscopy, inflammatory bowel disease, obesity, esophageal disorders, pancreaticobiliary diseases, and more. World-renowned faculty will deliver scientific presentations followed by question-and-answer sessions, optional bonus session “Learning Lunches,” and a choice of simultaneous symposia that will offer the latest clinical practice updates in gastroenterology and hepatology.

SATURDAY PRESENTATIONS The course will begin with Session 1A: “It’s All About Inflammation.” Moderated by Anita Afzali, MD, MPH, MHCM, FACG, this session will include presentations on treatments for refractory Crohn’s disease; the latest clinical trials updates for ulcerative colitis; diagnosing and treating non-IBD colitis; and healthcare maintenance for IBD patients by Sunanda V. Kane MD, MSPH, FACG, Millie D. Long, MD, MPH, FACG, Dr. Afzali, and Andres Yarur, MD, FACG. The session will conclude with a questionand-answer panel. Session 1A will be followed by the David Sun Lecture.  THE DAVID SUN LECTURE - In With the New, While Managing the Old: How to Care for the Changing Face of Those With Liver Disease by Paul Y. Kwo, MD, FACG

Following the David Sun Lecture will be Session 1B: “All About ‘Functional’ or Dysfunctional Bowel Disorders” moderated

by Baharak Moshiree, MD, MSc, FACG, and featuring presentations by Darren M. Brenner, MD, FACG, Lin Chang, MD, FACG, Dr. Moshiree, and Linda Anh B. Nguyen, MD, FACG on IBS treatment management clinical pearls; redefining functional GI disorders as disorders of gutbrain interaction; the role of bloating; and an update on gastroparesis and functional dyspepsia.

Saturday Learning Luncheons Bonus Sessions (separate registration required) Twelve (12) Learning Luncheon Bonus Sessions will be offered on key topics including virtual reality; nutrition; endohepatology; GI APPs; large polyps;

the microbiome; cyclic vomiting syndrome and autonomic dysfunctions; esophageal disorders; chronic diarrhea; pelvic floor dysfunction; C. difficile; and PPI use. Three simultaneous symposia will follow the Learning Luncheons. Symposium A: “Pancreas: Management Guide for the Practicing Clinician”

moderated by Vivek Kaul, MD, FACG and featuring presentations by Dr. Kaul, Tamas A. Gonda, MD, and Gregory A. Cote, MD, MS, on acute pancreatitis; high-risk pancreatic cancer; and chronic pancreatitis. Symposium B: “Obesity and Liver Disease: What’s the Latest?” moderated by Arun

J. Sanyal, MD featuring presentations by Dr. Sanyal, Jennifer Phan, MD, and Allison R. Schulman, MD, MPH on MASLD; GI medical management of obesity; and endobariatric and surgical obesity treatment. Symposium C: “Autoimmune and Dysbiotic GI Diseases From Celiac Disease to Eosinophilic Gastrointestinal Disorders: What Is the Scoop?” moderated by Maria

I. Vazquez-Roque, MD, MS and featuring presentations by Ali Rezaie, MD, FACG, Dr. Vazquez-Roque, and Alberto Rubio-Tapia, MD on SIBO and IBS; the role of food intolerances in eosinophilic GI disorders; and refractory celiac disease. Following the simultaneous sessions will be Session 1C: “All Things Colon” moderated by Aasma Shaukat, MD, MPH, FACG and featuring presentations by Dr. Shaukat, Neil Sengupta, MD, FACG, and Shanaz Sultan, MD, MHSc, FACG on CRC screening updates; lower GI bleeding; and sessile serrated lesions.

Esophagus and More: Elucidating the Esophageal Enigmas” featuring

presentations by Rena H. Yadlapati, MD, MSHS, FACG, Dr. Vaezi, Sachin B. Wani, MD, and Evan S. Dellon, MD, MPH, FACG on refractory reflux; FLIP vs HRM for esophageal motility disorders; Barrett’s esophagus management; and eosinophilic esophagitis.

Sunday Learning Luncheons Bonus Sessions (separate registration required)

Twelve (12) Learning Luncheon Bonus Sessions will be offered on Sunday on topics including cirrhosis complications; resistant H. pylori; difficult ERCP cases; complex esophageal and colonic strictures; hereditary cancer and genetic syndromes; non-IBD chronic pain; AI in GI; public policy and advocacy; gastric intestinal metaplasia and gastric polyps; ischemic and vascular GI disorders; nutritional deficiencies in short gut syndrome; and autoimmune hepatitis, PBC, and hemochromatosis. Three simultaneous symposia will be offered on Sunday afternoon featuring: Symposium D: “GI Endoscopy: Know Your Toolbox and Tricks to Succeed”

moderated by Shivangi T. Kothari, MD, FACG and including presentations by Dr. Kothari, Mouen A. Khashab, MD, and Neil R. Sharma, MD, FACG, on endoscopy complications; interventional EUS; and third space endoscopy. Symposium E: “GI

Saturday will conclude with Course Directors Shivangi T. Kothari, MD, FACG, Baharak Moshiree, MD, MSc, FACG, and Renuka Umashanker, MD, FACG, summarizing the day’s key learning points with “Take-Home Pearls: What Did We Learn Today?”

Emergencies and Dilemmas” moderated by Neena S. Abraham, MD, Msc (Epid), MACG and including presentations by Seth A. Gross, MD, FACG, Dr. Abraham, and Daniel J. Pambianco, MD, FACG, on upper GI bleeds; managing anticoagulation during GI emergencies; and foreign body removals. Symposium F: “Anorectal Disorders: A Practical Approach” moderated by

Gregory S. Sayuk, MD, MPH and featuring presentations by Lawrence J. Brandt, MD, MACG, Dr. Sayuk, and Nyree K. Thorne, MD on hemorrhoids and fissures; anorectal physiology testing; and medical and surgical treatments for fecal incontinence and anal pruritis. Following a break will be Session 2C: “Pancreatobiliary Challenges: Decoding the Dilemmas” moderated by Uzma D. Siddiqui, MD, FACG featuring presentations by B. Joseph Elmunzer, MD, MSc, Harry R. Aslanian, MD, FACG, Dr. Siddiqui, and Dr. Amrita Sethi, MD, on post-ERCP pancreatitis; cystic pancreatic neoplasms; difficult common bile duct stones; and intermediate biliary strictures. To conclude the Postgraduate Course, Course Directors Shivangi T. Kothari, MD, FACG, Baharak Moshiree, MD, MSc, FACG, and Renuka Umashanker, MD, FACG, will review the “Take Home Pearls: What Did We Learn Today” and discuss the practical take-home messages.

Professional 

Head Shot Station in the West Ballroom Foyer near  Located the Poster Sessions

Each session will offer time for questionand-answer periods with the faculty.

Saturday, October 21

12:30 pm - 1:45 pm

SUNDAY PRESENTATIONS Day two of the Postgraduate Course will begin with Session 2A: “Hepatology Consult in Your GI Practice,” moderated by Joseph Ahn, MD, MS, MBA, FACG with presentations by Anne M. Larson, MD, Mark W. Russo, MD, MPH, FACG, Dr. Ahn, and Paul Y. Kwo, MD, FACG, on acute liver failure; liver transplant; pregnancy and liver disease; and noninvasive markers for liver fibrosis.

Sunday, October 22

12:30 pm - 1:45 pm

Monday, October 23

10:30 am - 11:30 am 12:45 pm - 2:15 pm 3:45 pm - 4:45 pm

Tuesday, October 24

10:30 am - 11:30 am 12:45 pm - 2:15 pm 3:45 pm - 4:45 pm

Michael F. Vaezi, MD, PhD, MSc(Epi), FACG will moderate Session 2B: “The

4 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

ACG thanks Abivax SA for their support of the Professional Head Shot Station



the Latest in Clinical

ACG 2023 has set another record for abstract submissions and attendees will benefit with nearly 80 exceptional oral presentations and more than 4,200 poster presentations. The oral presentations are in addition to the simultaneous symposia, optional bonus sessions (formerly called breakfast sessions), featured lectures, and hands-on sessions that will be offered. MONDAY, OCTOBER 23

Monday morning kicks off with “Meet the Experts” Bonus Sessions. Faculty from Annual Scientific Meeting Bonus Sessions A-E will be available to discuss their topics and continental breakfast will be served. These “Meet the Experts” sessions are open to all Annual Scientific Meeting attendees. (The Bonus Sessions are an optional add-on to an Annual Scientific Meeting registration. Visit the ACG Registration Desk in Vancouver to purchase access or visit The “Meet the Experts” sessions will be followed by two Presidential Plenary sessions. Between the plenary sessions, ACG President Daniel J. Pambianco, MD, FACG, will deliver the ACG 2023 President’s Address. Don’t miss it! The Exhibit Hall opens at 10:00 am on Monday where you can visit with

exhibitors, attend an Exhibitor Theater presentation, or participate in an Endoscopy School Hands-On Workshop session. Posters will be on display from 10:30 am to 4:15 pm so stop by to see the latest in scientific advancements and meet the authors from 1:00 pm - 2:15 pm. Three simultaneous symposia are also

offered on Monday morning, including the ACG Past Presidents’ Symposium (1A), If It Bleeds, It Leads: Primetime and Practical GI Bleeding Information and Strategies (1B), and Hot Topics in Liver Disease (1C). Join the experts as they discuss these hot topics! Two additional simultaneous plenary sessions featuring Colon and Liver abstracts are offered on Monday afternoon from 2:15 pm – 3:00 pm.  THE AMERICAN JOURNAL OF GASTROENTEROLOGY LECTURE  Monday, October 23  3:05 PM – 3:35 PM Learn how clinicians can participate in research that moves the fields of gastroenterology and hepatology forward when Charles N. Bernstein, MD, FACG, presents The American Journal of Gastroenterology Lecture on “Using Epidemiology to Inform Clinical Practice in Gastroenterology.” The AJG Lecturer is chosen by the co-editors of The American Journal of Gastroenterology with approval from the ACG Educational Affairs Committee and the ACG Board of Trustees.

If you have burning questions about how to get your research published, there will be a special Tuesday afternoon session from 3:45 pm – 4:45 pm on How to Get Published: An ACG Journal Editors’ Roundtable featuring Jasmohan Bajaj, MD, MS, FACG, Millie D. Long, MD, MPH, FACG (EICs for AJG), Brian C. Jacobson, MD, MPH (EIC for CTG), and Vibhu Chittajallu, MD, and Khushboo Gala, MD (EICs for ACGCRJ). This session is free to all and perfect for GI fellows or anyone new to publishing. Three simultaneous sessions will begin at 4:45 pm on Monday afternoon discussing Challenges in IBD Care: I’m Not Responding to My Treatment, What Happens Next? (2A), What’s Good for the Goose Is Good for the Gander (2B), and Live From Vancouver! The 11th Annual Endoscopy Video Forum (2C).

Three simultaneous symposia are offered on Tuesday morning, including sessions on Diving Into the Rugae: A Potpourri of Gastric Conditions (3A), Colorectal Cancer (3B), and The GI Provider’s Role in Obesity (3C). Join the experts as they discuss these popular topics! In the afternoon, two additional simultaneous plenary sessions will take place with presentations of Liver abstracts (3A) and General Endoscopy, Practice Management, and Colorectal Cancer Prevention abstracts (3B). After these plenary sessions, Marcia Cross, actress, patient advocate, and co-founder of the HPV Cancers Alliance, will present the Emily Couric Memorial Lecture entitled, “HPV Related Cancers – Are Your Patients Being Misdiagnosed?" Be sure to visit the Exhibit Hall one last time before it closes at 4:30 pm on Tuesday! Then plan to attend one of two afternoon simultaneous symposia sessions

Attendees at the Endoscopy Video Forum will be able to vote, along with the moderators and a panel of judges, for the winning video at the end of the session.

that begin at 5:10 pm: Emerging Issues in Pancreaticobiliary Disorders (4A), or High Yield Topics: Changes to Bowel Habits (4B). Don’t miss these important practical topics.


Wednesday kicks off with two simultaneous plenary sessions focusing on Biliary, Pancreas, and Interventional Endoscopy abstracts (4A) and IBD, Obesity, Stomach, and Pediatrics abstracts (4B). After the plenary sessions, David A. Johnson, MD, MACG, will deliver the David Y. Graham Lecture entitled, “Intestinal Microbiome: Answer to All GI Ailments?” Two simultaneous symposia wrap up the educational agenda for the meeting— Challenging Consultations in Liver Disease (5A), and Practical Pearls in IBS: Clinical Cases Where the Art Meets the Science (5B). Be sure to arrange your schedule so you can stay to hear the latest information on these great closing topics.

Following the educational agenda on Monday, ACG will hold its Annual Business Meeting at 6:00 pm. All members and Fellows (FACG) are invited to attend.


Tuesday will again begin with “Meet the Experts” Bonus Sessions. Faculty from Annual Scientific Meeting Bonus Sessions F-J will be available to discuss their topics and continental breakfast will be served. These Meet the Expert sessions are open to all Annual Scientific Meeting attendees. The “Meet the Experts” sessions will be followed by two simultaneous plenary sessions with presentations of Functional and Esophagus abstracts (2A) and Small Intestine and IBD abstracts (2B). After the plenary sessions, Amrita Sethi, MD, will deliver the J. Edward Berk Distinguished Lecture entitled, “Changing the Course of Pancreatic Cancer: Identifying Innovation in Screening, Diagnosis, and Treatment.” The Exhibit Hall opens at 10:00 am on Tuesday, so plan to visit with exhibitors, attend an Exhibitor Theater presentation, or participate in an Endoscopy School Hands-On Workshop session. Posters will again be on display from 10:30 am to 4:00 pm. Stop by to see the latest in scientific advancements and meet the authors from 1:00 pm - 2:15 pm.

9th Annual

SCOPY AWARDS Ceremony & #ACG2023 #IRL In Real Life Social Media

Meetup Reception


 LEARN MORE about this year’s winners in the SCOPY Award Booklet, found in your attendee registration bag or at!

Sponsored by:

ACG thanks Abivax SA for their support of this event

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 5

Interview with ACG President Daniel J. Pambianco, MD, FACG (continued from page 1) insurance coverage without unintended copays; and a House bill proposing increased physician Medicare reimbursement based on existing Medicare inflationary adjustments that have been exclusionary to physicians. The Governors have had meetings directly with the congressional Doctors Caucus which has been a tremendous educational opportunity for our spectrum of young and seasoned College leaders. This meeting has produced a tour de force and revitalized resolve that has been personally rewarding to witness. The number of leadership programs under the auspices of the ACG Institute for Clinical Research and Education has been expanding under the leadership of Institute Director Dr. Neena S. Abraham. What has stood out for you as you have learned and worked with these members? Dr. Abraham and the Institute have been one of my presidential highlights! Having the opportunity to participate in the discussions and meetings over the course of this year has been enlightening, reassuring, and helped me better appreciate the scope of what they provide the College. The interface the Institute provides with industry and their desire to be philanthropic and advance the mission of patient care allows the Institute to expand mutually beneficial creative research and educational programs enhancing patient care that would otherwise not exist. This conduit provides the foundation for young scholars, leadership education, research funding, and foundational education to optimize and accelerate this process that is unprecedented. You have a strong interest in clinical research and have been involved in various studies over the years. With the ACG Institute issuing more than $2 million in research grants, why is the College's investment in this area important from your perspective? I am a believer and advocate that clinical research ideally should be conducted by clinicians in practice in conjunction with academic centers and industry to provide real world clinical trials and data for all patients. There is an unmet need to conduct clinical trials representing all members of our patient population and some needs that may not be economically attractive to industry. This has resulted in tremendous misalignment of research conducted and/or incomplete populations being studied leading to less effective treatment outcomes. The ACG Institute provides funding and opportunity to bring together industry, academics, and practicing clinicians to study areas and conduct trials representing our diverse racial, ethnic, economic, and demographic population. College committees continue to be very active in terms of developing new programs and resources while enhancing the ones that already exist. What would you like the membership to know about the ACG committees? I have been involved with the ACG for decades as a presenter, lecturer, member or chair of various committees, etc. It was not until these past 2 years as

President-Elect and President that I have been able to spend more time with our committees and witness first-hand the magnitude of personal dedication and work of all the committees in providing the ever evolving needs of our ACG members and our patients with educational programs, materials, journals, and resources. In addition, our committees, together with the Board of Governors, provide the College with a laboratory for new ideas, talent, and future leaders. Speaking personally, humbly, and with deepest respect, our members would have no concept of the arduous tasks performed by our committees. Among the opportunities you have had this year is participation in many of the educational programs put on by the College. Coming from Charlottesville, VA, you are obviously familiar with the long and fruitful partnership the College maintains with the Virginia Gastroenterological Society. As an experienced private practitioner, can you talk a bit about your impressions of ACG’s educational offerings? Firstly, I would like to say that the collaboration of the ACG with regional state societies can be no better exemplified than that of the Virginia Gastroenterological Society! This meeting and partnership have become a hallmark held within a landmark that includes physicians, APPs, nurses, endoscopy techs, industry, and world class experts that has been most successful and a template. In addition, I would like to add that the ACG has been visionary in our mission of bringing this degree of educational programing to our members with all our regional meetings and our focus on Hepatology, IBD, Functional GI, and Endoscopy Schools. The nature of clinical practice has changed profoundly due to increased pressures on physicians related to a whole host of issues including, but not limited to, business, liability concerns, regulatory oversight, and even patient access to information—both good and bad. Many of these things conspire to squeeze out time that was traditionally spent between a physician and patient. Now that your added role is administrative in a health system, what are your thoughts about this and the role of the College vis a vis supporting the membership during these challenging times? As COVID has propelled the transition of private practice from a cottage industry to consolidation through partnership or employment, we are rapidly in unprecedented times. Succinctly, this change is being catalyzed by the multifactorial inability of practices to self-capitalize. The processes of adding ancillary income and practice efficiencies such as ambulatory endoscopy, anesthesia, infusion, in contrast to how diagnostics have almost become marginalized due to reimbursement cuts, rapid overhead costs, insurance preauthorization, staffing difficulties etc. is concerning. This has equated to inability to rely on cost shifting to afford seeing Medicaid and Medicare patients. These reasons for seeking consolidation and the outcome of inevitable intended and unintended consequences need to be studied and hopefully understood to identify the potential benefits or

6 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

caveats affecting patient care. The ACG has a role to play in helping our members and/or consolidated groups, as well as training programs, in the aforementioned areas to compile data and study this phenomenon that will be paramount in the next few years. This year, you have had several opportunities to represent the College and, importantly, our members’ patients at public events focusing on important policy issues such as increasing colon cancer screening, especially in younger patients, and the battle against UnitedHealthcare’s introduction of prior authorization for GI procedures. Why did you decide to step away from your practice to participate and what does the College’s engagement on these issues mean to you? I see my role and responsibility as ACG President and as a physician is to set an example for our members and trainees to become more involved with our patients, not only as their clinicians but also their advocates. My most personally enlightening moments have been standing with patients on the great lawn of the National Mall in Washington, DC, and at United Healthcare’s corporate headquarters in Minnesota listening to patient stories of their lives being affected by not only their devastating diseases and not only by their inability to determine their own care choices, but also by their sense of not even being heard. I heard repeatedly their appreciation for my presence which represented my caring enough to take my time to hear them. This made me realize that we need to do a better job at being our patients’ advocates. I would not have had that experience were it not for the ACG. And it has raised my awareness and resolve for the role the ACG plays in the meaning of advocacy. Has your term as President provided you with any unique insight into the College that you would like to share with the membership? Like many of my predecessors, and especially Dr. Samir Shah, seeing the ACG as not only a society but our “professional home,” I have come to add my own dimension to his rubric. For those in academic institutions, an integral part of professional recognition in this sphere is promotion, advancement, and titles, which those of us in private practice generally don’t experience. While the relevance of such recognition can be debated, it goes without saying that there is no greater feeling of validation than being recognized in your own home. For me, I have had that gratification many times over with the ACG, but I most humbly admit, experiencing the presidency this year has truly been an honor coming from my ACG family! I can only hope I was worthy! Are there any words of wisdom you would like to share with Dr. Leighton as he prepares to take up the role of ACG President for the next year? The wisdom and formula I share with Dr. Leighton is to expect the unexpected, the necessity for rationale plasticity, the prudence of timing, a large aliquot of the ACG Board of Trustees, the sagacity of Brad Stillman, and the swaddling of the ACG staff!


YOUR PATIENTS FROM SUBSEQUENT C. DIFF* RECURRENCE VOWST—the FIRST and ONLY orally administered microbiome therapeutic to prevent C. diff* recurrence1,2

VOWST provided superior prevention vs. antibiotics alone1-3

88 79%






(vs. 60% of participants receiving antibiotics alone)1,2†‡



(vs. 53% of participants receiving antibiotics alone)1,3‡§

Generally well tolerated through 8 weeks1 • The majority of adverse reactions were mild or moderate in severity1 • Most adverse reactions occurred within 10 days of starting VOWST1 – The median duration of these events was ≤5 days1 • No serious adverse events were considered related to the use of VOWST1

VOWST is not authorized for sale in Canada IMPORTANT SAFETY INFORMATION

Discover more about VOWST at

*Clostridioides difficile (C. diff) infection. †Calculated by the rate of recurrence, which was significantly lower in VOWST recipients compared to those receiving antibiotics alone—12% vs. 40%, respectively—a 0.32 relative risk (95% confidence interval [CI], 0.18, 0.58; P<0.001). ‡ ECOSPOR III was a Phase 3, multicenter, double-blind, randomized, placebo-controlled trial evaluating C. diff recurrence at 8 weeks; secondary endpoints at 4, 12, 24 weeks. § Relative risk of 0.46 (95% CI, 0.30, 0.73; P<0.001). REFERENCES: 1. VOWST [Prescribing Information]. Cambridge, MA: Seres Therapeutics, Inc. and Nestlé Health Science. 04/2023. 2. Feuerstadt P, Louie TJ, Lashner B, et al. N Engl J Med. 2022;236:220–229. doi: 10.1056/NEJMoa2106516. 3. Cohen SH, Louie TJ, Sims M, et al. JAMA. Published Online: October 19, 2022. doi: 10.1001/jama.2022.16476. SERES and the Seres logo, VOWST and the Vowst logo are trademarks of Seres Therapeutics, Inc. Unless otherwise indicated, all trademarks are owned by Société des Produits Nestlé S.A., Vevey, Switzerland or used with permission. © 2023 Nestlé. VOW-PM-USA-0196 09/23

WARNINGS AND PRECAUTIONS Transmissible infectious agents: Because VOWST is manufactured from human fecal matter, it may carry a risk of transmitting infectious agents. Report any infection that is suspected to have been transmitted by VOWST to Aimmune Therapeutics, Inc. at 1-833-246-2566. Potential presence of food allergens: VOWST may contain food allergens. The potential to cause adverse reactions due to food allergens is unknown. ADVERSE REACTIONS The most common adverse reactions (reported in ≥5% of Vowst-treated participants, and at a rate greater than placebo) were abdominal distension (31.1%), fatigue (22.2%), constipation (14.4%), chills (11.1%), and diarrhea (10.0%).

DRUG INTERACTIONS Do not administer antibacterials concurrently with VOWST.

INDICATION VOWST is indicated to prevent the recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older following antibacterial treatment for recurrent CDI (rCDI). Limitation of Use: VOWST is not indicated for treatment of CDI. Click here for full Prescribing Information and Patient Information.

To report SUSPECTED ADVERSE REACTIONS, contact Aimmune Therapeutics at 1-833-AIM-2KNO (1-833-246-2566), or the FDA at 1-800-FDA-1088, or visit ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 7

NP/PA AWARD for Clinical Excellence

 THE NP/PA AWARD FOR CLINICAL EXCELLENCE recognizes a distinguished nurse practitioner or physician assistant who is an ACG Advanced Practice Provider member and has shown longstanding contributions to advancing clinical practice in the field of gastroenterology and hepatology. These efforts are demonstrated by the awardee’s substantial contributions in the areas of practice expertise, leadership, mentoring, and collaborative activities that have an impact at the state, regional, national, or international level. This award was given for the first time in 2022.

NP/PA Award (Community Practice) Terasa M. Astarita, MS, APRN, ANP-BC, BCPA

Terasa Astarita is helping to transform digestive care experiences and outcomes for the millions of Americans who struggle with GI disorders. Her impact is significant through her daily work with individual patients, in scaling access to evidence-based care via telehealth delivery, and in shaping the role of advanced practice providers (APPs) in collaborative clinical workforces. Astarita is a nurse practitioner nationally certified by the ANCC with over 20 years experience as an Advanced Practice Provider in gastroenterology and hepatology. As a founding member of the Oshi Health clinical team, Astarita shaped the pivotal role that nurse practitioners and advanced practice providers play in Oshi’s care delivery as the quarterback of an integrated, collaborative care team. Oshi Health provides high-quality research-based GI care virtually in a revolutionary care delivery organization where patients have access to a specialized team of clinicians delivering care, including often overlooked dietary and behavioral health interventions that are proven to improve outcomes in GI.

As Oshi’s clinical team grows to deliver care nationwide, Astarita models clinical excellence in the areas of intake, diagnosis, and care plan development and coordination. She serves as a leader and mentor to other advanced practice providers and all members of the Oshi Health care delivery team. As an extension of her clinical expertise, Astarita is a board-certified health advocate and a committed caregiver to her mother-inlaw. She is also a 500 RYT yoga teacher, and passionate about helping to create a healthier community through wellness initiatives and making yoga more accessible within her community. Astarita is a dedicated advocate for advancing GI care and healthcare more broadly and an active member of the ACG, as well as the American Gastroenterological Association (AGA), staying at the forefront of best practices and groundbreaking research in gastroenterology.



2023 ACG IBD SCHOOL & SOUTHERN REGIONAL POSTGRADUATE COURSE  December 1–3, 2023  Renaissance Nashville Hotel | Nashville, TN



NP/PA Award (Academic) Andrea A. Gossard, CNP

Andrea Gossard is a Certified Nurse Practitioner, an Associate Professor of Medicine and a Director of NP PA Practice at Mayo Clinic in Rochester, Minnesota. Her clinical and research interests are focused on the diagnosis and management of cholestatic and autoimme liver diseases including Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis. She is an Associate Fellow of the American Association for the Study of Liver Diseases (AASLD), member of the Governing Board and Chair of the Hepatology Associates Special Interest Group. In addition to her ACG membership, she is a member of the American Gastroenterological Association (AGA).

 March 1-3, 2024  Doubletree By Hilton New Orleans | New Orleans, LA

ACG/FGS ANNUAL SPRING SYMPOSIA  March 8-10, 2024  Naples Grande Beach Resort | Naples, FL


Gossard was one of the founding members of Gastroenterology and Hepatology for Advanced Practice Providers (GHAPP), an association led by Advanced Practice Providers (APPs) and is committed to education and professional development of APPs. She remains on the GHAPP Board of Trustees. She has a passion for advancing the NP and PA professions and has worked tirelessly on this effort as demonstrated by multiple leadership roles over nearly two decades. In her personal time, Gossard enjoys running, travel with her husband and four children, and spending time at the lake.

8 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

For more information visit:

TEXT YOUR QUESTIONS to the Moderators!

1. FIND THE CODE for your session below

Do you have a question for the moderator of a course you’re attending?

2. TEXT THE CODE AND YOUR QUESTION TO 22333 during the session 3. You MUST TEXT "LEAVE" to 22333 AT THE END OF EACH SESSION in order to participate in subsequent sessions. FOR EXAMPLE: if you have a question during Saturday’s Postgraduate Course Session 1A: Inflammation you would send a text to 22333 with the code ACGPG1A and your question.


GI Pathophysiology What’s New in GI Pharmacology Practice Management Summit Networking, Negotiating and Leadership Skills

7:00 am - 12:30 pm 1:45 pm - 5:20 pm 1:45 pm - 6:30 pm 5:45 pm - 9:00 pm

West Ballroom B West Ballroom B 109/110 212/213



Postgraduate Course Session 1A Postgraduate Course Session 1B Women in GI Luncheon PG Course Simultaneous Session A PG Course Simultaneous Session B PG Course Simultaneous Session C Postgraduate Course Session 1C

8:00 am - 9:40 am 10:30 am - 12:10 pm 12:20 pm - 1:35 pm 1:45 pm - 3:00 pm 1:45 pm - 3:00 pm 1:45 pm - 3:00 pm 3:20 pm - 5:00 pm

West Ballroom West Ballroom 223/224 West Ballroom A West Ballroom B West Ballroom C West Ballroom



Postgraduate Course Session 2A Postgraduate Course Session 2B Trainee Luncheon PG Course Simultaneous Session D PG Course Simultaneous Session E PG Course Simultaneous Session F Postgraduate Course Session 2C

8:20 am - 10:00 am 10:20 am - 12:10 pm 12:20 pm - 1:35 pm 1:45 pm - 3:00 pm 1:45 pm - 3:00 pm 1:45 pm - 3:00 pm 3:20 pm - 5:20 pm

West Ballroom West Ballroom 302-304 West Ballroom A West Ballroom B West Ballroom C West Ballroom



Presidential Plenary Session 1 Presidential Plenary Session 2 Resident Session- Navigating the GI Match Simultaneous Symposia 1A Simultaneous Symposia 1B Simultaneous Symposia 1C Plenary Session 1A Plenary Session 1B Journal Editors Roundtable Simultaneous Symposia 2A Simultaneous Symposia 2B Simultaneous Symposia 2C

8:00 am - 9:00 am 9:30 am - 10:30 am 10:30 am - 11:30 am 11:30 am - 12:45 pm 11:30 am - 12:45 pm 11:30 am - 12:45 pm 2:15 pm - 3:00 pm 2:15 pm - 3:00 pm 3:45 pm - 4:45 pm 4:45 pm - 6:00 pm 4:45 pm - 6:00 pm 4:45 pm - 6:00 pm

West Ballroom B West Ballroom B 301 West Ballroom A West Ballroom B West Ballroom C West Ballroom A West Ballroom B 211 West Ballroom A West Ballroom B West Ballroom C



Plenary Session 2A Plenary Session 2B Simultaneous Symposia 3A Simultaneous Symposia 3B Simultaneous Symposia 3C Plenary Session 3A Plenary Session 3B Simultaneous Symposia 4A Simultaneous Symposia 4B

8:30 am - 10:00 am 8:30 am - 10:00 am 11:30 am - 12:45 pm 11:30 am - 12:45 pm 11:30 am - 12:45 pm 2:15 pm - 3:45 pm 2:15 pm - 3:45 pm 5:10 pm - 6:25 pm 5:10 pm - 6:25 pm

West Ballroom A West Ballroom B West Ballroom A West Ballroom B West Ballroom C West Ballroom A West Ballroom B West Ballroom A West Ballroom B



Plenary Session 4A Plenary Session 4B Simultaneous Symposia 5A Simultaneous Symposia 5B

8:30 am - 10:15 am 8:30 am - 10:15 am 11:00 am - 12:15 pm 11:00 am - 12:15 pm

West Ballroom A West Ballroom B West Ballroom A West Ballroom B


ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 9

A Conversation with ACG’s Next President, Jonathan A. Leighton, MD, FACG (continued from page 1) importance of advancing knowledge in the clinical care of our patients to maintain quality and no one does it better than ACG. The Annual Scientific Meeting, which includes the Friday courses, the Postgraduate Course, and the scientific plenary sessions provide our membership with opportunities to learn from experts in the field and network with colleagues. Practice management is a key focus of our educational activities in the College and is critically important to our membership. The IBD, Hepatology, Functional, and Endoscopy Schools, in conjunction with the Regional Courses, are also effective ways to accomplish the same on a smaller scale. In addition to clinical gastroenterology, we are also focused on educating our leaders of the future through the ACG Institute, Edgar Achkar Visiting Professorships, and The Center for Leadership, Ethics & Equity. How do you see your institutional clinical commitments, as well as your administrative duties as Medical Director of the Office of Mayo Clinic Experience at the Mayo Clinic, balancing with your new and challenging responsibilities to the demands of the ACG presidency over the coming 12 months? It is critically important to balance my clinical and administrative commitments at Mayo Clinic in Arizona with my responsibilities at the ACG. I consider all of my commitments to be equally important. As Medical Director for the Office of Mayo Experience as well as the Office of Joy and Wellbeing, I have had a unique opportunity to better understand what is important to our patients as well as our staff. If we expect to continue to deliver great care to our patients, it is extremely important that we make sure our staff are engaged, empowered and energized. That has been an important focus of mine in my roles at Mayo Clinic. And of course, the ACG presidency year is extremely important to me and, as a result, I will reduce my clinical and administrative duties at Mayo Clinic while I serve as President. This will allow me to lead the College more effectively, attend regional meetings as much as possible, and interact with our membership to better understand what is important to them. In particular, I want to communicate closely with our Committee Chairs, as well as the Board of Governors, so I can understand what their goals and priorities are for the year, what is important to them, and support them as much as possible during my presidency. You have been focusing on how clinicians can maintain wellness and achieve greater professional satisfaction and joy in their jobs across the Mayo Clinic enterprise. Can you share what you are learning and how it may translate to your leadership role with the College? As Medical Director for the Office of Joy and Wellbeing at Mayo Clinic, Arizona, I have had the unique opportunity to understand the issues plaguing our healthcare workforce today. The healthcare sector, including gastroenterology and hepatology, have been struggling with this issue for many years. There are many factors involved, including stricter regulatory requirements, declining reimbursement, pressure to increase productivity, and the electronic health record.

This has led to increased burdens, disengagement, lower retention of staff, and burnout, which impacts our ability to develop highly functioning care teams and deliver the best care to our patients. We must focus on lessening the burden of our workforce, increasing peer support and community connections, and engaging and empowering our staff. To do this, we must look for ways to instill meaning and purpose in what we do every day to take better care of ourselves and our patients and also provide choice and autonomy for our staff. I also think that supporting our workforce through camaraderie and teamwork is key to supporting each other. Finally, we must create environments where there is physical and psychological safety that invites a diversity of ideas. Ultimately, we want everyone to feel valued, fulfilled, and supported to strive for excellence. During my presidency, I hope that we can help promote joy and wellbeing for our membership and in the practice of gastroenterology and hepatology. The Professionalism Committee has been promoting this within the College and I hope to work closely with them to look for innovative ways to reduce burnout and promote wellbeing. The ACG has an opportunity to lead in this area through its focus on education, leadership, innovation, and research.We need to promote individual and collective well-being and train our leaders in wellness-centered leadership where the emphasis is on trust, belonging, and inspiring change. We must also look for ways to reduce the burden in healthcare through more efficient and effective technology and innovative research focused in this area. Do you have any comments or advice for those interested in starting down the path toward engagement with and a potential future leadership position in the College? I would like to encourage all of our membership to get involved in the ACG. It is an amazing opportunity to enhance one’s career through education, leadership, and networking. Building connections with the right people at the right time could make the difference in taking one's career to the next level. Networking within the College can lead to an exchange of ideas and creative thinking. Most importantly, it builds relations, professional confidence, and expands visibility. It is a great opportunity to identify new mentors or become a mentor for someone who is just starting their career. Getting involved in the ACG allows all of us to attend clinical, educational, and research events in our areas of expertise. My advice is to get involved in an area that interests you, such as education, patient care, advocacy, scientific investigation, or practice management. All of these are available in the American College of Gastroenterology. The ACG committees and the Board of Governors are also an excellent way to get involved in the College. Let your curiosity lead the way and also consider what you have to offer. You have been a leader in quality measurement in GI, with a focus on IBD and the use of technologies like capsule endoscopy. How would you assess the work of the College in the area of establishing and using quality metrics effectively in clinical practice?

10 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

The ACG has been a leader in promoting quality in gastroenterology and hepatology. We have always emphasized this in the educational courses we offer throughout the year. In addition, through The American Journal of Gastroenterology, we have published many papers on quality indicators and practice guidelines as a means to improve safety, service, and outcomes in the care we deliver to our patients. The Quality Indicator papers that we have supported and published are extremely useful for our members to improve their own quality within their practices. In addition to quality indicator papers, we also have an assortment of practice guidelines to which our members have access. These highlight and promote the best practices and are authored by experts in the field. They encourage standards of care that can improve practice performance and the care that our patients receive. I also want to highlight the GI Quality Improvement Consortium (GIQuIC) in partnership with ASGE. This is a powerful quality improvement tool that is available to our members that can enhance patient care. At ACG we strive for excellence and quality in everything we do through our educational programs, research efforts, and leadership courses. I think our focus on clinical medicine and support of clinicians in practice is one of our greatest strengths as a society. The practice of medicine is in flux, both in terms of models for delivery of care and the regulatory environment in which our members practice. Tell us your thoughts on the challenges the College (and the rest of organized medicine) faces in its own programs over the coming years, and what we should look for educationally, in practice management and otherwise to help meet our members’ needs? The practice of medicine is under tremendous stress. As I mentioned earlier, this is due to many factors, including increased regulatory requirements, inefficiencies of the electronic health record, rising administrative costs, and declining reimbursement. In addition, growing patient expectations and social media have added to this burden. Access for our patients, as well as instructions for followup care, continues to be a growing problem, as does timely communication. Our healthcare workforce, like our patients, want to feel a sense of belonging, trust, and hope. Healthcare workers have felt disengaged, which leads to a lack of meaning and purpose in their mission to support each other and care for our patients. The unintended consequences of this have led to increased burnout, people working in silos, ineffective care teams, decreased retention, and healthcare workers leaving the field entirely. I believe that we must look for ways to develop highly functioning care teams that can support each other and their patients. As such, we need to think innovatively how we deal with all of these issues. We must find ways to enhance the human connection and cultivate leaders who listen effectively and create environments where individuals are motivated to excel and a sense of community flourishes. Service organizations also need to be more generous and invest in their staff. Wellbeing should be adopted as an institutional value and we need to promote

belonging, inclusion, and a diverse workforce. The College has been a leader in this area and needs to continue to innovate. We will continue our focus on legislative policy with help from the Board of Governors to address issues in reimbursement and healthcare policy. Our focus on education and practice management needs to educate our members not only on the important issues but also what the College is doing to find solutions to these problems. Ultimately, it is our responsibility to train future leaders who can help us address these challenging issues. As someone who has been involved with various international organizations, including the World Gastroenterology Organisation (WGO), among others, what do you think the College can provide to and learn from these organizations and vice versa? The world has become a global community and healthcare is no exception. On a population level, society level, and individual level, we are connected in so many ways to our global partners in medicine. As the American College of Gastroenterology, we have the opportunity to foster relationships with our international partners through education and research. We have an opportunity to collaborate and learn from these international organizations, such as the WGO, to improve quality through safety, service, and improved outcomes. We must be willing to come together and be open to diverse opinions and approaches to challenging issues in the delivery of care. By encouraging these partnerships and collaborations with our international colleagues and societies, we have a much better chance of being successful. We can all learn from each other. I do believe that a priority of the ACG should be

to look for more ways for us to engage with other international societies so that we can share innovative ways to improve the future of gastroenterology and hepatology. The ACG is already doing that, but I think there is more that we can do on the global and international stage. You have worked very closely with ACG President Dr. Dan Pambianco during this past year with a special focus on key committees and task forces. What positive role do you see for these entities and are there any challenges that are on your mind in relation to these groups? First, let me say that it has been an honor and a pleasure to work with my friend and colleague, ACG President Dr. Dan Pambianco. He has such incredible integrity and dedication to the College. He is a team player and has been extremely inclusive. He and I have been very focused on the success of our many committees. Our committees are critical to the effectiveness and overall functioning of the ACG. Our committee chairs and members are amazing individuals and also very dedicated to the mission of the College. The work that they do is so important to our success. What has been incredibly powerful is that we now have multiple committees with like-minded goals to work together to accomplish goals. This synergy has contributed significantly to the success of the College. In addition, task forces have been created to improve our focus in key areas such as environmental sustainability, international strategy, innovation and artificial intelligence. Through the synergy of committee work and taskforces, we are able to accomplish our goals more quickly and effectively.


Are there any final thoughts you would like to share with the membership as you embark upon this exciting new leadership role? It has been a great honor to serve the College over these many years. I have benefited in so many ways by my involvement with this organization. I am incredibly humbled to serve as the next President. My goal as President is to serve all of our members in every way I can so that they feel the College is addressing their needs and concerns. It is my goal to focus on the important current issues and challenges in gastroenterology and hepatology and make sure the College effectively addresses these issues with the best interest of our members in mind. I would also like to express my gratitude to the staff of the ACG for their partnership over so many years. The ACG staff led by Brad Stillman are all amazing individuals who are dedicated to the success of this organization. They are always helpful and effective, and I owe much of my success to all of them. I want to also thank the committee chairs and Board of Governors for all the work they do for the College. Finally, a big thank you to my colleagues on the Board of Trustees for their support as I take on this new important role.

In Association with


Walt Disney World Dolphin Hotel


With 2,200+ HCPs Treating IBD


With 75 Leading IBD Experts

PARTICIPATE In 100+ Educational Sessions


23.75 CME/CE Credits in Just 3 Days!


ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 11

ALL ACG 2023 COURSES will offer CME and MOC points

Earn MOC for the CME You are Already Doing —At No Additional Cost ACG is pleased to offer MOC points for all of its ACG 2023 CME courses. Attendees can earn MOC credit in

Please allow 72 hours for your MOC points to appear on your ABIM or ABP record. Contact ACG if you receive a message on the submission page that indicates an error with logging your credits or if points are not applied to your profile. ABIM Board Certified physicians with a 2023 year-end MOC deadline will need to complete their MOC submission by December 31, 2023 in order for the MOC points to count for 2022. No MOC credit will be awarded after April 30, 2024 for these activities.

the American Board of Internal Medicine’s (ABIM) and

ABP DIPLOMATES: AFTER completing your CME evaluation and

American Board of Pediatrics’ (ABP) MOC programs

submitting for CME credits for an individual course, ABP MOC can

commensurate with the number of AMA PRA Category

be claimed by emailing to obtain the required

1 Credits™ for each activity, at no additional cost or

forms for completion. ABP diplomates may NOT use the MOC link

extensive time commitment!

on the evaluation site to claim MOC points. ABP learner completion data should be submitted within 30 days of activity completion.

TO RECEIVE MOC POINTS FOR EACH COURSE, PARTICIPANTS MUST COMPLETE THE FOLLOWING STEPS: STEP 1: Complete the course evaluation at Participants who wish to receive MOC points for their participation must FIRST complete their meeting evaluation and claim the CME credit commensurate with their participation in the course. Evaluations can only be completed online at STEP 2: Access the MOC link on the evaluation site

(ABIM diplomates only) Once the CME evaluation has been submitted, the MOC link will be displayed for the course. Click the link next to the activity to complete the required assessment and submit your personal information to ACCME for the purpose of granting ABIM MOC credits. You must complete the CME evaluation and claim your CME credits prior to accessing the MOC site. MOC is available for a limited time. Attendees should complete the MOC assessment soon after the course. Full details are provided online before beginning the assessment.

12 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News




How to Care for the Changing Face of Those With Liver Disease Paul Y. Kwo, MD, FACG  Saturday, October 21  10:00 am – 10:30 am PT  West Ballroom

Join colleagues as Dr. Paul Kwo presents the David Sun Lecture on the changing epidemiology of liver disease and how to best care for the growing population of patients with MASLD, alcohol-associated liver disease, and end stage liver disease. Paul Y. Kwo, MD, FACG, is currently Professor of Medicine and Director of Hepatology at Stanford University where he joined the faculty in November 2016. Prior to joining the faculty at Stanford, he was at Indiana University for 21 years where he served as the Medical Director of Liver Transplantation. He has distinguished himself in the field of Hepatitis C therapeutics and has been the principal investigator on multiple international trials. He recently authored the ACG Clinical Guideline on Evaluation of Abnormal Liver Chemistries.

\ DAVID SUN LECTURE Saturday, October 21




\ DAVID Y. GRAHAM LECTURE Wednesday, October 25

 The David Sun Lecture, held during the Postgraduate Course, was established by Mrs. Sun in memory of her husband, Dr. David Sun, an outstanding gastroenterologist and investigator. Each year, a lecturer with a distinguished background in gastroenterology or an allied field is chosen by the ACG President subject to the approval of the ACG Educational Affairs Committee and the Board of Trustees.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 13





Identifying Innovation in Screening, Diagnosis, and Treatment

Charles N. Bernstein, MD, FACG

Amrita Sethi, MD

 Monday, October 23  3:05 pm – 3:35 pm PT  West Ballroom B

 Tuesday, October 24  10:05 am – 10:35 am PT  West Ballroom B

Join Dr. Charles Bernstein as he explores using epidemiology to inform clinical practice in the fields of gastroenterology and hepatology during Monday’s The American Journal of Gastroenterology lecture.

At this year’s J. Edward Berk Distinguished Lecture, Dr. Sethi will discuss the risk factors for pancreatic cancer as well as innovation in endoscopic methods for diagnosis and advances in management.

Dr. Charles Bernstein, a graduate from the University of Manitoba Faculty of Medicine, and the UCLA Division of Gastroenterology Fellowship Training Program, is Distinguished Professor of Medicine, Bingham Chair in Gastroenterology Research; and Director, Inflammatory Bowel Disease (IBD) Clinical and Research Centre at the University of Manitoba. His main research interests are primarily related to IBD; in terms of optimizing management approaches; exploring predictors of clinical outcomes; and disease etiology including related to the gut microbiome. Dr. Bernstein has been a pioneer in Canada in harnessing administrative health data to study chronic immune diseases and in developing a population-based database, the University of Manitoba IBD Epidemiology Database, that has both served as a model for the development of other similar databases in other provinces, as well as a unique tool to study IBD. More recently, he has been actively involved in exploring the biological and clinical intersection between different chronic immune-mediated inflammatory diseases. He has published over 680 peer reviewed articles, 29 book chapters, and is a co-editor of one of the seminal gastrointestinal clinical-pathology textbooks. As of April, 2023 his Scopus H-Index is 98 and he has had over 45,000 citations. In 2009, he was named the inaugural Bingham Chair in Gastroenterology at the University of Manitoba. In 2012, he was elected to the Royal Society of Canada -Life Sciences Division of the Academy of Science. In 2019, he was awarded the Crohn’s and Colitis Canada Research Leadership Award.

Amrita Sethi, MD, is an Associate Professor of Medicine at Columbia University Irving Medical Center in New York. She is the Director of Interventional Endoscopy and the Advanced Endoscopy Fellowship Program Director. Dr. Sethi completed her general GI fellowship at MCV in Richmond, VA, and then her advanced endoscopy fellowship at the University of Colorado. She started at Columbia in New York in 2008 and has remained there since. Her clinical practice and research interests include ERCP, cholangioscopy, therapeutic EUS, ESD, POEM, and other areas of third-space endoscopy, endoscopic innovation, and endoscopic education. Dr. Sethi has spoken extensively on these topics and served as course faculty during numerous live endoscopy courses, both nationally and internationally. She is the founder and president of Women in Endoscopy, a global organization started to foster mentorship and promote leadership for women in interventional endoscopy. She is also the Vice-Chair for AGA’s CGIT. In 2020, she was awarded the Master Endoscopist Award by the ASGE. She served as the President of the New York Society for Gastrointestinal Endoscopy in 2020 and helped to lead the NY GI community through the COVID crisis.

 The AJG Lecturer was chosen by the co-editors of The American Journal of Gastroenterology with approval from the ACG Educational Affairs Committee and the Board of Trustees.

 The J. Edward Berk Distinguished Lecturer is awarded to individuals prominent in gastroenterology or a related area. The lecturer is nominated by the ACG President, and the appointment is subject to approval by the Board of Trustees. The lectureship was established in recognition of the significant contributions made by J. Edward Berk, MD, MACG, to clinical gastroenterology during his long and distinguished clinical and academic career.

14 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News


HPV RELATED CANCERS – Are Your Patients Being Misdiagnosed?



Marcia Cross

David A. Johnson, MD, MACG

 Tuesday, October 24  4:30 pm – 5:00 pm PT  West Ballroom B

 Wednesday, October 25  10:20 am – 10:50 pm PT  West Ballroom B

Join Marcia Cross as she delivers the Emily Couric Memorial Lecture and discusses the role of the gastroenterologist and the GI care team in the recognition, diagnosis, and management of anal and other HPV related cancers. Marcia is the co-founder of the HPV Cancers Alliance, an organization that is committed to educating the public about the HPV virus and the cancers it can cause. Her own diagnosis and treatment of anal cancer inspired her to speak out to help destigmatize the shame that too often accompanies this cancer. She is fiercely dedicated to saving lives through prevention, early detection, and patient and doctor education. No one should lose their life because of this virus. As an actress, Marcia Cross is best known for her role as Bree Van de Kamp on the ABC hit series Desperate Housewives for which she was nominated for three Golden Globes and one Primetime Emmy. A graduate of The Juilliard School, she began her career doing plays at The Williamstown Theatre Festival, The Hartford Stage Company, as well as The Old Globe Theatre in San Diego where she was cast as Viola in Twelfth Night and Silvia in Two Gentlemen of Verona. She also starred in the television series Melrose Place and the critically acclaimed Everwood.

 The Emily Couric Memorial Lecture—developed by the ACG, the Virginia Gastroenterological Society, and the Old Dominion Society of Gastroenterology Nurses and Associates—is in honor of Virginia State Senator Emily Couric, who died of pancreatic cancer in October of 2001. Senator Couric was a strong advocate for health care issues, particularly in her instrumental work to pass the nation’s first legislation mandating health insurance coverage for colorectal cancer screening.

Attend Dr. Johnson’s David Y. Graham Lecture and gain a better understanding of the current associations between the intestinal microbiome and purported disease states. David A. Johnson, MD, MACG, is Professor of Medicine/Chief of GI at the Eastern Virginia School of Medicine. He has published more than 600 articles/ abstracts. He edited the books, “Sleep Effect on Gastrointestinal Health and Disease: Translational Opportunities for Promoting Health and Optimizing Disease Management” (2018), “Gut Microbiome: New Understanding and Translational Applications for Disease Management” (2015), and the ACP book “Dyspepsia,” (2008), as well as the 2005 and 2010 GI Clinics of North America series on “Obesity Issues for Gastroenterologists,” and edited the 2012 ACP module on CRC screening. He is a Past President of ACG (2006-2007). Since 2000, he has served on both the GI Multi-Society CRC Screening Task Force and ACG guidelines committee for CRC screening and has co-authored these screening guidelines and others. He has delivered multiple named lectures, including the AJG Lecture in 2005, the Emily Couric Memorial Lecture in 2010, and the J. Edward Berk Distinguished Lecture in 2015. In May 2012, he was acknowledged as invited lecturer at the National Institutes of Health as a “Great Teacher” (awarded to two non-NIH physicians each year). He has been honored by ACG as a Master of the American College of Gastroenterology, received ACG's Berk/ Fise Clinical Achievement Award in 2012 for lifetime achievements and contributions, and received the William D. Carey ACG Board of Governors Award for lifetime distinguished contributions in 2015. In 2016, Dr. Johnson received the AGA Distinguished Educator Award, and in 2018, was named Master of the ACP. He served for six years on the American Board of Internal Medicine (Gastroenterology) Board of Examiners, is currently section editor for MedScape GI, and was esophageal section editor for Journal Watch Gastroenterology (NEJM) from 2000 to 2018. From 1999 to 2000, he worked with Virginia State Senator Emily Couric to develop the historic legislation to mandate colon cancer screening, with colonoscopy as the preferred standard.

 The Graham Lecturer is chosen by the ACG President and is subject to approval by the ACG Board of Trustees. Established in 2004 in recognition of the many contributions to clinical gastroenterology made by David Y. Graham, MD, MACG, this named lectureship was made possible through a donation by Otsuka Pharmaceutical Co., Inc., and Meretek Diagnostics, Inc.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 15

Endoscopy School

HANDS-ON WORKSHOP CENTER Workshop Directors: Lauren G. Khanna, MD, MS and Christine Y. Hachem, MD, FACG

GAIN INSIGHT FROM LEADING EXPERTS and learn about the latest tools and techniques when you participate in one or more of the numerous sessions to be offered.

SUNDAY, OCTOBER 22, 2023 3:45 pm – 6:45 pm

Faculty Leader: Florence-Damilola Odufalu, MD

Foreign Body Removal

\ GI Fellows-only sessions will be offered on Monday, October 23.

Capsule Endoscopy

4:00 pm – 7:00 pm

Faculty Leader: Edith Y. Ho, MD, MS, FACG


\ Resident Training sessions will be offered on

Faculty Leader: Melissa Latorre, MD, MS

Sunday, October 22, and Monday, October 23. Please note: All Hands-on Workshop registration will be done via the meeting app; registration for a session will open in the app the day before the session. Space is limited.

MONDAY, OCTOBER 23, 2023 ERCP 10:15 am – 12:55 pm

Faculty Leader: Ahmad M. Al-Taee, MD

EMR/Polypectomy Faculty Leader: Kenneth H. Park, MD



10:30 am – 1:05 pm



7:45 am - 9:30 am

Faculty Leader: Mohit Girotra, MD, FACG Faculty: Aasma Shaukat, MD, MPH, FACG, Neal Shahidi, MD, Eric C. Lam, MD, Ashley L. Faulx, MD, FACG

Foreign Body Removal Faculty Leader: Jill K.J. Gaidos, MD, FACG Faculty: Akwi W. Asombang, MD, MPH, FACG, Julia F. Massaad, MD, FACG, Ara Sahakian, MD, Shirley C. Paski, MD

EUS 1:55 pm – 4:30 pm

2:05 pm – 4:40 pm

ERCP Faculty Leader: Vivek Kaul, MD, FACG

10:05 am – 12:45 pm

Enteroscopy Faculty Leader: Sofiya Reicher, MD, FACG

Mucosal Ablation Faculty Leader: Felice Schnoll-Sussman, MD, MSc, FACG

EMR/Polypectomy Faculty Leader: Ahmed Saeed, MD

BACK BY POPULAR DEMAND! 1:45 pm – 4:20 pm Sunday, October 22, 2023 | 4:00 pm – 6:00 pm

Hemorrhoid Therapy Faculty Leader: Waqar A. Qureshi, MD, FACG

Foreign Body Removal

Faculty Leader: Kavya Reddy, MD

16 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Hemorrhoid Therapy



Faculty Leader: Shanti L. Eswaran, MD, FACG

Faculty Leader: Ronald K. Hsu, MD, FACG Faculty Leader: Jessica L. McKee, DO

10:20 am – 12:55 pm

Monday, October 23, 2023 | 2:45 pm – 4:45 pm

ESD with the Experts Mucosal Ablation

Faculty Leader: Jianhua A. Tau, MD Faculty: Vladimir Kushnir, MD, Aimee L. Lucas, MD, FACG, Linda C. Cummings, MD, FACG, Sunil P. Amin, MD

Faculty Leader: Jennifer M. Ray, MD

Faculty Leader: Girish Mishra, MD, MS, FACG Faculty Leader: Parit Mekarookamol, MD


Monday, October 23, 2023 | 10:30 am – 12:30 pm

Hemostasis Faculty Leader: Jodie A. Barkin, MD, FACG

ERCP Faculty Leader: Ashley A. Vareedayah, MD Faculty: Prabhleen Chahal, MD, FACG, Ross C.D. Buerlein, MD, Truptesh H. Kothari, MD, MS, FACG, Venkataraman R. Muthusamy, MD, MAS, FACG

Faculty Leader: Marina Kim, DO

Faculty Leader: Charlene Prather, MD, MPH

1:55 pm – 4:30 pm

Esophageal/Anorectal Manometry Faculty Leader: Baharak Moshiree, MD, MSc, FACG

 Hands-On Endoscopy Sessions do not offer CME. Limited space available.

The 11th Annual


 Monday, October 23 |  4:45 pm – 6:00 pm |  West Ballroom C Cases Demonstrate Interesting Endoscopic Findings And Techniques Encountered In Daily Clinical Practice The Endoscopy Video Forum Symposium will feature the best video presentations submitted by colleagues from across the U.S. and around the world. Submitted during the Call for Abstracts and peer-reviewed and selected for oral presentation, the cases will feature interesting endoscopic techniques and challenging or unique cases encountered in daily clinical practice. At the end of the session, the audience, along with the judges, will vote to select the best video of ACG 2023. Moderators:


Jodie A. Barkin, MD, FACG Vivek Kaul, MD, FACG

Juan Carlos Bucobo, MD Laith H. Jamil, MD, FACG Tara Keihanian, MD Truptesh H. Kothari, MD, MS, FACG Amrita Sethi, MD C. Roberto Simons-Linares, MD

OVER THREE DOZEN ABSTRACTS SUBMITTED TO THE ENDOSCOPY VIDEO FORUM CATEGORY WERE ACCEPTED FOR POSTER PRESENTATION. To watch these videos and view their posters, visit  the ACG ePoster Hall site and  click on the Browse by Category option.

Presenting Authors are UNDERLINED Successful Endoscopic Submucosal Dissection of a Large Sessile Polyp in the Gastric Fundus Ahmed Eltelbany, MD, MPH, Amit Bhatt, MD; Cleveland Clinic, Cleveland, OH

We Innovate. We Disrupt. We Change the World of Gastrointestinal Health.

Biliary Reconstruction for High Grade Bile Leak: A Bidirectional Approach Rebecca Sullivan, MD1, Husameddin El Khudari, MD1, Ramzi Mulki, MD2, Sergio A. Sánchez-Luna, MD2, Ali Ahmed, MD2, Kondal Kyanam, MD2, Shajan Peter, MD2; 1University of Alabama at Birmingham, Birmingham, AL, 2Basil I. Hirschowitz Endoscopic Center of Excellence, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, AL


Bridging the Gap: Successful Endoscopic Ultrasound-Guided Gastrojejunostomy With a Lumen-Apposing Metal Stent Placement in the Setting of Malignant Ascites Reem Dimachkie, MD1, Shivantha Amarnath, MD1, Mohammed Shakhatreh, MD1, Jean Chalhoub, MD2, Sherif Andrawes, MD2, Youssef El Douaihy, MD2; 1Staten Island University Hospital, Staten Island, NY, 2Staten Island University Hospital, Northwell Health, Staten Island, NY

A Case of Endoscopic Repair of Tracheoesophageal Fistula With Septal Occluder Device Myunghoon Kim, BS, MD1, Abraham Mathew, MD2; 1Penn State Milton S. Hershey Medical Center, Hershey, PA, 2Penn State University, Hershey, PA


Pre-register at

ACG 2023 Scientific Meeting & Postgraduate Course Meeting ACGAnnual 2020 Annual Scientific Meeting & Postgraduate Course MeetingNews News | | 17 17



Receives the DIVERSITY, EQUITY AND INCLUSION AWARD Anita Afzali, MD, MPH, MHCM, FACG, is awarded the 2023 ACG Diversity, Equity, and Inclusion Award for her commitment to reaching underserved populations and including underrepresented minorities in clinical trials. Dr. Afzali has garnered a strong reputation for encouraging the representation of underrepresented minorities and women in GI and leverages her leadership roles to uplift others in the GI community. Anita Afzali, MD, MPH, MHCM, FACG, is Professor of Medicine at the University of Cincinnati (UC) and specializes in inflammatory bowel disease (IBD). She is also Executive Vice Chair for internal medicine and the Associate Chief Medical Officer at UC Health. Prior to joining UC, she built the first standalone multidisciplinary IBD Center at The Ohio State University and served as the center’s Medical Director. Dr. Afzali is an outcomes researcher, clinical trialist, and principal investigator of nearly 30 clinical trials. Early in her career, she recognized the poor representation of underrepresented minorities in clinical trials. While at the University of Washington Harborview Medical Center, she partnered with industry sponsors to provide appropriate educational resources for patients from all backgrounds. She then served the Crohn’s and Colitis Foundation as Chair of the IBD Disparities and Health Maintenance Steering Committee to promote research in health equity. This early work in clinical trial advocacy has evolved to her service as steering committee member of the inaugural AGA Clinical Trials Bootcamp, designed to recruit, train, and equip underrepresented minority physicians practicing in rural or underserved areas on clinical trials, to enhance patient access and increase the diversity of investigators.

As Vice-Chair of the World Gastroenterology Organisation (WGO) Publications Committee and co-editor of the WGO quarterly newsletter, Dr. Afzali has leveraged these global platforms to promote and enhance diverse perspectives in medicine. She is Chair of the ACG Educational Affairs Committee, which also allows her to promote inclusivity and engage diverse speakers and topics. She is a cofounder of IBD Horizons, a non-profit educational organization tailored to improve knowledge and standardize IBD care. Dr. Afzali has a strong commitment to the promotion of women in the field of GI and medicine. She is a global invited lecturer on gender disparities in medicine. She co-founded Scrubs & Heels, a professional network that provides leadership skills and career advancement tools for women to achieve professional success in gastroenterology. Dr. Afzali began her medical career at the University of Washington Harborview Medical Center, the largest safety net hospital in the Pacific Northwest. As a strong advocate for vulnerable and underserved populations, she developed their first multidisciplinary IBD program. She spearheaded several initiatives to improve patient access and reduce health disparities. Disease outcomes for IBD

ACG is offering


BAG STORAGE during ACG 2023

CHECK YOUR BAG and continue participating in the ACG conference before you depart Vancouver.

 Located Near ACG Registration in ROOM 107/108 SUNDAY, OCTOBER 22

7:30 am - 6:30 pm


6:30 am - 6:30 pm


7:00 am - 6:45 pm


8:15 am - 12:30 pm

18 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

patients were optimized by providing social worker and financial counseling resources, improving health literacy through hosting patient education programs and multilingual educational content, and offering free vaccination clinics. Born in Afghanistan, Dr. Afzali is a strong advocate for gender equity across the globe and uses her voice and community engagement to raise awareness and support. She completed medical school, residency, and fellowship at the University of Washington. A lifelong learner, she also obtained a Master of Public Health degree and recently a Master of Health Care Management degree for physician executive leadership and business administration from the Harvard T.H. Chan School of Public Health.

 THE DIVERSITY, EQUITY AND INCLUSION AWARD The Diversity, Equity and Inclusion Award is awarded to an ACG member, in recognition of outstanding work in the areas of clinical practice, research, teaching and/or leadership which has demonstrated an emerging or sustained commitment to the values of diversity, health equity and inclusion.

GI FELLOWS-IN-TRAINING events  These sessions are available for in-person attendees only NAVIGATING, NETWORKING, AND NEGOTIATING YOUR FIRST JOB WORKSHOP Friday, October 20 | 5:45 pm - 9:00 pm | Rooms 212/213

The ACG Women in GI Committee is hosting a program geared towards senior GI fellows and junior faculty, addressing the specifics of both the private practice and academic job search. Discussions will focus on details of private practice versus academics, contract analysis, networking skills, negotiating skills, and work-life balance. Separate breakouts for small group discussions are planned. Advance registration is required and space is limited. There is a $25 fee for this workshop. Food will be provided. Visit the Registration Desk on Level 1 for registration information, however, this event may be sold out. CAREER OPPORTUNITIES FOR WOMEN IN GI LUNCHEON Saturday, October 21 | 12:20 pm - 1:35 pm

The ACG Women in GI Committee is hosting a program geared toward residents, trainees, and junior faculty who are facing difficult decisions regarding the future of their medical careers. Female gastroenterologists from a variety of medical backgrounds will address the issues of being a female subspecialist, balancing career and family, and opportunities for women in medicine, and more specifically, gastroenterology. This program is free for ACG 2023 attendees. Advance registration is required and space is limited. Visit the Registration Desk on Level 1 for registration information, however, this event may be at capacity.



Sunday, October 22 | 12:20 pm - 1:35 pm

The American College of Gastroenterology is introducing a special session for internal medicine residents who are interested in pursuing a career in gastroenterology. Gastroenterology & Hepatology fellowship continues to be one of the most competitive internal medicine subspecialties. This session will focus on answering questions that prospective GI fellowship applicants may have. In addition, a panel of GI fellowship program directors and current GI fellows will share their experiences and tips regarding the application process.

Enjoy a special luncheon session reconnecting with colleagues and interacting directly with our panel of ACG leaders. Advance registration is required and space is limited. This luncheon is available to all trainees in gastroenterology and hepatology, and has a fee of $25. Visit the Registration Desk on Level 1 for registration information, however, this event may be sold out. ENDOSCOPY SCHOOL HANDS-ON WORKSHOP CENTER - RESIDENT-ONLY SESSIONS | Exhibit Hall (Exhibition Level) Sunday, October 22 | 4:00 pm – 6:00 pm Monday, October 23 | 10:30 am – 12:30 pm Tuesday, October 24 | 2:45 pm – 4:45 pm

Residents will be able to get hands-on endoscope training in our residents-only training sessions. Experts will be available to guide residents on the use of the scopes as they navigate tasks using the Thompson Endoscopic Skills Trainer (T.E.S.T). ENDOTITANS HANDS-ON CHALLENGE Sunday, October 22 | 5:30 pm - 7:00 pm | Exhibit Hall (Exhibition Level)

The EndoTitans Challenge is back! Join us in the Hands-On Workshop area of the Exhibit Hall to cheer on the competitors. Winners will take home both bragging rights and a travel grant for ACG 2024. The EndoTitans Challenge is sponsored by Abivax SA.



Saturday, October 21 | 5:15 pm - 7:00 pm | Rooms 109/110

Monday, October 23 | 7:45 am – 9:30 am | Exhibit Hall (Exhibition Level)

ACG’s favorite quiz show, GI Jeopardy, is back! Contestants are all current Fellows-in-Training, but all are welcome to attend the competitive final round, a spirited GI version of the television classic. The programs competing this year are: Brooklyn Hospital Center, Creighton University, Duke University, National Capital Consortium, and University of Iowa.

Monday, October 23 | 10:30 am – 11:30 am | Rooms 301-305

This free session is open to all residents attending the Annual Meeting. No pre-registration is required. HOW TO GET PUBLISHED: AN ACG JOURNAL EDITORS ROUNDTABLE Monday, October 23 | 3:45 pm - 4:45 pm | Room 211

ACG’s journal editors frequently receive questions about how best to get published, how they assess submissions, and how to best format a manuscript. In this session, the editors discuss the most commonly asked questions they receive about the publication process and share pearls of wisdom about what works—and what doesn’t—when submitting papers for publication. If you want to start or improve your publishing career, then don’t miss this valuable opportunity to hear directly from the editors who are eager to help! This session is free and open to all in-person attendees.

The always popular FREE Endoscopy School Hands-On Workshop Center sessions will again be offered in the Exhibit Hall. Expert faculty will demonstrate techniques using a wide variety of equipment and products. Attendees will then have an opportunity to practice using the equipment. Pre-registration for these GI Fellows-only sessions is required.

Be a Part of the



SATURDAY, OCTOBER 21 | 5:15 PM – 7:00 PM | ROOMS 109/110 ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 19

Seven Members



2009 and is currently a member of The American Journal of Gastroenterology Editorial Advisory Board. He has served on the faculty of multiple ACG Regional Postgraduate Courses as well as the ACG Annual Scientific Meeting. He has also been a co-author of the two most recent ACG Barrett’s Esophagus Guidelines. Dr. Falk is a Past President of the American Society of Gastrointestinal Endoscopy, and current chair of the AGA Clinical Practice Section of DDW. He is a recipient of the Sidney Cohen University of Pennsylvania GI Fellowship Teacher of the Year Award, University of Pennsylvania GI Clinical Excellence Award, AGA Distinguished Clinician Award, and AGA Imaging & Advanced Technology Section Research Mentor Award.



 Distinguished careers in gastroenterology and contributions to the College through service, leadership and education have earned seven colleagues the distinction of Master of the American College of Gastroenterology (MACG). GARY W. FALK, MD, MS, MACG Gary W. Falk, MD, MS, MACG, is currently Professor of Medicine at the University of Pennsylvania Perelman School of Medicine and Hospital of the University of Pennsylvania. He received his undergraduate and medical school training at the University of Rochester before going to George Washington University for his medical internship and residency. After a clinical and research fellowship at the University of Michigan, he was a member of the Department of Gastroenterology and Hepatology at the Cleveland Clinic from 1986-2010 before moving to Penn where he was director of the Esophageal Program from 2010 to 2023. While in Cleveland, he also received a master’s degree in clinical research from Case Western Reserve University. His clinical research has focused on Barrett’s esophagus, early detection and prevention of esophageal adenocarcinoma, and novel therapeutic strategies and natural history of eosinophilic esophagitis. He has been part of multidisciplinary NIH U54

funding in both Barrett’s esophagus and eosinophilic esophagitis over the past 10 years. Contributions of his research group include the significance of high-grade dysplasia in Barrett’s esophagus, including biopsy forceps yield and findings of unsuspected cancer at esophagectomy, the use of cytologic sampling as an alternative to biopsy-based surveillance and the development of the concept of cytology specimens as a platform for molecular based biomarker studies. Other studies in Barrett’s esophagus have focused on epidemiologic observations related to the role of Helicobacter pylori in the disease along with issues of age and gender in the development of cancer. Collaborations with other centers have led to studies on familial risk, molecular imaging paradigms, chemoprevention, radiofrequency ablation and endomicroscopy. Dr. Falk has served the ACG on multiple committees and initiatives including GI Fellows-in-Training, Research, Public Relations, GI Program Directors, Practice Parameters, Esophageal Section Abstract Selection, Annual Meeting Program Selection, and Publications. He was an Associate Editor of The American Journal of Gastroenterology from 2003-

Mahesh K. Goenka, MD, DM, MACG, is currently the Director of the Institute of Gastrosciences and Liver Transplant at Apollo Multispecialty Hospitals in Kolkata, India. He has served as editor-in-chief for the Journal of the Society of Gl Endoscopy of India for the last 10 years. He has published around 300 scientific articles and book chapters, and he is involved in collaborative works with institutions including Johns Hopkins and the University of Pittsburgh. Dr. Goenka’s contributions to gastroenterology earned him numerous honors, including Sisco-Pentax oration by the Society of Gastrointestinal Endoscopy of India, J. Mitra Award from the Indian Society of Gastroenterology, Research Fellowship by the Indian National Association for the Study of the Liver, Lifetime Achievement Award from the Association of Physicians of India, the IM Modi Award for Excellence in Medicine from the Global Association of Physicians of Indian Origin. This year at DDW, he was awarded International Service Award by the American Society of Gastrointestinal Endoscopy (ASGE). Dr. Goenka has been affiliated with ACG for the last 24 years, having been appointed as a Fellow of the College in 2003. He has served as the ACG Governor for India for the last six years, during which he was instrumental in enrolling around 1,000 physicians from India as members of ACG. He also initiated the "Best of ACG" meetings in India as course co-director and these meetings were attended by many gastroenterologists and were hugely appreciated. He was also awarded the prestigious International Leadership Award by ACG in 2020. Dr. Goenka has been a medical teacher for the last 35 years, and he has been a mentor to both national board-enrolled students and short-term trainees from all over the world, including in Europe,

20 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Africa, Bangladesh, Bhutan, and the U.S. He is Convenor of the Specialty Board of Medical Gastroenterology of India, being instrumental in policy decisions of GI training in India. He has served as the national secretary and president of the Society of Gastrointestinal Endoscopy of India, and he was also the national president of the Indian Society of Gastroenterology last year. He is an adjunct professor of gastroenterology at the Medical School of Wisconsin. Dr. Goenka has served on the international committees of ASGE and ACG. He was elected as the president of Asia-Pacific Digestive Week in 2019 and organized the largest Asia-Pacific meeting of Gastroenterology in 2019. He also serves on the Governing Council of the AsiaPacific Association of Gastroenterology and is presently co-editor of the periodical e-WGN from the World Gastroenterology Organisation.

FRANK GRESS, MD, MACG Frank Gress, MD, MACG, is an academic interventional gastroenterologist practicing in New York, NY. He completed medical school at the Icahn School of Medicine at Mount Sinai and internal medicine residency at Montefiore Medical Center in Bronx, NY, followed by a fellowship in gastroenterology at The Brooklyn Hospital and the State University of New York, Health Sciences Center & Downstate Medical Center, Brooklyn, NY, under the direction of Dr. Maurice Cerulli. After completing his GI fellowship, he went on to complete an advanced endoscopy fellowship at the Indiana University Medical Center under the mentorship of Dr. Robert Hawes. It was at IU where Dr. Gress developed his interest in the emerging technology of endoscopic ultrasound (EUS) during its early days of clinical development. He has contributed significantly to advancing the technology from a diagnostic modality to an interventional platform including describing techniques for fine needle aspiration and biopsy for sampling and celiac plexus neurolysis and block. Dr. Gress has contributed important clinical endoscopic research including emerging techniques and clinical applications for interventional endoscopy and has contributed to training guidelines and training programs for advanced endoscopy training. He has published over 100 original research articles in peer-reviewed journals, numerous invited book chapters and editorials, and has edited two highly regarded EUS textbooks: Endoscopic Ultrasonography Fourth Edition, and the Atlas of Endoscopic Ultrasonography Third Edition, to support those seeking EUS training or wishing to learn more about interventional endosonography. These

texts are recognized as important teaching resources for many trainees and advanced/ interventional fellowships. In addition, He has mentored over 60 interventional endoscopy fellows during his career and his advanced/interventional fellowship is a sought-after opportunity for fellows desiring to learn advanced endoscopy. Dr. Gress has been involved in the field of interventional endoscopy for almost 30 years with leadership roles at prestigious GI Centers of Excellence including Indiana University Hospital, Duke University Hospital, SUNY Downstate Medical Center, Columbia University Irving Medical Center, and Mount Sinai Hospital where he is now Professor of Medicine and Chief, Gastroenterology & Hepatology at Mount Sinai South Nassau, and Medical Director, Center for Interventional Endoscopy. Dr. Gress has had the honor to be invited as faculty to many national and international live endoscopy courses, as well as serving as a course director at many courses including those at his own institutions. With over 30 years of experience in the medical field, Dr. Gress has extensive clinical and research experience in interventional endoscopy, pancreatic disease, gallbladder/bile duct diseases, esophageal disorders and the endoscopic diagnosis and management of GI malignancies. Dr. Gress has participated in numerous multicenter and collaborative studies involving such areas as ERCP, interventional EUS, endoscopic resection techniques and pancreatitis and has authored papers and reviews on these topics. Dr. Gress has been an active member of many professional medical organizations for many years and has served in many leadership roles with the national GI societies and also with the American College of Physicians (ACP). In 2010, Dr. Gress served as President of the local GI society, New York Society of Gastrointestinal Endoscopy (NYSGE). He currently serves on the ACG Technology Committee and is the ACG Governor representing Long Island, NY.

KIM L. ISAACS, MD, PHD, MACG Kim L. Isaacs, MD, PhD, MACG, is Professor of Medicine at the University of North Carolina at Chapel Hill. She received her PhD in Basic Health Sciences and MD from the State University of New York at Stony Brook. She then completed internal medicine residency, chief residency, and gastroenterology fellowship at the University of North Carolina at Chapel Hill. She was the first woman gastroenterology fellow at UNC and the first woman gastroenterology faculty member at UNC in 1991. She has been very active in the clinical care of patients with inflammatory bowel disease (IBD), endoscopy, and fellow

education. She started the clinical trials program for IBD at the University of North Carolina in 1991 and was codirector of the IBD center at UNC from its inception until 2019. The UNC IBD clinical trials group has been involved with most of the major trials in drug development in ulcerative colitis and Crohn's disease over the past three decades. Dr. Isaacs was a co-author on the 2018 ACG Guideline on the Management of Crohn’s Disease in Adults. She has published multiple articles, guidelines, and book chapters on IBD. She was member, then Chair, of the ACG Practice Parameters Committee from 2010-2015. She is honored to have been a long-term mentor in the ACG mentoring program, allowing her to provide career guidance to young gastroenterologists interested in IBD. She considers her greatest accomplishment to be raising her family and has two children who are pilots in the Army and Coast Guard.

IRVING M. PIKE, MD, MACG Irving M. Pike, MD, MACG, a graduate of Emory University, received his medical school education at the Medical College of Georgia. His postgraduate training was completed in Dallas, Texas, at the University of Texas Southwestern Health Science Center, Parkland Hospital, and Dallas VA Medical Center, completing internal medicine residency in 1981 and gastroenterology fellowship in 1983. Following his training, he began practicing gastroenterology in Virginia Beach, Virginia. While practicing in Virginia Beach, Dr. Pike helped the community of gastroenterologists form Gastrointestinal and Liver Specialists of Tidewater, PLLC, a practice of over 40 physicians and providers. He served as a community faculty member for the Eastern Virginia Medical School. Dr. Pike served as Chief of Staff of Sentara Bayside Hospital and President of the Virginia Beach Medical Society. In 1986 his practice introduced office-based endoscopy to the Commonwealth of Virginia which is now the predominant form of ambulatory endoscopy in Virginia. Dr. Pike has served on the ACG’s Awards, Practice Management, and Finance Committees. He was chair of the Practice Management Committee and served as cochair of the 2005 ACG/ASGE Task Force for the Development of Quality Indicators for Gastrointestinal Endoscopy, and again as co-chair of the Task Force in 2015 for the update of these indicators. In 2007, Dr. Pike started a grassroots Benchmarking Advisory Committee which became the prototype for the GI Quality Improvement Consortium (GIQuIC), a gastroenterology quality registry which has grown to become a resource for establishing important national quality

metrics in gastroenterology and a source for important clinical research while being a tool to support the improvement of performance by more than 4,500 gastroenterologists utilizing the registry. He served as GIQuIC’s first president (2009-2017). Dr. Pike served three terms as a Trustee for the College and served in each elected officer position, including as ACG President from 2017 to 2018. He is honored to have presented the Emily Couric Lecture in 2015. Dr. Pike currently serves as ACG Trustee for Administrative Affairs. During his time practicing in Virginia Beach, Dr. Pike began working in administrative part-time roles for Sentara Health Care, eventually serving as Vice President of Medical Affairs for the hospital where he was practicing. In 2012, Dr. Pike moved to Alamo, California, to accept the role of John Muir Health’s first Senior Vice President and Chief Medical Officer. Dr. Pike retired from this role in the summer of 2021. He and Randy, his wife of 50 years, continue to reside in Alamo. Most recently, Dr. Pike serves as Co-Director of the University of California San Francisco Network Physician Leadership Academy.

RICHARD I. ROTHSTEIN, MD, MACG Richard I. Rothstein, MD, MACG, is the Chair of the Department of Medicine at DartmouthHitchcock (D-H) Medical Center (DHMC), the Senior Vice President for the Medical Specialties Service Line at Dartmouth-Hitchcock, and the Joseph M. Huber Professor of Medicine at the Geisel School of Medicine at Dartmouth. He is also the Senior Associate Dean for Clinical Affairs at Geisel and a Professor of Surgery. Dr. Rothstein is a graduate of the Boston University School of Medicine and did his internal medicine residency at the University of Massachusetts Medical Center in Worcester, MA. He pursued his fellowship training in gastroenterology at DHMC, joining Geisel’s faculty in 1985. Dr. Rothstein was Director of Gastroenterological Research and Director of the Gastrointestinal Motility Lab before becoming the Section Chief of Gastroenterology and Hepatology in 1997, a position he held for 15 years. He enjoys mentoring learners at all levels, including medical students, residents, fellows, and faculty colleagues. He was a member of the D-H Board of Governors and served on the D-H Board of Trustees. He has served as Chief Academic Officer for the Dartmouth-Hitchcock Health System. Dr. Rothstein served as American College of Gastroenterology Governor for New Hampshire from 1996 to 2002 and as a Regional Councilor. During his engagement on the Education Committee, he helped plan ACG Annual Scientific Meetings and Postgraduate Courses. He also served as Chair of CME

Accreditation while on the Education Committee. Dr. Rothstein greatly enjoyed his opportunities to teach when invited to participate in the faculty of ACG meetings and courses. In 2012, he became an inaugural member of the Academy of Faculty Master Educators at the Geisel School of Medicine. He has participated actively in national and international educational programs concerning current and future endoscopic technologies. His main areas of academic research involve endoscopic device development and therapeutic intervention for gastroesophageal reflux disease, Barrett’s esophagus, natural orifice transluminal endoscopic surgery (NOTES), and obesity. His work was at the vanguard of innovation in these areas, and he served as principal investigator for numerous clinical trials to determine the efficacy and safety of these novel technologies. He has been consistently funded in his research efforts for over 38 years and has continuously published papers, chapters, and abstracts in his areas of interest. When not engaged in his clinical or academic work, you may find him in his woodworking shop turning wooden bowls.

MICHAEL F. VAEZI, MD, PHD, MSC(EPI), MACG Michael F. Vaezi, MD, PhD, MSc(Epi), MACG, is currently a Professor of Medicine and Otolaryngology at the Vanderbilt University Medical Center in the Division of Gastroenterology, Hepatology, and Nutrition. He is the Associate Chief and Clinical Director of the Division and Director of Center for Swallowing and Esophageal Disorders and Director of Clinical Research. Dr. Vaezi served on the ACG Research Committee and the Publications Committee, which he also chaired from 2006 to 2008. He is the lead author of the ACG Diagnosis and Management of Achalasia Guideline. He is past chair of the EGD Section of the AGA and the outgoing Associate Editor for Gastroenterology and member of the AGA research Council. Dr. Vaezi received a BS degree in Chemistry at Birmingham-Southern College in Birmingham, Alabama. He then went to the University of Alabama at Birmingham and received his PhD in BioOrganic Chemistry. From there, Dr. Vaezi went to the University of Alabama School of Medicine where he received his MD degree in 1992. He completed a four-year academic residency in internal medicine in a program focused on clinical research at the University of Alabama Hospitals in Birmingham. Subsequently, he completed his fellowship in gastroenterology at the Cleveland Clinic Foundation where he was elected as the Chief Fellow. He also received a master’s degree in Epidemiology and Clinical Research from Case Western Reserve University.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 21



SYMPOSIA PROVIDE ADDITIONAL EDUCATIONAL OPPORTUNITIES FOR ATTENDEES. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. The ACG is not the continuing medical education provider of these programs, unless otherwise noted. For more information, see the company sponsor.

FRIDAY, OCTOBER 20 Mastering the Management of IBD: Challenging Cases TBD  6:00 pm – 7:30 pm |  Fairmont Waterfront Hotel Waterfront Ballroom AB The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly, as novel pharmacologic agents continue to advance the treatment of Crohn’s disease and ulcerative colitis. In this live symposium, 3 IBD experts will discuss and differentiate these new and emerging therapies, provide context for their use in clinical practice, and use patient cases to illustrate evolving concepts in risk stratification, treat-to-target approaches, and therapeutic monitoring. The symposium will be presented in a “Test and Teach” format that will pose challenging, case-based questions to the audience to explore the learner’s current knowledge and therapeutic approach, and then “teach” through them in-depth, evidence-based discussion. The program will conclude with an interactive audience Q&A session. This activity is supported by an independent educational grant from AbbVie Inc.

SATURDAY, OCTOBER 21 An Overview of Health Disparities in IBD Marla C. Dubinsky, MD; Damie Odufalu, MD  5:30 pm - 7:30 pm |  Fairmont Waterfront Hotel Waterfront Ballroom This symposium will review the definition of health disparities, provide an overview of health disparities in IBD, and present possible strategies that could help reduce barriers to health equity. This program is sponsored by Pfizer.

Eosinophilic Esophagitis: Optimizing Diagnosis and Treatment for Improved Patient Outcomes – A Wheel of Knowledge Challenge! Evan S. Dellon, MD, MPH, FACG; Nirmala Gonsalves, MD, FACG; Joy W. Chang, MD, MS; Calies Menard-Katcher, MD, MSCs  5:30 pm - 7:30 pm |  Vancouver Convention Centre East Ballroom A Don’t miss this hybrid CME/CNE/AAPA-certified symposium where expert faculty will review the pathogenesis and risk factors for EoE, the modalities and best practices for accurate diagnosis of EoE, and the most recent guidelines and clinical data that aid in the selection of optimal treatment regimens. BONUS: This program includes A Wheel of Knowledge Challenge, a highly interactive gaming segment in which your team will partner with a faculty member to compete against your peers! This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc., and Sanofi.

Expert Guidance on Harnessing New Therapeutic Approaches in Ulcerative Colitis Marla C. Dubinsky, MD; Corey A. Siegel, MD, MS  7:30 pm - 9:30 pm |  Vancouver Convention Centre East Ballroom B Join us for a CME/CE-certified program that provides expert guidance on the role of S1P receptor modulation, the implications of JAK inhibitor selectivity, and the positioning of new and approved therapies in UC treatment plans. This program is supported by an educational grant from Pfizer, Inc.

Practical Management of Variceal Bleeding and Hepatorenal Syndrome: Evidence-Based Interventions in Complications of Cirrhosis Chair: Andrew P. Keaveny, MD Faculty: Michael P. Curry, MD; Don C. Rockey, MD, FACG  7:30 pm - 9:30 pm |  Pinnacle Hotel - Harborfront Ballroom This educational program is designed to equip gastroenterologists with an in-depth understanding of two critical aspects of advanced liver disease: variceal bleeding and hepatorenal syndrome. These complications pose significant challenges in the management of patients with cirrhosis. This activity is supported by an educational grant from Mallinckrodt Pharmaceuticals.

SUNDAY, OCTOBER 22 Treatment Selection in Ulcerative Colitis: Optimizing Outcomes through Patient-Centered Decision Making Marla C. Dubinsky, MD; Bruce E. Sands, MD, MS, FACG  5:30 am - 7:30 am |  Vancouver Convention Center West - Room 301 This interactive educational program is designed to provide gastrointestinal healthcare providers with patient-centered strategies to individualize therapy selection in ulcerative colitis. Using a combination of didactic lecture and animated/video simulation case challenges, this program aims to increase clinician knowledge of the safety, efficacy, and mechanism of action of recently approved and emerging therapies; and improve their ability to incorporate the assessment of bowel urgency into management strategies for patients with ulcerative colitis. This activity is supported by an educational grant from Lilly.

Crohn’s Disease Management: The Power of “What Else? Remo Panaccione, MD, FRCPC; Millie D. Long, MD, MPH  7:30 pm – 9:30 pm |  Pinnacle Hotel – Harborfront Ballroom Join us to understand the unmet needs in patients with Crohn’s disease using a holistic approach, reexamine the “treat-to-target” approach for Crohn’s disease, and apply the power of “What else?” in your practice through a patient case discussion. This program is sponsored by Eli Lilly and Company

Building Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists Kimberly A. Brown, MD; Mazen Noureddin, MD; Alina M. Allen, MD  7:30 pm – 9:30 pm |  Fairmont Waterfront Hotel – Waterfront Ballroom C This interactive symposium aims to position gastroenterologists to improve patient care and outcomes by increasing their awareness of NAFLD/ NASH and enhancing their ability to engage patients with NAFLD in the clinical care pathway.

22 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Expert faculty will take a deep dive into late-stage clinical trials to address unmet clinical needs and the potential for new agents to address them. Gastroenterologists will benefit from reviewing the safety and efficacy data, as it will help prepare them to quickly integrate new agents into their practice when these agents become available. This activity is supported by an independent educational grant from Madrigal Pharmaceuticals.

MONDAY, OCTOBER 23 Managing Recurrent Clostridioides Difficile Infection: Advancing the Science of MicrobiomeBased Therapies Paul Feuerstadt, MD, FACG; Teena Chopra, MD, MPH; Anne J. Gonzales-Luna, PharmD, BCIDP  5:30 am – 7:30 am |  Vancouver Convention Centre East – East Ballroom A Join a panel of two expert clinicians as they discuss new and emerging microbiome-based therapies for preventing recurrent Clostridioides Difficile infection and how these agents may substantially improve patient quality of life. Earn 1.5 AMA PRA Category 1 CreditTM or 1.5 Accreditation Council for Pharmacy Education (ACPE) contact hour. Complimentary breakfast provided! Visit the Gastroenterology & Endoscopy News exhibit booth, #1714, for more information. This activity is supported by an educational grant from Ferring Pharmaceuticals, Inc.

Exclusive from Vancouver: A Spotlight on Ulcerative Colitis Experts David T. Rubin, MD, FACG; Bruce E. Sands, MD, MS, FACG; Marla C. Dubinsky, MD  7:00 pm – 8:30 pm |  Pinnacle Hotel – Cordova Ballroom Please join our expert faculty as they explore the mechanism of action (MOA), key clinical trial efficacy and safety outcomes, and patient reported outcomes (PROs) for advanced ulcerative colitis (UC) therapies. The experts will also share how they discuss MOA, efficacy, safety, as well as the impact of UC symptoms, with their patients. This program is sponsored by Eli Lilly and Company

A New Era in the Management of Gastroesophageal Reflux Disease TBD  7:30 pm – 8:45 pm |  Fairmont Waterfront Hotel – Waterfront Ballroom C Gastroesophageal reflux disease (GERD) is a highly prevalent, chronic gastrointestinal disorder that can result in serious complications if undertreated. Proton pump inhibitors (PPIs), the mainstay of GERD treatment, are generally safe and effective; however, some patients undergo PPI therapy for years but have recurrent or refractory symptoms. A new class of acid-suppressing therapies is in latestage clinical development and nearing approval. In this live, interactive townhall, expert faculty will discuss the latest evidence regarding the diagnosis and management of GERD and erosive esophagitis (EE), including new medical therapies. Faculty will use patient cases to contextualize clinical information on GERD diagnosis and management that learners can apply in their own practices. Supported by an independent educational grant from Phathom Pharmaceuticals.

ATTENDEES. These presentations provide additional educational opportunities for attendees. No CME is provided for Theater presentations. The Exhibitor Product Theater is located in booth 2319 in the Exhibit Hall.


Data Connections in Crohn’s: An Expert-Led Discussion Introducing a Treatment That Helps Deliver Clinical Remission and Endoscopic Outcomes For Adult TNFi-IR Patients With Moderate to Severe Crohn's

A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients

Remo Panaccione, MD  1:00 pm – 1:30 pm

Please join Bristol Myers Squibb for a conversation on A Treatment Option That Can Be Used Before Biologics For Your Moderate UC Patients. The presentation will include an overview of a treatment option for ulcerative colitis and key efficacy and safety data from a phase 3 clinical trial and ongoing open-label extension trial.

1. Appreciate the burden of uncontrolled disease in CD.

Case by Case: An Expert-Led Patient Case Study That Reviews a Hypothetical Patient Treated With Moderate to Severe Crohn’s

2. Introduce a treatment that helps deliver efficacy results in moderately to severely active CD, including clinical remission and endoscopic response.

Michael V. Chiorean, MD, FACG  5:30 pm – 6:10 pm

3. Examine the treatment's well-studied safety profile.

1. Examine clinical and objective treatment goals.

This program is sponsored by AbbVie.

2. Follow the journeys of patients with moderate to severe CD. 3. Review the treatment’s safety and efficacy for patients with moderate to severe CD. This program is sponsored by AbbVie.

Taking Current PBC Treatment Further Marcelo Kugelmas, MD  6:20 pm – 7:00 pm Join us for an informative presentation that discusses taking treatment for Primary Biliary Cholangitis (PBC) a step further. Learn about an approved therapy for patients with PBC.

Eosinophilic Esophagitis: Discover a Treatment Option For Your Patients Bryan G. Sauer, MD, MSc, FACG  1:45 pm – 2:15 pm Take an afternoon break with us to learn about a treatment option for your appropriate patients with Eosinophilic Esophagitis. An expert will walk us through long-term clinical data, an example of an appropriate patient, and answer your questions! This program is sponsored by Sanofi and Regeneron and intended only for US HCPs.

This program is sponsored by Intercept Pharmaceuticals, Inc.

Discover a Different Mechanism of Action to Treat Adults With IBS-C: A Case Based Discussion


Kavita R. Kongara, MD; Kimberly D. Orleck, PA-C  2:30 pm – 3:00 pm

Optimizing Management of Constipation and Abdominal Symptoms in Adult IBS-C Patients Philip S. Schoenfeld, MD, MSEd, MScEpi, FACG  10:30 am – 11:15 am Constipation and abdominal symptoms are the hallmark indicators of irritable bowel syndrome with constipation (IBS-C), a chronic and burdensome condition. Come to a clinical review to learn more about management of IBS-C in adult patients. This program is sponsored by Ironwood.

The ENTYVIO (vedolizumab) You Know With An Exciting Update Miguel D. Regueiro, MD, FACG  11:30 am – 12:00 noon An interactive presentation of the latest clinical data, dosing and administration guidance, and patient access information. Hear the ENTYVIO highlights in under 30 minutes. This program is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

NASH Explored: Emerging Concepts in Nonalcoholic Steatohepatitis Kimberly A. Brown, MD; Zobair M. Younossi, MD, MPH, FACG  12:15 pm – 12:45 pm

Please join us for an engaging discussion led by Kavita Kongara and Kimberly Orleck as they share important clinical considerations in managing adult patients with IBS-C. The presentation will include interactive patient case studies, along with efficacy and safety data from two phase three clinical trials. This program is sponsored by Ardelyx.

Rise Above Recurrent C. Difficile Infection with REBYOTA® Paul Feuerstadt, MD, FACG  3:45 pm – 4:30 pm Objectives: • Understand the microbial composition, potency, and standardized manufacturing process of REBYOTA® • Review the efficacy and safety data for REBYOTA® • Discuss the use of REBYOTA® in clinical practice This program is sponsored by Ferring Pharmaceuticals.

TUESDAY, OCTOBER 24 The Power to Help Eradicate H. pylori Infection in Adults Colin W. Howden, MD, FACG  10:35 am – 11:30 am

This session will explore several emerging concepts in NASH including: (1) epidemiology and comorbidities, (2) pathophysiology and the role of lipotoxicity in the liver, (3) morbidity and mortality, (4) patient identification and monitoring approaches, and (5) disease management strategies.

Join Dr. Colin Howden for an engaging session on a new therapeutic option in the treatment of H. pylori infection and the role of acid suppression in enhancing antibiotic effectiveness. Canadian physicians and any Canadian healthcare professionals will not have access to this event.

This program is sponsored by Madrigal Pharmaceuticals, Inc.

This product theater is sponsored by Phathom Pharmaceuticals and is not a continuing medical education program. © 2023 Phathom Pharmaceuticals

Michael V. Chiorean, MD, FACG  11:45 am – 12:15 pm

This event is sponsored by Bristol Myers Squibb, and the speaker is a paid consultant of Bristol Myers Squibb. The information contained in this product theater does not necessarily reflect the content of the approved Canadian product monograph. Only open to U.S. HCPs and AHCPs. Not intended for Canadian Audience.

Long-Term Clinical Outcomes and Safety Data in Bio-Naive Patients Anita Afzali, MD, MPH, MHCM, FACG  12:30 pm – 1:00 pm A case-based review of Stelara’s clinical results with highlights of data for bio-naïve patients. This program is developed and sponsored by Janssen Biotech, Inc.

Eosinophilic Esophagitis: Clinical Implications of Disease Progression Quan Nhu, MD, PhD  1:15 pm – 1:45 pm EoE is a chronic, type 2 inflammatory esophageal disease associated with dysphagia, regurgitation, and food impaction. Diagnostic delays may result in disease progression, including stricture formation. Join us to explore beyond symptoms and uncover the essential role endoscopy and histology play in EoE diagnosis and management. This program is sponsored by Sanofi and Regeneron and intended only for US HCPs.

The ENTYVIO (vedolizumab) You Know With An Exciting Update Bincy P. Abraham, MD, MS, FACG  2:00 pm – 2:30 pm An interactive presentation of the latest clinical data, dosing and administration guidance, and patient access information. Hear the ENTYVIO highlights in under 30 minutes.



This program is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

Bowel Urgency in Ulcerative Colitis Millie D. Long, MD, MPH, FACG; Angelina Collins, NP and Adam C. Ehrlich, MD, MPH, FACG  2:45 pm – 3:15 pm This program is sponsored by Eli Lilly and Company.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 23




R ME OR .1 SF E0 1 0 AN TR OOM R

Special Events & Exhibitors




345 352 344 353


346 351


347 350

324 325

300 301

323 326

299 302 298 303

322 327 321 328

297 304 296 305




339 358 338 359 337 360


340 357


341 356


342 355


343 354

319 330

295 306

318 331

294 307

317 332

293 308

314 335 313 336

316 333

292 309 291 310

315 334

290 311 289 312

267 286

320 329

276 277

252 253 251 254 250 255

273 280 272 281 271 282

274 279

249 256 248 257 246 259

270 283 269 284

245 260 243 262 242 263

266 287

241 264

265 288

244 261

221 236 220 237 219 238 218 239 217 240

268 285

223 234 222 235

199 210

247 258

226 231 225 232

275 278

204 205

228 229

180 181

224 233

227 230

203 206 201 208

202 207

178 183 177 184

200 209

174 187

198 211 197 212

173 188

195 214 193 216

172 189 171 190 170 191

194 215

169 192

196 213

175 186

176 185

179 182

132 133

156 157 155 158

131 134

153 160

130 135

154 159

129 136

150 163

126 139 125 140

149 164


Erbe USA

631 FODZYME by Kiwi Biosciences

627 Amgen Medical




R a

Provider Solutions & Dev by Providence


Chongqing Jinshan Science & Tech (Group) Co., Ltd

Mallinckrodt Pharmaceuticals




View the latest in clinical research with the ACG 2023 poster sessions. Colleagues will share their latest research as well as interesting cases/ clinical vignettes. Browse and visit with authors during the Exhibit Hall Opening Reception on Sunday, and the lunch breaks on Monday and Tuesday. In addition, both in-person and virtual attendees will have access to the virtual ePoster Hall during and after the meeting. ACG’s ePoster Hall allows poster authors to share their research and interesting clinical cases virtually, and visitors can submit questions directly to them. No CME is provided for poster sessions.

THE ENDOTITANS CHALLENGE Join us in the Hands-On Workshop area of the Exhibit Hall to cheer on the competitors. Winners will take home both bragging rights and a travel grant for ACG 2024.


Hone your technical skills at one of the more than 40 hands-on sessions to be offered. Experts will lead demonstrations using the latest tools and techniques. Get hands-on experience and participate in Q & A with the experts. No CME is provided for hands-on sessions.

10:05 am – 4:30 pm




CRH Medic Corpora






Tuesday, October 24

American College of Gastroenterology



Salix Pharmaceuticals Medical Affairs





Open to all ACG 2023 attendees, Exhibitor Theaters are provided by ACG exhibitors. These presentations offer additional educational opportunities for attendees. No CME is provided for Theater presentations.

10:15 am – 4:45 pm


FUJIFILM Healthcare Americas Corporation


Monday, October 23

Micro-Tech Endoscopy



EndoGIMedical Inc. Booth #515



24 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News


United Owlstone Digestive Medical

Boston Scientific




MR10 MR13


Merit Medical

Ovesco Endoscopy





Wolters Kluwer

SonoScape Adler Medical Micromed Corp


PathAI Healthcare Diagnostics

515 Endo Tools Therapeutics U.S. Corp





Ambu, Inc In

























MercyOne m El

Mindset Organon Health LLC









7:45 am – 9:30 am

151 162

128 137



MARK YOUR CALENDARS! Join colleagues at the largest social event of the meeting, Sunday, October 22, from 5:30 pm – 7:00 pm. Explore the Exhibit Hall while you enjoy hot and cold hors d’oeuvres, beer, wine, and non-alcoholic beverages. ACG thanks AbbVie for their support.

(Fellows-in-training only)

148 165

124 141



Monday, October 23

147 166

123 142

Pinnacle GI Partners


There is always plenty to see and do on the exhibit hall floor, including:

3:45 pm - 6:45 pm

146 167

122 143 121 144



Sunday, October 22

145 168

98 119 97 120








127 138

152 161

84 85

108 109 105 112

74 95 73 96

100 117

50 71 49 72

99 118

101 116

102 115

103 114

104 113

107 110

60 61

83 86 82 87 81 88

26 47 25 48

75 94

76 93

77 92

78 91

79 90

80 89

106 111

36 37

59 62 57 64 56 65 55 66 54 67

30 43 29 44

6 19 5 20 4 21

28 45

2 23 1 24



53 68

MR20 MR23

52 69

MR14 MR17

3 22


51 70

MR21 MR24

58 63

12 13 10 15

MR15 MR18

27 46



35 38

11 14

33 40 32 41

34 39

9 16 8 17

MR22 MR25

31 42

MR16 MR19

7 18


348 349



MR9 MR12

MR8 MR11

807 Biocon Biologics

Meeting Rooms





& Motility Society

• American Society for

Gastrointestinal Endoscopy

• Amgen Medical • AnX Robotica • Ardelyx • ASONxT Holdings Ltd. * • Baylor Scott & White Health • Benefis Health System • Biocon Biologics • Biological Dynamics • Boehringer Ingelheim Pharmaceuticals, Inc.

• Boston Scientific • Bristol Myers Squibb • Cairn Diagnostics • Calmoseptine Inc. • CapsoVision, Inc.* • Castle Biosciences • CDx Diagnostics • CHI Mercy Health • ChiRhoClin, Inc. • Chongqing Jinshan Science & Technology (Group) Co., Ltd

• Color of Crohn's and Chronic Illness • ColoWrap, LLC • Commonwealth Diagnostics International, Inc.*

• Community Liver Alliance • CompHealth

• Concord Hospital Medical Group • ConMed Corporation E • Cook Medical • CoxHealth • CRH Medical* • Digestive Care, Inc. • Eli Lilly and Company • Ellodi Pharmaceuticals • Endo Therapeutics, Inc. • EndoGastric Solutions • EndoGI-Medical Inc.* • EndoSoft • ERBE USA, Inc. • Essentia Health* • Evoke Pharma • Exact Sciences • ExeGi Pharma • Ferring Pharmaceuticals • FODZYME by Kiwi Biosciences • Food and Drug Administration BLACK WATER EQUIPMENT AREA E014




• FoodMarble Digestive Health • Fresenius Kabi USA, LLC • FUJIFILM Healthcare Americas Corporation

• Gastro Girl* • Gastro Health, LLC • Gastroenterology & Endoscopy News • Gastroenterology & Hepatology; The Independent Peer-Reviewed Journal

• Gemelli Biotech • Geneoscopy, Inc.* • GI Alliance • GI OnDEMAND* • GiftHealth • GIQuIC* • Good LFE LLC • GRAIL • GutChek, Inc. • Happy Colon Foods LLC




GI Alliance Pha


22'-6" W x 23'-11" H

• AbbVie • Abivax SA • Adler Micromed, Inc. • Advanced Health Solutions • Advanced Pathology Solutions • Alcresta Therapeutics • Alimetry • Ambu, Inc • American College of Gastroenterology* • American Neurogastroenterology






Eli Lilly and Co


EndoSoft 1018


1119 Endo Therapeutics




Boehringer Ingelheim Pharmaceuticals

Happy Colon Foods



EndoGastric Solutions

Intercept Pharmaceuticals

Mother to Baby Pregnancy Studies Conducted by the Organization of Teratology Information Specialists


Intercept Pharmaceuticals

Braintree-A Part of Sebela Pharmaceuticals


Procter & Cell Gamble Science

Hepatiq Nextservices Inc

Gastro Health

Gastroenterology & Endoscopy News








Modernizing Medicine

RMEI Medical Education



1404 1405

1380 1381

1403 1406 1402 1407 1399 1410 1398 1411 1397 1412 1396 1413

1372 1389 1371 1390 1370 1391

1394 1415 1393 1416

1395 1414


2335 2434


2333 2432


Food and Drug Non-Profit 2231 Administration CDER/DDI

2231 2330 World Gastroenterology Organisation


Community Liver Alliance

2229 2328



2329 2428


Int'l Foundation for Gastrointestinal Disorders

2227 2326


Phathom Pharmaceuticals





Enterra Medical

Pfizer Canada




2313 2412


Veterans Health Administration

Prometheus Labs

2311 Madrigal Madrigal Pharmaceuticals Pharmaceuticals

1209 1308



Pfizer Canada




2309 2408


2307 2406


Universal Health Srv (UHS)


Ardelyx 2201



* Virtual booth upgrade with additional company information.

SPONSORS AbbVie Abivax SA Ardelyx Biocon Biologics Bristol Myers Squibb Eli Lilly & Company

Ferring Pharmaceuticals Inc.






Sunday, October 22 3:00 pm – 7:00 pm Monday, October 23 10:00 am – 4:45 pm Tuesday, October 24 10:00 am – 4:30 pm

FUJIFILM Healthcare Americas Corporation Intercept Pharmaceuticals, Inc. Janssen Biotech, Inc. Madrigal Pharmaceuticals Nestle Health Science and Seres Therapeutics Pfizer Phathom Pharmaceuticals Regeneron & Sanofi Salix Pharmaceuticals Takeda Pharmaceuticals U.S.A., Inc.







Thank you




Hayes Evoke Locums Pharma




Northwell Essentia Health Health


• Organon LLC • Orphalan, Inc. • Owlstone Medical • PathAI Diagnostics • PE GI Solutions • Pfizer • Phathom Pharmaceuticals Gastrointestinal Disorders • Pinnacle GI Partners • Interpace Diagnostics • Precisionary Instruments LLC • InterVenn Biosciences WATERFRONT RD. Laboratories • Prometheus • IntroMedic America, Inc. • ProVation • Ipsen Biopharmaceuticals, Inc. • Provider Solutions & Development • Iterative Health • QDX Pathology Services • Janssen Biotech* • Regeneron and Sanofi • Konsyl Pharmaceuticals, Inc.* • RMEI Medical Education, LLC* • LABORIE • Rocky Mountain Gastroenterology • Locumstory • RosmanSearch • Lucid Diagnostics • Salix Pharmaceuticals • Madrigal Pharmaceuticals • Sandoz Inc. • Mahana Therapeutics • Smart Medical Systems Ltd. • Mallinckrodt Pharmaceuticals • Sonic Incytes Medical Corp. • Mayo Clinic • SonoScape Medical Corp. • Medtronic • SpeciVue* • MercyOne • STERIS Endoscopy • Merit Medical Systems • Takeda Pharmaceuticals U.S.A., Inc.* • Micro-Tech Endoscopy USA* • The Permanente Medical Group • Mindset Health* • The Rome Foundation • Modernizing Medicine • United Digestive • ModifyHealth • Universal Health Services (UHS) • Mother to Baby Pregnancy Studies • US Digestive Health Conducted by the Organization of • Vibrant Gastro Teratology Information Specialists • Weatherby Healthcare • Naturlax* • Wolters Kluwer • Nestle Health Science • World Gastroenterology Organisation • Nestle Health Science Pharma | Seres • Xillium


Madrigal Pharmaceuticals

2105 2204




2107 2206


Non-Profit 2233

2233 2332

Vibrant Gastro

2013 2112

1369 1392

1348 1365 1346 1367 1345 1368

2337 2436


The Rome Foundation


Non-Profit 2235

2235 2334

American Neurogastroenterology & Motility Society


Freeman Service Center

1400 1409

1401 1408

1356 1357

1375 1386 1374 1387 1373 1388

Janssen Biotech

1376 1385

1351 1362 1350 1363 1349 1364

2230 Commonwealth Diagnostics Int'l Inc

1347 1366

1324 1341 1323 1342 1322 1343 1321 1344

2237 2336

Non-Profit 2233


1352 1361

1327 1338 1326 1339 1325 1340


CHI Mercy Health


PE GI Solutions

1379 1382 1378 1383 1377 1384

1332 1333

1354 1359 1353 1360

1355 1358

1308 1309

1330 1335 1329 1336

1331 1334

1284 1285

1328 1337

1307 1310

1282 1287

1306 1311

1281 1288

1305 1312 1302 1315

1280 1289 1279 1290

1303 1314

1278 1291

1299 1318

1275 1294

1300 1317

1277 1292

HCA Houston Healthcare Conroe


1276 1293

1301 1316



Non-Profit 2237

1298 1319

1274 1295

Benefis Health

2033 2132


1297 1320

1273 1296

Rocky Mtn Gifthealth Gastro

Mahana Therapeutics

1304 1313

1283 1286

1236 1237 1232 1241

1256 1265

1231 1242

1255 1266

1230 1243

1254 1267

1229 1244

1253 1268

American Society for Gastrointestinal Endoscopy



Pfizer Canada

1252 1269

1228 1245

2035 2134


Non-Profit 2237

Non-Profit 2235


Takeda Pharmaceuticals U.S.A., Inc

1260 1261 1258 1263

2037 2136

2034 2032

1251 1270

1227 1246

1250 1271 1249 1272


1226 1247 1225 1248

1207 1218 1206 1219 1205 1220 1202 1223 1201 1224

1203 1222

1204 1221

1183 1194 1182 1195 1181 1196

1235 1238

1259 1262

1234 1239 1233 1240

1257 1264

1188 1189

1212 1213 1211 1214 1210 1215 1209 1216

1164 1165

1187 1190 1185 1192

1163 1166 1162 1167

1186 1191

1161 1168 1159 1170 1158 1171 1157 1172 1156 1173

1179 1198 1178 1199 1177 1200

1155 1174 1154 1175 1153 1176

1132 1149 1131 1150 1129 1152

1130 1151

1107 1126 1106 1127 1105 1128

1180 1197

1135 1146 1134 1147

1133 1148

1208 1217

1136 1145

1111 1122 1110 1123 1109 1124

1108 1125

1087 1098

1086 1099

1085 1100 1082 1103

1083 1102

1084 1101

1063 1074

1081 1104




• Hayes Locums • HCA Houston Healthcare Conroe • Healio • Hemosure, Inc. • Hepatiq Inc. • Intercept Pharmaceuticals, Inc. • International Foundation for

1184 1193

1139 1142

1116 1117 1115 1118 1112 1121

1040 1049 1039 1050 1038 1051

1062 1075

1037 1052

1061 1076 1060 1077

1036 1053 1035 1054

1058 1079 1057 1080



Janssen Biotech, Inc 1831


ASONxt holdings

Konsyl Pharmaceuticals

Takeda Pharmaceuticals U.S.A., Inc

1721 Braintree, A Part of Sebela Pharmaceuticals


1059 1078

1034 1055 1033 1056


One GI


1012 1029 1010 1031 1009 1032

Gemelli CapsoVision Biotech




1011 1030

965 980

964 981

988 1005

963 982 962 983

986 1007

961 984

985 1008

987 1006

941 956 940 957 939 958 938 959 937 960

917 932


1160 1169

1138 1143 1137 1144


1140 1141

1114 1119 1113 1120

1092 1093 1090 1095 1089 1096

1016 1025 1015 1026 1014 1027

995 998

1013 1028

968 977

992 1001

967 978

991 1002

966 979

990 1003 989 1004

944 953 943 954

942 955

923 926 920 929 919 930 918 931



Therapeutics, Inc. • Nextservices • Northwell Health • Olympus America Inc. • One GI

915 934



overhang 9'2"

916 933 914 935 913 936

Bristol Myers Squibb

Concord Hospital Medical



Exact Sciences

1068 1069

1091 1094

1066 1071 1065 1072

Iterative Health

1088 1097

1042 1047 1041 1048


Gastroenterology & Hepatology; The Independent Peer-Reviewed Journal


The Permanente Medical Grp

Salix Pharmaceuticals


1044 1045

1018 1023 1017 1024



1043 1046

1067 1070

994 999


1064 1073

970 975 969 976

993 1000

ExeGi Pharma

1429 1528


996 997

946 951 945 952


Digestive Cook Care, Inc Medical


1020 1021

922 927 921 928

899 902

875 878 872 881

896 905

871 882

895 906 894 907

868 885 867 886

891 910

824 833

870 883

893 908

869 884

890 911

892 909

866 887

889 912



Gastro Girl, 1331


1019 1022

972 973 971 974

898 903 897 904

852 853 846 859

865 888

U.S. Digestive Health

Fresenius Kabi

1433 1532

Sonic AnX Incytes Medical Robotica Corp

924 925

948 949 947 950

874 879 873 880

900 901

850 855

822 835

845 860

821 836

844 861

820 837 819 838

843 862

818 839

842 863 841 864

817 840

876 877

851 854

826 831 825 832

849 856

823 834

847 858

798 811 797 812 796 813 795 814 794 815 793 816


FoodMarble Digestive Health

848 857

800 809 799 810

774 787

756 757

828 829 827 830

802 807 801 808

804 805 803 806

778 783 777 784

780 781

755 758

779 782

754 759 753 760 752 761

776 785

751 762

775 786

750 763 749 764

773 788 772 789

748 765

771 790

747 766 746 767

770 791 769 792

731 734 728 737 727 738 726 739 725 740 724 741 723 742

1335 1434

Smart Medical


722 743


1425 1524

CDx Diagnostics

Laborie Medical Tech


721 744

Cairn Diagnostics



Ferring Pharmaceuticals

745 768

732 733

708 709

730 735 729 736

707 710

683 686

684 685 682 687

706 711

681 688

705 712 702 715

680 689 679 690

703 714

678 691

701 716

677 692 676 693 675 694

697 720

699 718

674 695

698 719

673 696

Mayo Clinic

1436 Baylor Scott & White Health





704 713

659 662

Castle Biosciences

Sandoz Inc.


Ipsen Biop harmaceut icals, Inc




Biological Dynamics



Olympus USA Inc

700 717

636 637 635 638 634 639

658 663

633 640

657 664

632 641

656 665

631 642

655 666

630 643

654 667 653 668

629 644 628 645

652 669

627 646

650 671

651 670

626 647 625 648

649 672


Ellodi Medtronic Pharmaceuticals


660 661

588 589

612 613 611 614

586 591

610 615

585 592

608 617 606 619

584 593 583 594

607 618

582 595

Alcresta Therapeutics






Abivax SA

605 620

581 596 580 597

603 622




609 616

587 590

Nestle Health Science Pharma | Seres Therapeutics


Ferring armaceuticals

579 598

InterVenn Biosciences


Precisionary Orphalan


Color of Crohn's and Chronic Illness 20'

578 599





602 623

559 570 558 571

Nestle Health Science

577 600

535 546 534 547 533 548

557 572 556 573

532 549 531 550

554 575 553 576


1033 1132

555 574

530 551 529 552

1035 1134

601 624

511 522

485 500

509 524

508 525

484 501 483 502

507 526

482 503

506 527

481 504

Lucid Diagnostics


mBIOTA lemental

505 528




461 476 459 478

458 479 457 480

Advanced Interpace Diagnostics Pathology Solutions

Regeneron and Sanofi

H cal ation

460 477

437 452

413 428 412 429

436 453 435 454 433 456

411 430 410 431

434 455

409 432



388 405 386 407

387 406

383 384

385 408


389 404


604 621

564 565 562 567

540 541

563 566

538 543

561 568

536 545

487 498 486 499

510 523

560 569

537 544

539 542

492 493

516 517 515 518 514 519

491 494 490 495 489 496

512 521

463 474 462 475

488 497

513 520

444 445

468 469

439 450

464 473

467 470 466 471 465 472

420 421 419 422

442 447 441 448

443 446

418 423 417 424 416 425 415 426

414 427

438 451

440 449

392 401



391 402


390 403


395 398


394 399




393 400

396 397


VIRTUAL EXHIBIT HALL In addition to the in-person Exhibit Hall in Vancouver, ACG 2023 added a Virtual Exhibit Hall component with new, dynamic features designed to enhance your experience, whether it’s in-person or online-only!

 Visit the virtual exhibitor

booths on the ACG 2023 Virtual Conference Platform. All attendees will have access to the Virtual Exhibit Hall until October 25, 2023.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 25


ACG Announces

2023 SCOPY AWARD WINNERS The College takes tremendous pride in the GI community’s commitment to colorectal cancer (CRC) prevention and to embracing patient education and advocacy in their local communities. Since 2015, ACG recognizes highly creative, innovative, and impactful CRC awareness efforts by ACG members with SCOPY — Service Award for Colorectal Cancer Outreach, Prevention & Year-Round Excellence.


17 winners were selected by the 2023 SCOPY Awards judges:


Tauseef Ali, MD, FACG Chair, ACG Public Relations Committee Chief, Gastroenterology Section, SSM Health St. Anthony Hospital; Clinical Assistant Professor, University of Oklahoma

Many of this year’s initiatives involve local outreach and meeting the needs of underserved members of their communities, which has been a key tenet of the SCOPY Awards since its inception. We recognize our applicants’ commitment to CRC awareness and prevention, and the time and effort they have dedicated to these important projects.

Rashmi Advani, MD, ABOM-D Icahn School of Medicine at Mount Sinai Daniela Guerrero Vinsard, MD University of Minnesota

SCOPY AWARDS FOR 2023 Best Coordinated Awareness Campaign by a Health System: Temple University Hospital, Philadelphia, PA: The Philly Colon Crusade: Powered by Temple University Health System Multidisciplinary Colon Cancer Awareness Outreach in North Philadelphia Best Coordinated Community Awareness Campaign & Health Intervention: Bristol Bay Area Health Corporation, Dillingham, AK: Endoscopy Program Revitalization Project in Rural Alaska & Colonoscopy Prep Care Packages Best Coordinated Social Media Campaign by GI Fellows & Residents: EBGI CRC Awareness Month Chairs Michelle Baliss, DO; Aileen Bui, MD; Romy Chamoun, MD; Frances Lee, MD: #EBGIvsCRC Colorectal Cancer Awareness Campaign

Best Screening Initiative with Nurse Navigation: Brown University/ Rhode Island Hospital, FIT Intervention Team, Providence, RI: Patient Navigator Pilot to Improve Completion of FIT in Primary Care SCOPY Clever & Creative Award: Gastroenterology Associates, Kingsport, TN: Door Decorating Contest for CRC Month SCOPY Consistent Creativity & Commitment Award: Allegheny Health Network, Pittsburgh, PA: We Have Your Back SCOPY Good Works Award: Trupti Shinde, MD, Crystal River, FL: Citrus Colorectal Cancer Foundation SCOPY Inspiration & Impact Award: The Faith Leader/UK Healthcare Collaborative, University of Kentucky, Lexington, KY: The Faith Leader/UK Healthcare Collaborative

Best International Effort: Vishwa M. Dayal, MD, DM; Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India: Colorectal Cancer Awareness

SCOPY Making CRC Awareness Fun Award: Association of Black Gastroenterologists and Hepatologists: Bustin' a Gut — An ABGH Community Medutainment Event


SCOPY Screening Excellence Award: Texas Tech University Health Sciences Center El Paso and University Medical Center of El Paso, El Paso, TX: Southwest Coalition for Colorectal Cancer Screening (SuCCCeS)

Best Multilingual Patient Outreach: Alicia Gorin, MS; Caesar Ferrari, BS; Julia Gonzalez Engle, BS; Ann Rutter, MD, MS, FAAFP & Micheal Tadros, MD, MPH, FACG, Albany Medical College, Albany, NY: Empowering Colorectal Health: An Integrated Multilingual Educational Approach to Colonoscopies Best Multilingual Patient Outreach: Alex Zhornitskiy, MD; Bao Sean Nguyen, MD; Christine Shieh, MD & Ronald Hsu, MD, FACG; University of California, Davis, Sacramento, CA: Lost in Translation No Longer: Expanding Patient Education Materials on Colorectal Cancer Screening to Ten Different Languages

Best Spanish Language Multi-Channel Colorectal Cancer Awareness Campaign: Latino Colorectal Cancer Indiana, Indiana University, Indianapolis, IN: Methods to Increase Colorectal Cancer Awareness in the Latino Population of Indianapolis

SCOPY Scoping the CEO & Leading by Example Award: Joan Culpepper-Morgan, MD, FACG & Mr. Georges Leconte, New York, NY: NYC Health + Hospitals/Harlem CEO Shares Colonoscopy Experience on Video to De-Stigmatize Lifesaving Procedure SCOPY Service Award: LSU Health Shreveport, Shreveport, LA: Cutting Out Cancer SCOPY Staying Strong & Scoping On Award: Sita Chokhavatia, MD, MACG & The Valley Hospital, Ridgewood, NJ: Increasing Colorectal Cancer Awareness with a Focus on Underrepresented Communities in Bergen County, New Jersey

26 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Community Service Award Presented to


For Raising Colorectal Cancer Awareness in Oklahoma and Reaching the Global IBD Community Tauseef Ali, MD, FACG, is recognized by the College for his dedication to colorectal cancer awareness and prevention in Oklahoma City. In addition to his steadfast service to the College, Dr. Ali regularly organizes and participates in local events to raise CRC awareness and ensure that the conversation about colorectal cancer screening continues. For commitment to his local community and reaching the GI community at large, Dr. Ali is the recipient of a 2023 ACG Community Service Award. Dr. Tauseef Ali is a consultant gastroenterologist and IBD specialist at SSM Health Saint Anthony Hospital, Oklahoma. He is the Executive Medical Director of SSM Health Digestive Institute and Director of the Crohn's and Colitis Center. He is a Clinical Associate Professor at the University of Oklahoma and serves as adjunct faculty at Oklahoma State University. He is a Fellow of the American College of Gastroenterology (ACG) and has served on ACG International Relations, Training, Educational Affairs, Bylaws, Membership, and Public Relations Committees. Dr. Ali has also served as ACG Governor for Oklahoma and is a member of the Board of Directors of the ACG Institute. He was awarded the ACG Junior Governor’s Award in 2018 and the Senior Governor’s Award in 2022 for his exceptional contributions and commitment to services to the Board of Governors. He is also a faculty moderator for the ACG and Crohn’s and Colitis Foundation of American (CCFA) IBD Circle, an online physician discussion forum. He regularly tweets through his educational Twitter account (@ibdtweets) and is the founder and moderator of the international social media IBD Journal Club (@ibdclub). He has been involved

in multiple social media advocacy and patient awareness programs. He has advocated for U.S. healthcare policies and founded the hashtag #respectmyprescription to share existing issues with prior authorization and denials of medications and diagnostic investigations. Dr. Ali has successfully established a multidisciplinary and comprehensive Crohn's and Colitis Center in a private health care system. For his exceptional services to the ministry and community, he was awarded the prestigious St. Luke Award by his healthcare system. His passion for IBD education in the community is also reflected by authoring a book for patients and their caregivers. His book, Crohn's and Colitis for Dummies, published by Wiley is one of the best­ selling gastroenterology books on Amazon. For the last two years, he has successfully led colon cancer awareness walks with more than 300 participants in Oklahoma. Dr. Ali has also extended his services to Pakistan, where he initiated colon cancer awareness activities at his alma mater, King Edward Medical University, with special arrangements for colon cancer lectures and kicking off a colon cancer walk in 2022. In addition, he has contributed to many ACG SCOPY submissions through

his community work and has been a leader in ACG's #RideOrStrideFor45 campaign to promote colorectal cancer awareness in March of each year. Dr. Ali graduated from King Edward Medical College in Pakistan. He completed his internal medicine residency and gastroenterology fellowship at the University of Oklahoma Health Sciences Center. He also completed a CCFA visiting IBD fellowship at the University of Chicago.

 ABOUT THE ACG COMMUNITY SERVICE AWARD The Community Service Award is bestowed upon an ACG Allied Health Member, Resident Member, Trainee Member, Member, Fellow, or Master who has initiated or has been involved in volunteer programs or has provided extensive volunteer service posttraining. The service must have been performed on a completely voluntary basis and not for the completion of training or position requirements. Such service may include but is not limited to the following: community education programs (e.g., colon cancer awareness); working in free clinics; mentoring advocacy groups or local government committees; teaching in under-served schools related to health education; and political work on committees for comprehensive health insurance or other issues.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 27

Defining and Transforming Quality in GI When physicians decided they needed a reliable way to measure adenoma detection rate, the American College of Gastroenterology (ACG) and the American Society for Gastrointestinal Endoscopy (ASGE) worked together to create GIQuIC. Although it was built in collaboration with the two societies and continues to follow their recommended guidelines, GIQuIC is a separate entity and is guided by the leadership of its own physician board.


Costas Kefalas, MD, MMM, FACP, FACG, FASGE, AGAF President and Director

Colleen Schmitt, MD, MHS, MASGE, FACG Vice President and Director

Katie Farah, MD, CPE, FASGE Director

Brett Bernstein, MD, MBA, FASGE Secretary and Director

Joseph Vicari, MD, MBA, FACG, FASGE Director

Jay Yepuri, MD, MS, FACG Treasurer and Director

Aasma Shaukat, MD, MPH, FACG, FASGE Director

Demonstrated to Improve the Quality of Patient Care

GIQuIC and the MIPS 2023 QCDR Reporting Option

Since the registry’s inception, overall adenoma detection rate across all physicians has increased from 25% in 2011 to over 40% in 2019 through 2022. The registry currently captures data for colonoscopies and EGDs and provides measure reports in order to gauge, benchmark, and improve quality.

For the tenth year in a row, CMS has approved GIQuIC as a Qualified Clinical Data Registry (QCDR) for reporting to the Merit-based Incentive Payment System (MIPS). As a result, GIQuIC participants have the option of reporting to the Quality, Promoting Interoperability, and Improvement Activities (IA) performance categories to decrease negative payment adjustments and even increase payouts. For more information about utilizing GIQuIC as a QCDR to report to MIPS or to inquire about the benefits of implementing GIQuIC as a performance benchmarking registry, visit our website at

Stay Tuned! GIQuIC is adding new clinical modules, including inflammatory bowel disease (IBD), ERCP, endoscopic bariatric therapy (EBT), wireless capsule endoscopy (WCE), and endoscopic ultrasound (EUS).

Nominating Committee Proposes

Slate of Officers and Trustees

The ACG Nominating Committee, composed of ACG Past Presidents Samir A. Shah, MD, FACG, David A. Greenwald, MD, FACG, and Mark B. Pochapin, MD, FACG, and ACG Governors Russell Cohen, MD, FACG and Jay N. Yepuri, MD, MS, FACG, met by telephone conference call on June 6, 2023 and proposed the following slate of Officers for 2023 – 2024 and the following slate of Trustees for 2023 – 2025: Nominating Committee Proposes Slate of Officers

Nominating Committee Proposes Trustees for two-year terms

OCTOBER 2023-2024

OCTOBER 2023-2025

• President: Jonathan A. Leighton, MD, FACG

• Brooks D. Cash, MD, FACG

• President-Elect: Amy S. Oxentenko, MD, FACG

• Seth A. Gross, MD, FACG

• Vice President: William D. Chey, MD, FACG

• James C. Hobley, MD, MSc, FACG

• Secretary: Nicholas J. Shaheen, MD, MPH, MACG*

• Neil H. Stollman, MD, FACG

• Treasurer: Costas H. Kefalas, MD, MMM, FACG

• Patrick E. Young, MD, FACG

*The Nominating Committee has designated Jill K. J. Gaidos, MD, FACG, to fill out the final year of Dr. Shaheen’s term as Trustee should this slate be approved by the membership and Dr. Shaheen become Secretary.

 ACG’s Secretary, Costas H. Kefalas, MD, MMM, FACG, has announced that the College’s 2023 Annual Business Meeting will be held on Monday, October 23, 2023, at 6:00 pm at the Vancouver Convention Centre in the West Ballroom B in Vancouver, BC, Canada. The Nominating Committee will present its proposed slate of officers and trustees at that time, and all Fellows and Members are encouraged to attend and to vote on this and all other items of business at the meeting. 28 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Community Service Award Presented to


For Supporting Colorectal Cancer Awareness and Prevention in Northern California

Ronald K. Hsu, MD, FACG, is recognized by the College for his commitment to colorectal cancer awareness efforts and sustained advocacy in Northern California. In addition to his engagement with state and local policymakers, Dr. Hsu organizes local events, including a collaboration with Davis Senior High School Baroque Ensemble to combine CRC messages with orchestral music. For his consistent attention to reaching Northern California communities and sharing colorectal cancer awareness and prevention messages, Dr. Hsu is a recipient of a 2023 ACG Community Service Award. Ronald K. Hsu, MD, FACG, is a Clinical Professor at the University of California Davis School of Medicine. He is the ACG Governor for Northern California and the USA (West) Regional Advisor for the Royal College of Physicians, Edinburgh, United Kingdom. He completed his gastroenterology and advanced therapeutic endoscopy fellowship at the University of California, Davis Medical Center, where he served as the Director of Endoscopy for the GI Fellowship Program and is the current Medical Director of the Sutter Roseville Endoscopy Center. Dr. Hsu has made persistent efforts to raise awareness for colorectal cancer. He has authored articles for news releases, produced animations, spoken at seminars, and given interviews to local TV and radio stations. He created the Colorectal Kid cartoon character, a mascot featured in his animation series “Breaking the Barriers.” Dr. Hsu connected two healing disciplines to aid the community during the COVID pandemic by directing the Bridging Medicine and Music Seminar and Concert in 2022. Physician experts, including ACG past presidents and governors, presented at a virtual round table. Dr. Hsu energized young musicians and performed with the Davis Senior High School Baroque Ensemble in the concert curated by his two violin mentors, music directors

from UC Davis and Davis Senior High School. This program was livestreamed to ACG members and the public. In 2023, American violinist Rachel Barton Pine endorsed Bridging Medicine and Music. Her performance was aired on cable networks and featured at the annual ACG Tune It Up virtual concert. Sutter Health also featured Dr. Hsu in an educational video highlighting the new recommendation of CRC screening starting at age 45. This year, he led a joint community event with the California Colorectal Cancer Coalition, American Cancer Society Cancer Action Network, and Fight Colorectal Cancer to host Light the Capitol Blue – An Awareness Rally to Fight Colorectal Cancer at the State Capitol in Sacramento. This event provided a tour inside an inflatable colon and displayed 5,530 blues flags in memory of the Californians projected to die from colon cancer in 2023. ACG, UCD Health, and Sutter Health endorsed the program. Dr. Hsu mentored UC Davis GI fellows to conduct a pilot project, Lost in Translation No Longer: Colorectal Cancer Screening, to increase CRC screening rate in the non-English-speaking communities in Sacramento. The project won the UC Davis GME High-Value Care Competition Award. The group also created an ACG Colorectal Cancer by

the Numbers infographics flyer in ten languages to raise public awareness. Dr. Hsu has provided free screening colonoscopies to underserved and uninsured individuals in his practice for many years. He also volunteers yearly to direct and speak at the Crohn’s and Colitis Foundation Patient and Family Education Symposium in Sacramento and Oakland. He has been program director for the CCF Regional Professional Education Symposium since 2020 and has received eight consecutive ACG SCOPY Awards.  ABOUT THE ACG COMMUNITY SERVICE AWARD The Community Service Award is bestowed upon an ACG Allied Health Member, Resident Member, Trainee Member, Member, Fellow, or Master who has initiated or has been involved in volunteer programs or has provided extensive volunteer service posttraining. The service must have been performed on a completely voluntary basis and not for the completion of training or position requirements. Such service may include but is not limited to the following: community education programs (e.g., colon cancer awareness); working in free clinics; mentoring advocacy groups or local government committees; teaching in under-served schools related to health education; and political work on committees for comprehensive health insurance or other issues.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 29


Virtual 5K Run & Onsite Fun Runs

A Special Virtual Run / Walk to Benefit ACG Summer Scholars and Celebrate Diversity JOIN YOUR ACG COLLEAGUES AND THE GI COMMUNITY FOR THE DIVERSITY IN GI VIRTUAL 5K to celebrate the diversity of the GI profession, shine a light on a critical issue in gastroenterology and medicine, and create a fun, healthy, and thoughtful event with potential for widespread social media visibility and engagement – not to mention enthusiasm from a vocal core constituency of ACG members who run! Registrants will run or walk on their own, log their activity online, take photos in race “swag” and celebrate via social media during the ACG 2023 Annual Scientific Meeting in October. The Virtual 5K is a chance for the entire GI community to show their support, get some exercise, and connect via social media in the weeks surrounding the ACG 2023 Annual Scientific Meeting (October 20–25, 2023). There is a small registration fee but thanks to generous sponsorships from Ironwood, Takeda, and Biocon Biologics, proceeds of the event will benefit the ACG Summer Scholars mentorship program for medical students and residents from groups under-represented in medicine.

HOW IT WORKS: Registrants will run or walk on their own, log their activity online, take photos in race “swag” and celebrate via social media using #DiversityinGI during the ACG 2023 Annual Scientific Meeting and through November 10, 2023.


SHARE ON SOCIAL MEDIA & CELEBRATE DIVERSITY After you run/walk wearing your #DiversityinGI 5K race tee shirt, importantly, be sure to post photos on social media! Encourage your colleagues, friends and family to participate and celebrate the diversity of the GI profession. Support this event by conveying with your words and actions how diversity drives excellence and innovation.



FUN RUN MEETUPS IN VANCOUVER: CALLING ALL RUNNERS! Plan to meet up with other avid runners for a morning run to support #DiversityinGI at the Burrard Street Entrance of the Vancouver Convention Centre West Building, under the globe.

• Saturday, October 21 at 6:45 am PT [Dr. Aasma Shaukat, Leader] • Sunday, October 22 at 6:45 am PT [Dr. Dana Lukin & Dr. Reezwana Chowdhury, Leaders]

• Monday, October 23 at 6:45 am PT [Dr. Matt McNeill, Leader] • Tuesday, October 24 at 6:45 am PT [Dr. Millie Long & Dr. Baha Moshiree, Leaders] ACG’S COMMITMENT TO DIVERSITY, EQUITY AND INCLUSION Under the leadership of ACG DEI Committee Chair Dr. Sophie Balzora—and with inspiration and commitment from numerous College leaders—ACG continues to strengthen and deepen its longstanding commitment to diversity, equity, and inclusion. ACG offers "Health Equity and DEI in Gastroenterology" educational module via the ACG Education Universe and collaborates with sister GI organizations as part of the Intersociety Group on Diversity. Through the ACG Institute, the College is proud to offer a Health Equity Resarch Award of $75,000 to fund research to produce actionable science that will translate to reducing health and/or healthcare disparities, thereby promoting health equity. This virtual 5K event celebrates the sense of inclusion, representation, and community at the center of the life of the College and offers a dose of healthy activity as we gather for the ACG 2023 Annual Scientific Meeting.

30 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Sophie M. Balzora, MD, FACG Chair, ACG Diversity, Equity & Inclusion Committee; NYU Langone Health

SIRIUSXM'S “DOCTOR RADIO” Broadcast Live from Vancouver Dr. Mark Pochapin to Host Live Broadcast Sunday, October 22nd

SIRIUSXM’S DOCTOR RADIO WILL BROADCAST LIVE FROM THE ACG ANNUAL SCIENTIFIC MEETING. ACG Past President Mark B. Pochapin, MD, FACG will host a two-hour radio show from 5:00 pm to 7:00 pm PT on Sunday, October 22, from a studio set up in the Exhibit Hall Booth #301, happening concurrently with the Opening Welcome Reception. The program will feature Dr. Pochapin in conversation with ACG leaders, special lecturers, noteworthy clinical investigators, and other special guests.

SiriusXM broadcast from ACG 2022 in Charlotte included a discussion of ACG’s Pregnancy Monograph with L to R: Aline Charabaty, MD, FACG; Baharak Moshiree, MD, MSc, FACG; Mark B. Pochapin, MD, FACG; Sunanda V. Kane, MD, MSPH, FACG

For SiriusXM’s patient audience, this discussion brought some important issues to the forefront, “Just Because They’re Common Doesn’t Make Them Easy: Management of Common GI Issues.” Guests included L to R: Amy S. Oxentenko, MD, FACG; Brian E. Lacy, MD, PhD, FACG; Dr. Pochapin; Lawrence J. Brandt, MD, MACG; William D. Chey, MD, FACG; and Kyle D. Staller, MD, MPH.

In Charlotte at ACG 2022, this group tackled, “Critical Issues in Colorectal Cancer Screening: Access; Young Onset Disease, Genetic Factors, Disparities & More!” L to R: David A. Greenwald, MD, FACG; Carol A. Burke, MD, FACG; Dr. Pochapin; Folasade P. May, MD, PhD, MPhil, FACG; and Aasma Shaukat, MD, MPH, FACG.

A distinguished group of gastroenterologists and hepatologists discussed “Show Some Gut Love and Protect Your Liver” at ACG 2022 in Charlotte via SiriusXM. L to R: Mark S. Riddle, MD, DrPH; Brooks D. Cash, MD, FACG; Dr. Pochapin; Paul Y. Kwo, MD, FACG; and A. Sidney Barritt, IV, MD, FACG.

 ON THE AIR FOR 2023! SiriusXM "Doctor Radio Live from ACG" returns to the ACG Annual Scientific Meeting with vibrant conversations and special guests. Dr. Pochapin and his producers at SiriusXM have partnered with the College to update listeners on GI health topics and share breaking news during live broadcasts from the ACG Annual Scientific Meeting starting in 2017. Doctor Radio always offers an engaging take on critical topics important to GI and liver health, touching on key science presented at the ACG meeting. The College is grateful to SiriusXM and Doctor Radio for their partnership and support. SiriusXM subscribers can listen to the show online via SiriusXM On Demand and on Doctor Radio (Channel 110). Guests for 2023 include:

• Feel the Burn: Heartburn, Barrett’s Esophagus, and EoE Evan S. Dellon, MD, MPH, FACG David A. Greenwald, MD, FACG Prasad G. Iyer, MD, MD, MSc, FACG Rena H. Yadlapati, MD, FACG

• Obesity Treatment in the Spotlight: GLP-1 Agonists and Endobariatric Approaches Jennifer Phan, MD Shelby A. Sullivan, MD, FACG Baharak Moshiree, MD, MSc, FACG Cynthia A. Moylan, MHS, MD

• “Functional” and Dysfunctional GI Disorders – New Insights, New Nomenclature, Non-Pharmacologic Treatments Darren M. Brenner, MD, FACG Lin Chang, MD, FACG David J. Hass, MD, FACG Linda Anh B. Nguyen, MD, FACG

• What’s Food Got to Do with It? Diet, GI & Liver Disorders Jasmohan Bajaj, MD, MS, FACG Claire Jansson-Knodell, MD Anthony J. Lembo, MD, FACG William K. Oelsner, MD

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 31



 Posters will be displayed in the Exhibit Hall. OVER 300 PRESIDENTIAL POSTER AWARDS IN 2023 Learn about the latest clinical research from colleagues from across the U.S. and around the world when you visit the ACG 2023 Poster Hall. Posters will be presented beginning Sunday afternoon through Tuesday. Over 300 of the more than 4,250 posters presented this year have been honored with a Presidential Poster Award. Determined by the ACG Abstract Selection Committee, approximately 7% of accepted abstracts annually receive this distinction for high-quality, novel, unique and interesting research. Listed below are this year’s Presidential Poster Award recipients, which will be recognized with a blue Presidential Poster ribbon pinned to the poster during the ACG 2023 poster sessions. Additionally, all posters will be viewable online as ePosters on the ACG 2023 Conference Platform beginning at 12:00pm (Pacific time) on Sunday, October 22 until March 31, 2024 when the platform closes. Presidential Poster Award recipients will be recognized in the ePoster Hall with a blue ribbon icon.


 Sunday, October 22  Poster viewing time: 3:30 pm – 7:00 pm

P0001. Deep Learning for Automatic Diagnosis and Morphologic Characterization of Malignant Biliary Strictures Using Digital Cholangioscopy: A Multicentric Study P0022. A “Smart ROSE” Device for Immediate Feedback on Sample Adequacy and Cancer Presence in Pancreatic Biopsies: Initial Results From a Clinical Trial With NsCanary P0059. Hepatopulmonary Fistula With Bilioptysis as a Complication of Radical Hepatobiliary Reconstruction P0088. Acute Pancreatitis as the Initial Manifestation of Undiagnosed Sarcoidosis P0096. Cutaneous Inguinal Lesion as an Initial Presentation for Metastatic Pancreatic Adenocarcinoma P0105. Mucinous Adenocarcinoma of the Gallbladder with Signet Ring Cells: A Rare Histopathological Phenomenon P0114. Biliary Ductal Dilation from Altered Anatomy and Type IV Hiatal Hernia P0140. Uncommon Complications of Acute Pancreatitis P0149. Right Hepatic Duct Intraductal Papillary Neoplasm of the Bile Duct: A Rare Cause of Obstructive Jaundice P0159. Deep Learning and High-Resolution Anoscopy: Assessing the Impact of Staining and Overcoming the Impact Therapeutic Anal Manipulation in the Automated Detection and Differentiation of Anal Squamous Cell Cancer Precursors P0162. Health-Related Quality of Life With Fecal Microbiota Spores, Live (Formerly SER-109), an Oral Microbiota Therapeutic for Recurrent Clostridioides difficile Infection: Exploratory Analysis of ECOSPOR IV P0172. ADS051, an Oral, Gut-Restricted, Small Molecule Neutrophil Modulator in Patients With Moderate-To-Severe Ulcerative Colitis: Results From a Multiple

Ascending Dose Study P0192. Predicting Recurrent C. difficile Infection in IBD Patients: An Application of AutoML Tabular and Text Classification Models on Electronic Health Records and Clinical Notes P0222. Perforation of Transverse Colon by Ventriculoperitoneal Shunt P0238. Lumen-apposing Metal Stent Drainage of Colonic Mucocele at Site of Anastomosis P0245. Spontaneous Regression of Colon Adenocarcinoma: Unraveling the Astonishing Phenomenon P0249. An Unexpected Finding of Cronkhite-Canada Syndrome (CCS) Mimicking Inflammatory Bowel Disease P0267. A Unique Presentation of Familial Idiopathic Colonic Varices P0279. An Epstein Anomaly P0289. Chilaiditi Syndrome: A Rare Case of Recurrent Chest Pain Due to Colonic Interposition P0326. Sessile Serrated Lesion Detection Rate in Individuals with Positive Fecal Immunohistochemical Test Undergoing Colonoscopy: A Systematic Review and Meta-Analysis P0356. Detection of Gastrointestinal Cancer in Individuals Without Clinical Suspicion of Cancer Using a Multi-Cancer Early Detection Test in the PATHFINDER Study P0358. Performance Evaluation of a Next-Generation Multitarget Stool DNA (mt-sDNA) Screening Test for Colorectal Cancer (CRC) P0359. Targeting the Sugar Code: Serum Glycoproteome Profiling for Early Detection of Advanced Adenoma and Colorectal Cancer P0365. Increasing Incidence of Colorectal Cancer in Younger Adults: A Population-Based Time-Trend Analysis Using the Global Burden of Diseases Database, 1990-2019 P0366. Performance of Colon and Rectal Cancer Detection with a Multi-Cancer Early Detection (MCED) Blood Test P0372. Guard Up: A Case Series of Colon Cancer Diagnoses With Negative Updated Cologuard Screenings

P0390. Efficacy and Safety of IRL201104, a Novel Peptide Immunomodulator, in a Phase 2a, Double-Blind, Placebo-Controlled Multi-Center Study in Patients With Active Eosinophilic Esophagitis P0391. Dupilumab Efficacy in Eosinophilic Esophagitis Persists for Histologic, Symptomatic, and Endoscopic Outcomes Regardless of Concomitant High-Dose Proton Pump Inhibitor Use P0392. Dupilumab Improves Dysphagia Symptoms in Adolescent and Adult Patients With Eosinophilic Esophagitis P0431. An Investigation About the Role of Stimulated and Unstimulated Saliva Cholinesterase Activity and Saliva Flow Rate in Gastroesophageal Reflux Disease vs Healthy Individuals P0457. Boerhaave Syndrome Mimicking Acute Coronary Syndrome P0477. Endoscopic Palliative In-Stent Liquid Nitrogen Spray Cryotherapy for Esophageal Adenocarcinoma P0500. Poor Consumption: A Case of Gastrointestinal Tuberculosis Mimicking Malignancy in an Immunocompromised Patient P0516. Disappearing Dysphagia and the Spontaneous Intra-Esophageal Hematoma P0522. The Gut Microbiome and Symptoms in Irritable Bowel Syndrome P0533. A Virtual Integrated Care Program Improves Patient Outcomes, Engagement, and Satisfaction at Reduced Costs: A Prospective Trial P0549. Endoscopist and Procedure-Level Factors Associated With Increased Adenoma Detection With the Use of a Computer-Aided Detection Device P0552. Predictors and Impact of Aspiration Pneumonia in Patients Undergoing Esophagogastroduodenoscopy: National Inpatient Sample 2016-2020 P0565. Prevalence of Musculoskeletal Injuries in Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis P0566. Adenoma Detection Rate After Positive StoolBased Screening and Risk of Interval Post-Colonoscopy Colorectal Cancer P0569. An Uncommon Presentation of Candy Cane Syndrome P0600. Risk of Bleeding During Percutaneous Endoscopic Gastrostomy Tube Insertion in Patients on Continued Antiplatelet Therapy: A Systematic Review and Meta-analysis P0602. Does EGD Prior to TEE Change the Incidence of Adverse Outcomes? P0629. Gastric Plexiform Fibromyxoma: A Rare Cause of Recurrent Upper GI Bleeding P0650. A Rare Cause of Upper GI Bleeding: Ampullary Dieulafoy Lesion P0656. Successful Treatment of Refractory Small Intestinal Angioectasias with Bevacizumab: A Novel Therapeutic Approach P0659. Gastric Perforation Due to Explosion Induced by Argon Plasma Coagulation P0667. Gastrointestinal Bleeding From Gastric Varices in the Excluded Stomach of a Roux-en-Y Gastric Bypass in a Cirrhotic Patient P0673. Hemorrhagic Shock as an Unusual Presentation of Mallory Weiss Syndrome: A Case Report P0676. Deep Learning and Minimally Invasive Inflammatory Activity Assessment: Development and Score Correlation of a Pan-Endoscopic Convolutional Network P0685. Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Bio-Naïve Patients With Early Crohn’s Disease: Results from the EVOLVE Expansion Study P0709. Acceptability and Preferences for Multimodal Inflammatory Bowel Disease (IBD) Self-Help Resources: Patients’ and Providers’ Perspectives P0723. Response Trajectory by the Clinical Decision Support Tool Probability Groups in Vedolizumab-Treated Patients With Crohn’s Disease: A Pooled Analysis of GEMINI 2, VISIBLE 2, and VERSIFY P0729. Efficacy and Durability of Ozanimod by Baseline Endoscopic Disease Activity in Advanced Therapy–Naive Ulcerative Colitis Patients Suboptimally Controlled on Conventional Therapies P0821. Walking on Pins and Needles: Adalimumab Induced Acute Disseminated Encephalomyelitis (ADEM) P0828. Characterization of Intraductal Papillary Muci-

32 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

nous Neoplasm Subtypes Using EUS-Guided Confocal Laser Endomicroscopy P0840. Performance Characteristics of a Novel Endoscopic Insufflator: Adapting to the Future Needs of Endoscopic Surgery P0845. Predictors of Successful Stone Fragmentation and Extraction Using Electrohydraulic Lithotripsy: A Multicentric Study P0848. Esophageal Endoscopic Submucosal Dissection in Elderly Patients Is Safe and Feasible: A Retrospective Single-Center Cohort Study in the United States P0852. Using an Endoscopic Full Thickness Resection Device to Obtain Histologically Complete Resection or Formal Staging in Patients With Previous Piecemeal Resection of Malignant Colon Polyps P0865. Choose Wisely – Location Matters When Selecting Appropriate Endoscopic Tool for Post-Operative Anastomotic Defects P0869. Endoscopic Treatment of “Rabbit Ear” Pouch P0872. First Reported Case of Endoscopic En Bloc Resection of Esophageal Liposarcoma P0873. A Rare Case of Esophageal Obstruction After Rupture of an Esophageal Duplication Cyst P0875. Endoscopic Debulking of a Large Colonic Lipoma Causing Recurrent Intussusception Using Endoscopic Mucosotomy Technique P0903. EDGE Gone Wrong! Salvaged Using a NOTESStyle Technique P0913. Comparative Analysis of Noninvasive Tests of Hepatic Fibrosis With Liver Histopathology in a Large Clinical Cohort P0936. High-Risk Alcohol Use Is Associated With Significantly Greater Risk of Incident Hepatocellular Carcinoma in a National Cohort of U.S. Veterans With Metabolic Dysfunction Associated Fatty Liver Disease P0941. Skin Glue for Prevention of Fluid Leaks Following Therapeutic Paracentesis: A Randomized Trial P0942. Explainable Artificial Intelligence Accurately Predicts High-Risk Nonalcoholic Steatohepatitis and Identifies New Subphenotypes in Lean Individuals P0956. Examination of Timing of Palliative Care Consultation in Patients With Grade 3 Acute on Chronic Liver Failure at a Large Academic Transplant Center P0957. Palliative Care Is Underutilized in Patients with Cirrhosis Admitted to the Intensive Care Unit Observations from a Large Academic Transplant Center P0999. A Rare Case of Esophageal Hepatoid Adenocarcinoma With Lung and Liver Metastases Mimicking Hepatocellular Carcinoma P1005. Hepatitis B Reactivation & Liver Failure Due to COVID-19 Infection P1013. A Diagnostic Odyssey: Congenital Portosystemic Shunt Between Left Mesenteric Vein-Superior Mesenteric Vein and Inferior Vena Cava Causing Refractory Hepatic Encephalopathy P1022. A Novel Approach in the Treatment of Entamoeba Liver Abscess P1033. A DILI-terious Response to Allopurinol: Acute Immunoallergic Hepatitis in Chronic Gout Patient P1038. Hepatic Mass in Non-Cirrhotic With Direct Extension to the Right Atrium P1045. Mechanical Thrombectomy: A Novel Approach for Portal Vein Thrombosis After Balloon-Occluded Retrograde Transvenous Obliteration P1071. When it’s Not Cirrhosis: A Case of Portal Hypertension After Neonatal Instrumentation P1095. A Case of Bilomas in Acute Sickle Cell Hepatic Crisis P1115. A Diagnostic Challenge: Differentiating Embryonal Sarcoma of the Liver from Other Hepatic Masses in an Adult Patient P1126. Herb-Induced Liver Injury Due to Ashwagandha: Unique Cases With Different Liver Injury Patterns P1134. Fulminant Liver Failure Associated With Use of Dietary Weight Loss Supplement P1178. Association of Gut Microbiome With COVID-19 Status in Children in the BRAVE Cohort P1184. Muscular Ultrasonography of the Rectus Femoris Muscle to Evaluate for Sarcopenia is Correlated With PELD/MELD Score in Children P1185. Solid Pseudopapillary Tumor of the Pancreas: A Rare Cause of Acute Abdomen in Teenage Girl P1187. Dupilumab in Fibrostenotic Pediatric-Onset

Eosinophilic Esophagitis - It Has a Nice Ring to It P1189. Why so Glum? A Case of a Pediatric Gastric Glomus Tumor P1193. Improvements in Colonoscopy Bowel Preparation Quality and Procedure Completions Following Introduction of a Full-Time Patient Navigator P1199. The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis P1205. Examining the Impact of a GI Hospitalist Model on the Outcomes of Double Balloon Enteroscopy: A Single Center Retrospective Study P1220. Refining Patient Care in Cyclic Vomiting Syndrome: Enhancing Quality Through Implementation of a Guideline-Based Approach in the Emergency Department P1222. "Open Table" Approach for Colonoscopy Direct Patient Self Scheduling via Patient Portal: A Pilot Program P1223. Understanding the Landscape: The Emergence of AI, ChatGPT, and Google BARD in Gastroenterology P1227. Improved Timely Documentation and Chart Encounter Closure Rates With the Implementation of a Validated Quality Improvement Process in the Division of Gastroenterology and Hepatology P1242. Reducing Inappropriate PPI Use Among the Veteran Population Using a Two-Step Process P1249. Rising Incidence and Poor Survival of Enteropathy-Associated T-Cell Lymphoma P1250. Characteristics and Associations of Celiac Disease in Minorities P1256. Prevalence and Symptoms of Disaccharidase Enzyme Deficiency in Adult Patients with Unexplained Gastrointestinal Symptoms P1294. Alpha Gal Syndrome-Induced Vasculitis P1327. Peripheral Neuroectodermal Tumor Found in the Duodenum P1333. A Case of Gastrointestinal Alpha Heavy Chain Disease With Persistent Campylobacter jejuni Colonization and Refractory Giardiasis P1336. More Than You Can Swallow: Mycotic Aneurysm, an Uncommon Etiology of Dyspepsia P1383. Gastro-gastric Fistula and Gastro-pericardial Fistula Presenting as Pneumopericardium and Pericarditis in a Patient with Roux-en-Y Gastric Bypass and NSAID Abuse P1402. Gastric Kaposi Sarcoma: An Underdiagnosed Entity in HIV Patients P1405. An Unexpected Connection: A Rare Case of Gastrosplenic Fistula in Diffuse Large B-Cell Lymphoma

 Monday, October 23  Poster viewing time: 10:30 am – 4:15 pm

P1421. Deep Learning and Endoscopic Ultrasound: Automatic Characterization of Pancreatic Cystic Lesions - A Bicentric Study P1435. Computerized Tomography Volumetric Analysis of Pancreatic Fluid Collections Is Predictive of Need for Step-Up Therapy and Re-Intervention P1440. Development of a Model to Predict Post-Acute Pancreatitis Diabetes P1446. Comparing the Performance of Revised International Consensus Guidelines, Manual and Artificial Intelligence Interpretation of Needle-Based Confocal Endomicroscopy in Predicting Advanced Neoplasia of IPMNs P1456. Progression from Recurrent Acute to Chronic Pancreatitis During Long-Term Follow-Up of Up to 22 Years in a Well-Defined North American Cohort P1487. A Rare Phenomenon: Acute Cholecystitis Presenting as Acute Inferior STEMI P1504. Endoscopic Management of a Bronchobiliary Fistula With EUS-Guided Hepaticogastrostomy in the Setting of a Complex Postsurgical Anatomy P1517. An Elusive Cholangiocarcinoma Mimic: Primary Biliary Tuberculosis P1541. A Twisted Tale of Intractable Vomiting: The Wandering Spleen P1553. Wriggling Biliary Crisis: A Roundworm-Induced Cholangitis Chronicle P1582. Tumor Microenvironment Analysis in Metastatic

Sites of Colorectal Cancer P1597. Tenapanor Can Improve Abdominal Symptoms Independent of Changes in Bowel Movement Frequency in Adult Patients with IBS-C P1598. Probiotics Counterfeit! Study Finds Most Labels Mislead Customers P1605. Surveillance of Frameshift Neoantigen-Specific T Cells During Tumor Development in Patients with Lynch Syndrome and Mismatch Repair Deficient Colorectal Cancer P1609. Water Exchange Colonoscopy Decreased Right Colon Serrated Polyp Miss Rate: A Multicenter Prospective Randomized Tandem Study P1626. A Near Miss: Failure of the Inpatient Prep P1640. Perianal Mpox Infection in a Patient Without Risk Factors or Exposure P1648. Lyme Disease Manifesting as Inflammatory Bowel Disease P1651. Brain and Adrenal Metastasis Resulting from Unexpected Recurrence After Endoscopic Resection of Low-Risk T1 Colon Cancer: A Case Report P1701. From Breast to Bowels : A Rare Presentation of Colonic Metastasis of Primary Breast Cancer P1718. Multitarget Stool DNA Test is Not a Substitute for Colonoscopy After Diverticulitis - A Case Report P1722. When it Is Not Adenocarcinoma: Primary Squamous Cell Carcinoma of the Ascending Colon Presenting as Unexplained Iron Deficiency Anemia P1737. Appendiceal Adenocarcinoma Presenting as Bilateral Breast Masses P1745. Evaluation of Computer Aided Detection During Colonoscopy Among Veterans: A Randomized Clinical Trial P1755. Precancerous Colonic Polyps and Colorectal Cancer in Patients Under 45 Years P1772. Surveillance Colonoscopy After Endoscopic Resection of Large Laterally Spreading Tumors (≥20 mm) Detects High-Risk Synchronous Lesions P1777. Implementing an Organized Colorectal Cancer Screening Program Across a Large Health System P1779. Statewide Burden of Colorectal Cancer and Its Attributable Risk Factors Across the United States Between 1990-2019: A Systematic and Comparative Benchmarking Study P1805. Successful Flexible Endoscopic Septotomy for the Treatment of Zenker’s Diverticulum After Failed Surgical Attempts P1808. Diagnostic Potential of Salivary Bile Acid for Laryngopharyngeal Reflux P1812. Dual Release Gastro-Resistant Pantoprazole 80mg for Treatment of Partial or Non-Responders to Standard Dose of Proton Pump Inhibitor in Gastroesophageal Reflux Disease – A Prospective pH-Metry/ Impedance-Controlled Study P1818. Artificial Intelligence and Capsule Panendoscopy: Development of a Convolutional Neural Network for the Automatic Detection of Pleomorphic Esophageal Lesions P1832. A Multicenter Retrospective Evaluation of the Clinical Performance and Safety of an Enhanced 16 Fr CryoDecompression Tube for Use in Liquid Nitrogen Spray Cryotherapy P1857. Addressing Diagnostic Dilemmas in Eosinophilic Esophagitis Using Esophageal Epithelial Eosinophilic-Derived Neurotoxin P1877. A Rare Case of Metachronous Squamous Cell Carcinoma of the Esophagus After Resolution of Prior Adenocarcinoma P1881. Beyond the Bone Marrow: Uncommon Manifestation of Multiple Myeloma - A Case Report of Extramedullary Esophageal Involvement P1897. A Cruel Jest to Be Unable to Ingest: A Case of Multi-Factorial Dysphagia P1899. Diffuse Esophageal Hyperkeratosis: What? How? Why? P1910. Adapting an Endoscopic HeliX Tacking System to Serve as Fiducial Markers in Esophageal Malignancy P1912. Navigating the Narrow Path: Chronic Benign, Severe Esophageal Strictures in a Patient With Acquired Immune Deficiency Syndrome P1913. Plummer-Vinson Syndrome: A Rare Sequela of Roux-En-Y Gastric Bypass Highlighting the Importance of Close Monitoring for Years After Surgery P1923. Proximal Esophageal Rupture Secondary to

Sexual Assault P1941. Effects of COVID-19 in Patients With Gastroparesis: An Analysis of Patients in the NIH Gastroparesis Registry P1950. Combined Oral Contraceptives Are Associated With Increased Risks of Developing Irritable Bowel Syndrome P1977. Higher Rates of Endoscopic Mucosal Resection (EMR) in Colonoscopy Following Positive Stool Test vs Average Risk Screening P2022. A Syndrome of Diarrhea, Anasarca, and Nail Dystrophy: A Curious Case of Cronkhite-Canada Syndrome P2035. Gastrointestinal Bleeding Episodes Following Aortic Valve Replacement in Heyde’s Syndrome: A Large Scale Database Study Using TriNetX P2038. Safety and Efficacy of Continuous vs Intermittent Terlipressin for Acute Esophageal Variceal Bleeding - A Systematic Review and Meta-Analysis of Randomized Controlled Trials P2045. Is My Patient Bleeding? A Prospective Clinical Trial of a Novel Swallowed Bleeding Sensor P2046. The Clot Thickens - Hemostatic Powder as Primary Therapy in Non-variceal Upper Gastrointestinal Bleeding: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials P2051. A Case of Upper GI Bleeding in Heart Transplantation: A Jejunal GIST P2064. Diverse Consequences of Simultaneous Extramedullary Plasmacytomas of the Gastrointestinal Tract in Multiple Myeloma P2097. Adult Onset Meckel’s Diverticulum Presenting as Overt Gastrointestinal Bleeding Requiring Massive Transfusion P2110. Risk of Major Adverse Cardiovascular Events in Patients With Inflammatory Bowel Diseases or Other Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: A Systematic Review and Network Meta-Analysis P2154. Prevalence of Bowel Urgency and Its Associations with Quality of Life in a Real-World Ulcerative Colitis Population: Results from the Measuring Urgency Symptoms in Inflammatory Bowel Disease Collaboration (MUSIC) Study P2174. Analysis of Baseline Characteristics Associated With Clinical Response to Ustekinumab IV Re-induction Strategy in Patients With Crohn’s Disease in the POWER Trial P2194. Burden of Bowel Urgency Among Pediatric Patients with Ulcerative Colitis: Results from a Physician and Patient Survey P2200. Efficacy and Safety of Etrasimod in Patients With and Without Concomitant Corticosteroid Treatment in the Phase 3 ELEVATE UC 52 and ELEVATE UC 12 Trials P2217. Transcriptional Analysis of Colonic Biopsies from Patients with Ulcerative Colitis Treated with Omilancor P2224. SARS-CoV-2 Breakthrough Infections Are Associated with Corticosteroid Use, Waning Anti-Spike IgG Titers, and Reduced T-Cell Clonal Expansion Among Vaccinated Adults with Inflammatory Bowel Disease P2244. Dyssynergic Defecation in Patients With Inflammatory Bowel Disease P2254. Therapeutic Drug Monitoring of Vedolizumab in Management of Immune Checkpoint Inhibitor-Mediated Colitis P2274. Efficacy and Safety of Transoral Outlet Reduction for Dumping Syndrome After Roux-En-Y Gastric Bypass: A Systematic Review and Meta-Analysis P2275. Stricture Rates Following Esophageal Endoscopic Submucosal Dissection: Systematic Review and Meta-Analysis P2278. Selective Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography: Effects of Dexamethasone P2280. Feasibility and Safety of Endoscopic Mucosal Resection of Large Colon Polyps Performed at an Ambulatory Surgery Center: A Retrospective Study P2281. Cystic Duct Stenting vs Other Treatment Modalities for Management of Acute Cholecystitis in Patients With Decompensated Cirrhosis P2289. Successful Biliary Re-Cannulation and Neo-Anastomosis Creation in Complete Bile Duct Occlusion or Disruption Using a Combination of Interventional Radiology and Endoscopy Techniques:

A Case Series P2292. Comparing Endoscopic Suture vs Over-theScope Clips vs No Intervention in Preventing Esophageal Stent Migration: A Network Meta-Analysis P2305. A Rare Case of an Isolated Duodenal Varix Treated Endoscopically With Endo Clips P2318. McKittrick-Wheelock Syndrome: Chronic Diarrhea Due to a Giant Tubulovillous Adenoma With Endoscopic Management P2320. Endoscopic Suturing for Treatment of Candy Cane Syndrome After Roux-en-Y Gastric Bypass P2321. Lynch- Not a Cinch: Hereditary Metastatic Breast Cancer With Diffuse GI Involvement P2328. When Less Is More: Endoscopic Closure of Chronic Gastric Perforation Following Graham Patch Procedure P2336. OVESCO to Rescue – Novel Use of OVESCO Clip in Variceal Bleed P2337. Incongruent EUS-PPG vs Trans Jugular HVPG: A Case Series P2338. Successful Endoscopic Closure of an Iatrogenic Hypopharyngeal Perforation Using MANTIS™ Clips P2340. Case Series: Creation of a Neo-Bile Duct in Patients With Hepatic Duct Injury or Transection During Laparoscopic Cholecystectomy P2344. Management of Gastric Adenomas by Cryoablation in the Setting of Familial Adenomatous Polyposis P2366. Hepatocellular Carcinoma Incidence is Increasing in Older Men: A Population-Based Time-Trend Analysis Using the Global Burden of Diseases Database, 2000-2019 P2373. The Addition of Fenofibrate to Ursodiol Improves Levels of Alkaline Phosphatase Among Patients with Primary Biliary Cholangitis That Do Not Respond to Ursodeoxycholic Acid Monotherapy P2389. Characteristics of Patients With PSC Undergoing Liver Transplantation Based on Patient Race P2421. Gut Microbiota as a Biomarker of Hepatocellular Carcinoma in Patients With Cirrhosis P2430. Patterns of Abnormal MUC1 Expression in Patients with PSC and Cholangiocarcinoma P2445. Patients Receiving Simultaneous Liver-Kidney Transplant Have Improved In-Hospital Outcomes Compared to Patients in the Safety Net Pathway P2468. A Rare Case of HBV Reactivation With Delayed Cholestatic Effect Secondary to Acalabrutinib P2496. Unintended Connection P2497. A Case of Delayed Immune Checkpoint Inhibitor Hepatitis in a Patient With Malignant Melanoma P2526. Unresectable Metastatic Solid Pseudopapillary Pancreatic Neoplasm Treated With Liver Transplantation: A Case Report P2544. A Rare Case of Adult Hepatoblastoma With Concomitant Hepatitis B Coinfection P2548. Lethal Invasion: Clostridium perfringens Pyogenic Liver Abscess Causing Massive Intravascular Hemolysis and Septic Shock P2566. Hepatitis B Virus Reactivation on Tenofovir Alafenamide During Immunosuppressive Therapy P2599. A Rare Presentation of Acute Hepatitis: Q Fever P2609. Development of a Virtual Reality-Based Endoscopic Sleeve Gastroplasty Simulator P2613. Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study P2614. The Association Between Diabetes Microvascular Complications and Type-2 Diabetes Remission in Patients Undergoing Roux-En-Y Gastric Bypass or Sleeve Gastrectomy P2627. Association of Excess Methanogenesis With Age and Sex: A Large Scale Database Analysis P2633. Adult Patients With Celiac Disease Are Under-Vaccinated Against Pneumococcal Disease P2640. Neutralizing IL-15 Inhibits Pro-Inflammatory Cytokine Production and Promote Protective Immune Responses P2650. Severe Gastric and Duodenal Ulceration with Bowel Perforation as Rare Immunotherapy Related Adverse Events in Hepatocellular Carcinoma: A Case Report P2653. An Unusual Case of Metastatic Cancer Presenting as a Duodenal Obstruction P2664. Not Your Usual Duodenal Pearls: Unveiling the True Nature of a Supposed Duodenal Type Follicular

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 33

Lymphoma as a Classic Follicular Lymphoma P2669. Not Your Typical Case of Terminal Ileitis P2675. It’s All About the ACE: Angiotensin Converting Enzyme Inhibitor-Induced Intestinal Angioedema P2712. Risk Factors for Gastric Intestinal Metaplasia in the United States P2714. A Single Institution Performance Curve for Gastric Full Thickness Resection: A Safe and Effective Management Strategy for Foregut Lesions P2715. Optimizing Surveillance Strategies for Gastric Cancer in Lynch Syndrome: A Cost-Effectiveness Analysis P2719. Evaluating the Impact of a Dedicated Gastric Biopsy Clinic Visit on Gastric Intestinal Metaplasia Surveillance Compliance P2723. Delayed Gastric Emptying Among Persons Living With HIV: A Control-Matched Retrospective Cohort Study P2745. Long Term Outcomes (≥ 3 Years) Following Gastric Peroral Endoscopic Myotomy for Gastroparesis: A Systematic Review and Meta-Analysis P2748. Short- and Long-Term Reproducibility of Body Surface Gastric Mapping P2751. Comparing Artificial Intelligence-Assisted and Clinician-Performed Endoscopy in the Diagnosis of Chronic Atrophic Gastritis: A Diagnostic Accuracy Meta-Analysis P2752. Study Design Considerations for Thoracic Neuromodulation in Diabetic Gastroparesis P2761. Effect of Chronic Gastric Electrical Stimulation on Regeneration of Gastric Interstitial Cells of Cajal in Gastroparesis Patients P2763. Unveiling the Power of Molecular Testing in Detecting Clarithromycin-Resistant Helicobacter pylori in Stool: A Systematic Review and Meta-Analysis P2766. Effects of Stomach Shortening on Weight Loss Following Endoscopic Sleeve Gastroplasty P2767. Quantification of Interstitial Cells of Cajal in the Gastric Muscles of Patients With or Without Gastroparesis P2773. Gastric Small Cell Carcinoma: An Unfortunate Case of Hematemesis

 Tuesday, October 24  Poster viewing time: 10:30 am – 4:00 pm

P1333. P2868. Clinical Course of Hereditary Pancreatitis in Pediatric Patients P2876. The Impact of Bariatric Surgery on Fat Content of Pancreas P2902. Coil Migration Woes P2908. Endoscopic Ultrasound With Fine Needle Biopsy Confirming a Diagnosis of Immune Checkpoint Inhibitor-Related Type III Autoimmune Pancreatitis P2992. Bile Cast Syndrome in a Young Female Following Severe COVID-19 Infection P2998. Looped in Inflammation: The Link Between Ansa Pancreatica and Acute Pancreatitis P3036. Racial and Ethnic Differences in Colon Cancer Surgery Type Performed and Delayed Treatment Among People 45 Years Old and Older in the USA Between 2007-2017: Mediating Effect on Survival P3043. Is There a Geographical Variation of Colon Cancer Prevalence in the United States of America: A Multi-Center Retrospective Analysis P3054. A Not so Fun Guy: A Curious Case of Fungal Colitis P3077. Novel Use of an Interleukin-4 and Interleukin-13 Monoclonal Antibody to Treat Refractory Eosinophilic Colitis P3078. Colon Cancer: An Unexpected Cause of Dysphagia P3079. Melanoma Presenting as Anorectal Mass P3096. Mesenteric Arteriovenous Malformation With Associated Inferior Mesenteric Vein Occlusion: A Rare Cause of Ischemic Colitis P3114. Mixed Adenoneuroendocrine Carcinoma of the Colon: A Challenging Entity From Diagnosis to Management P3116. Navigating Uncommon Presentations of Colorectal Syphilis: Case Series and Literature Review

P3143. Treatment of Refractory Lupus Intestinal Pseudo-Obstruction with the Euro-Lupus Protocol P3144. Therapy Associated Polyposis: A Case Series P3149. Basidiobolomycosis Mimicking Colon Cancer: An Ongoing Dilemma in Arizona P3171. Association Between NAFLD/NASH and Colorectal Polyps and Neoplasms in Young Adults With Obesity: A Retrospective Study P3194. Cost-Effectiveness of Mt-sDNA vs Fecal Immunochemical Test for Colorectal Cancer Screening in a Medicare Population P3201. The Effect of Preoperative Endoscopic Tattooing on Lymph Node Retrieval in Colorectal Cancer: A Systematic Review and Meta-Analysis P3219. Percutaneous Endoscopic Cecostomy as Definitive Treatment in an Elderly Patient with Recurrent Ogilvie’s Syndrome P3227. Deep Submucosal Resection of Duodenal Neuroendocrine Tumors Using Over-the-Scope Clip - A Prospective Single Center Study P3236. Non-Endoscopic Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma P3258. First Interim Analysis of Safety and Effectiveness in View Study: A Multicenter, Single-Arm, Prospective, Non-Interventional Study of Vonoprazan in Real-World Clinical Practice in China P3264. The Tissue Systems Pathology Test Predicts Risk of Progression in Medicare-Eligible Patients with Barrett’s Esophagus P3281. Analysis of Reported Adverse Events Related to the Magnetic Sphincter Augmentation Reflux Management System: An FDA MAUDE Database Study P3287. The Case of Asymptomatic Esophageal Screws P3299. In Patients With Autoimmune Disease and Achalasia Diagnosed by HRM and FLIP Can Clarify Lower Esophageal Sphincter Function P3322. A Rare Case of Esophageal Duplication Cyst With Esophago-Pleural Fistula and Pyopneumothorax P3342. Dilated Azygous Vein Secondary to Inferior Vena Cava Atresia as a Rare Cause of Dysphagia P3345. It's Not Always in the Skin: Diagnosing Systemic Sclerosis Sine Scleroderma in a Patient With a Large Hiatal Hernia P3374. The Efficacy of Treatments for Bile Acid Diarrhea: A Systematic Review and Meta-Analysis P3395. Artificial Intelligence for Pre-Colonoscopy Patient Guidance: An Evaluation of ChatGPT's Accuracy Against Clinical Guidelines P3402. Efficacy of Over-the-Scope Clips Compared to Standard Therapy for Nonvariceal Upper Gastrointestinal Bleeding - A Systematic Review and Meta-Analysis of Randomized Trials P3413. The Stealthy Invader Unveiled: Duodenal Biopsy Discovers Strongyloides stercoralis in an Immunosuppressed Patient P3419. Endoscopic Resection of a Rare Ileocecal Valve Polyp P3442. Systemic Mastocytosis P3451. The Impact of a CT Angiography-Guided Protocol for Severe Lower Gastrointestinal Bleeding on Utilization and Outcomes P3452. Endoscopic Screening and the Risk of Post Left Ventricular Assist Device Gastrointestinal Bleeding: A Multicenter Retrospective Cohort Study P3453. Deep Learning and Capsule Endoscopy: Automatic Panendoscopic Detection of Vascular Lesions P3464. Over-The-Scope Clip vs Conventional Endoscopic Therapy for Bleeding Peptic Ulcers: An Updated Meta-analysis P3465. Outcomes from Hemorrhoidal Artery Embolization in a Multidisciplinary Outpatient Interventional Center: A Review of 211 Patients P3476. Unraveling the Silent Strangler: Takayasu Arteritis Unleashing Hematochezia P3497. PD1 Inhibitor Induced Hemorrhagic Gastritis P3505. Isolated Duodenal Variceal Hemorrhage Related to a History of Sleeve Gastrectomy P3511. A Rare Case of Duodeno-Caval Fistula Presenting as Gastrointestinal Bleeding in the Setting of Vena Caval Phlebitis P3565. Wireless Patches Reveal Differences in Gastric and Colonic Motility Between Crohn's Disease Patients in Flare and Remission

P3568. Network Meta-Analysis to Evaluate the Comparative Efficacy of Biologics for Maintenance Treatment of Adult Patients With Crohn’s Disease P3581. The Anti-TL1A Antibody PRA023 Demonstrated Proof-of-Concept in Crohn’s Disease: Phase 2a APOLLO-CD Study Results P3596. Correlation Between Intestinal Ultrasound and Fecal Calprotectin With Endoscopic Severity Scores (SES-CD, UCEIS) for Determining the Activity in Inflammatory Bowel Diseases P3646. Number Needed to Treat to Maintain Clinical Remission With Advanced Therapies in Patients with Moderate to Severe Ulcerative Colitis P3648. A Functional Medicine Program for Patients With Inflammatory Bowel Disease and Improvement in Fecal Calprotectin Levels P3660. Disease Monitoring by Self-Performed Handheld Intestinal Ultrasound in Severe Ulcerative Colitis P3670. Kaposi Sarcoma Following Liver Transplantation in a Patient With Ulcerative Pancolitis on Vedolizumab P3677. An Unusual Pulmonary Presentation of Inflammatory Bowel Disease P3679. Ustekinumab and Tofacitinib Combination Therapy: Success in a Difficult Case of Crohn’s Disease With Enteropathic Arthritis P3691. Device Malfunctions Related to the “Spyglass” Cholangioscope During ERCP: A MAUDE Database Analysis P3701. Efficacy and Safety of EUS-Guided Hepatogastrostomy: A Systematic Review and Meta-analysis P3705. Outcomes of ERCP in Prone versus Supine Position: A Large Multi-center Study P3712. Lumen Apposing Metal Stents in the Management of Complex Pelvic Abscesses P3725. EUS-Guided Transgastric Kidney Biopsy: A Novel Approach P3741. Successful Endoscopic Management of Gallstone Ileus Using Electrohydraulic Lithotripsy P3744. Successful Endoscopic Treatment of Bouveret Syndrome P3746. Transcolonic Drainage of Walled-Off Pancreatic Necrosis: A Case Report P3747. Endoscopic Mucosal Incisional, Closure, ResectiON (E-MICRON): A Novel Technique for Safe and Efficient En-Bloc Foregut Resection P3750. Endoscopic Closure of a Gastrocutaneous Fistula With the Application of Dermabond With Ventricular Septal Defect Occluder P3760. Case Series: Application of Radiofrequency Ablation in Various Pancreatic Neoplastic Lesions

P3779. Racial Disparities in Graft and Patient Survival After Orthotopic Liver Transplantation P3783. Disparity in Orthotopic Liver Transplant Listing With Respect to Race and Access to Care: An Analysis of the National Inpatient Sample 2016-2020 P3794. Liver Frailty Index is a Significant Predictor of Mortality in Patients Needing Liver Transplantation: A Retrospective Large Single Center Analysis P3809. Utility of Novel FibroScan-Based Scores in the Diagnosis of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease P3811. Racial Differences in Primary Sclerosing Cholangitis Risk Factors and Outcomes: A Nationwide Study Leveraging a New ICD-10 Code P3823. Risk of Colorectal Cancer With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis Compared to Primary Sclerosing Cholangitis Only: A Need for Consensus on Colonoscopy Surveillance Guidelines for PSC Without IBD P3872. Budd-Chiari Syndrome Secondary to Congenital Vascular Malformation: A Novel Complication in a Patient with Trisomy 21 P3896. Acute Cerebral Edema and Hyperammonemia After Transjugular Intrahepatic Portosystemic Shunt Placement in a Patient With Chronic Liver Disease P3941. Hepatic Chylothorax in the Absence of Ascites: A Rare Pleural Effusion P3944. Combined BRTO and ESG: A Multi-Disciplinary Approach to Recurrent NASH Allograft Fibrosis P3965. Noncirrhotic Causes of Portal Hypertension P4033. Appetite-Related Physiological Adaptations to a Low-Calorie, Low-Fat Diet in Obesity Compared to Normal Weight P4035. Efficacy and Safety of Tirzepatide for the Management of Obesity in People With or Without Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials P4089. Effectiveness of a Structured Education Intervention in Improving GERD Symptom Reassessment and Reducing Long-term PPI Use in an Underserved Population P4114. Video Capsule Endoscopy in the Elderly P4138. Gut Mimicking the Heart (SBO Presenting as STEMI) P4192. Composite Mesh in Incisional Hernia Repair: A Case Report of Unprecedented Gastric Penetration and Gastrocutaneous Fistula Formation P4219. Passing the Pyloric Checkpoint: A Rare Case of Pyloric Stenosis from Pembrolizumab Related Ulcer Disease



The College is pleased to once again provide recognition for “Outstanding Poster Presenter” at this year’s Annual Scientific Meeting. ACG hopes to cultivate the ability of clinical GI researchers to use critical storytelling and presentation skills essential for a career as a clinical investigator and scientific communicator. During the daily Poster Rounds with the experts, poster presenters may be invited to give a succinct and informative two-minute briefing on their research, followed by one minute of Q&A with a faculty judge. Each judge will select one or more presenters within a poster category who are best able to communicate their key findings, the significance of their data, and articulate the potential impact of their work for clinicians and patients, to receive an “Outstanding Poster Presenter” distinction. Recipients of this designation will be recognized with a red ribbon and will receive a certificate. Poster Rounds with the experts will take place on Sunday (5:15 pm - 6:30 pm), Monday (1:00 pm 2:15 pm), and Tuesday (1:00 pm - 2:15). Attendees who wish to attend these rounds can join the Experts at the Poster Counter in the Exhibit Hall 10 minutes before the start time.

34 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

2023 Samuel Weiss Award to

EAMONN M. M. QUIGLEY, MD, MACG ACG’s Highest Honor to Dr. Quigley for the Magnitude of His Service

In light of the magnitude of his service to the College and his impressive and sustained record of accomplishment, ACG Past President Dr. Eamonn M. M. Quigley is honored with the 2023 Samuel Weiss Award, a service award in commemoration of ACG’s founding father, Samuel S. Weiss, presented periodically, and not necessarily annually, to a Fellow of the College in recognition of outstanding career service to ACG. Internationally known for his research experience in gastrointestinal motility disorders, neurogastroenterology, the gut microbiome, and the role of probiotics in health and disease, Dr. Quigley’s credentials establish him as an exceptional physician, educator, investigator, leader, mentor, and role model. His career has spanned five decades, and his continued energy and accomplishments are exemplary. He has had a profound influence on ensuring the continuing success of the College and the GI field. Trained in Ireland, Scotland, and then the Mayo Clinic, he represents an incredible diversity of clinical, teaching, and research interests and he has served in leadership positions in multiple medical schools and universities, including Dean at the National University of Ireland (Cork) from 2000 to 2007. He is currently Professor of Medicine and Chair of Medicine in Digestive Disorders at Houston Methodist Hospital. ACG SERVICE Dr. Quigley is uniquely qualified for the Weiss Award recognizing exceptional service to the College. Notable among his decades of exemplary contributions to ACG are the excellence of his tenure in two of the College’s most important roles, President (2008-2009) and Editorin-Chief of The American Journal of Gastroenterology (1997-2003). The breadth of his service to ACG is noteworthy, including directing the annual Postgraduate Course in 1995 and service as ACG Governor for Nebraska (1996-1998). He was elected to the Board of Trustees in 1998, serving as a member of the executive leadership team culminating in service as President from 2008-2009. In 2011, he received the ACG International Leadership Award. Dr. Quigley was honored with the designation of Master of the ACG in 2015 and received the Berk/Fise Clinical Achievement Award in 2017. Over the years, he has served on and/or chaired multiple College committees, including Publications, International Affairs, Educational Affairs, Awards, Credentials, Finance, and Nominations.

SERVICE TO THE RED JOURNAL Dr. Quigley also devoted 12 years of service as Associate Editor (19911997) and then Editor-in-Chief (19972003) of The American Journal of Gastroenterology, which thrived under his leadership. Thanks to his hard work and extraordinary vision, during his tenure as Editor-in-Chief, AJG’s impact factor by increased by 68%, manuscript submissions increased, page numbers grew from more publications, and its reputation as THE clinical journal of gastroenterology in the U.S. became evident. He was a tremendous source of inspiration to the Red Journal editors who followed him. AN EXCEPTIONAL AMBASSADOR FOR ACG His service as ACG President overlapped for one year with his role as President of the World Gastroenterology Organisation (WGO) from 2005 to 2009. Through his leadership and presidency of both organizations, he was the champion of getting ACG involved in collaborative meetings and initiatives. His insight in fostering ACG participation in the WGO “Train the Trainer” programs was instrumental in developing and solidifying ACG’s role in supporting training for clinician leaders/educators around the world. In 2019, he was named Master of the WGO. One nominator for the Weiss award reflected upon Dr. Quigley’s leadership positions with ACG and WGO and how they elevated the College’s stature internationally, “Due to his unique life journey, gregarious personality, and extensive network of friends throughout the world, the ACG’s international profile became higher than ever. He always has been happy to take up the burden, to go the extra mile, and to see each task to its completion, all while excelling at his day job as a researcher and professor.” Dr. Quigley is a talented and profound medical educator. He has delivered hundreds of lectures all over the world. He has provided innumerable honorary lectures including two of the College’s named lectures, The J. Edward Berk Distinguished Lecture in 2003, and the David Y. Graham

Lecture in 2013. His continued regular and frequent involvement in countless lectures at national and regional ACG meetings is a testimony to his esteemed reputation as a clinician and educator. He served recently as one of the ACG Institute’s Edgar Achkar Visiting Professors. “He represents the ACG in all his activities with a professionalism and sense of ethics and propriety that is laudable,” wrote one of his nominators. For his loyal commitment to the advancement, reputation, and success of the College and its flagship clinical journal, Dr. Quigley is recognized with ACG’s highest honor, the Weiss Award.

served as Chief of Gastroenterology and Hepatology. Returning to Cork in 1998, he served as Dean of the Medical School at UCC for seven years and was a principal investigator at the Alimentary Pharmabiotic Center (now Institute) from its inception. He took up his current position in January 2013 as the Chief of the Division of Gastroenterology and Hepatology at Houston Methodist Hospital. Over the years, Dr. Quigley has served as ACG Governor for the State of Nebraska, Director of the ACG Postgraduate Course, and on several ACG committees. He is a past Editorin-Chief of The American Journal ABOUT DR. QUIGLEY of Gastroenterology and served as Eamonn M. M. Quigley, MD, MACG president of the College from 2008 is David M. Underwood Chair of to 2009. He also served as president Medicine in Digestive Disorders, Chief of the World Gastroenterology of the Division of Gastroenterology Organisation (2005-2009). and Hepatology, Medical Director He has authored over 1,000 of the Lynda K. and David M. publications which include editing or Underwood Center for Digestive co-editing 22 books or monographs. Disorders, Professor of Medicine, He has received numerous awards and Weill Cornell Medical College at honorary titles worldwide. Dr. Quigley Houston Methodist Hospital, Houston, has been married for over 40 years to Texas, and Adjunct Professor of Dr. Una O’Sullivan and they have four Medicine at Texas A & M University. children: Joanna, Killian, Finola, and A native of West Cork in the most Aisling, and five grandchildren who southerly corner of Ireland, Dr. have been a constant source of pride, Quigley attended Hamilton High support, and happiness. His interests School and Glenstal Abbey School outside of medicine include literature, and went on to graduate MB BCh music, and sport – rugby, in particular. BAO from the medical school at Despite his many overseas moves, University College Cork, Ireland, Dr. Quigley remains a passionate where he also completed internship. supporter of Munster and Irish rugby. He trained in internal medicine in Glasgow, Scotland, where he also  ABOUT THE SAMUEL S. WEISS began his training in gastroenterology AWARD under the direction of Dr. Geoffrey The Samuel S. Weiss Award was Watkinson. Following a two-year established as a service award in research fellowship on gastrointestinal commemoration of the founding father motility at the Mayo Clinic, Rochester, of the ACG, Samuel S. Weiss, MD, Minnesota, under the direction of whose efforts and initiative resulted Dr. Sidney Phillips (which led to the in the establishment of the College award of MD by thesis), he completed in 1932. Since its inception in 1972, it training in internal medicine and has been presented periodically (not gastroenterology in Manchester, always annually) to a Fellow of the UK where he served as a Lecturer College in recognition of outstanding in Medicine at the University of career service to the American College Manchester under Professor (now of Gastroenterology. Nominations are Lord) Leslie Turnberg. In 1986, he solicited and reviewed by the Awards joined the faculty at the University of Committee and the recipients must Nebraska Medical Center in Omaha, be approved by the ACG Board of Trustees. Nebraska, where he rose to become a Professor of Medicine and ultimately

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 35



Published by ACG

• Fully indexed, online-only, Gold Open Access journal published monthly

• Translational studies, Clinician's Toolbox, reviews, and more • Discounted APC pricing for ACG members and transfers from AJG • Now a double-blind peer review journal

Learn More:



* 2022 Journal Citation Reports (Clarivate Plc)


MICHAEL CAMILLERI, MD, DSC, MACG AND C. PRAKASH GYAWALI, MD, FACG 2023 HONOREES Two renowned gastroenterologists are the recipients of this year's Distinguished Mentorship and Teaching Award: Dr. Michael Camilleri and Dr. C. Prakash Gyawali. Among their many contributions to the field of gastroenterology, these two stand out for the breadth of their interests and the numbers of GI trainees and postdoctoral fellows/scientists who benefited from their mentorship.

MICHAEL CAMILLERI, MD, DSC, MACG Michael Camilleri, MD, DSc, MACG, is Professor of Medicine, Pharmacology, and Physiology at Mayo Clinic College of Medicine and Science, and Consultant in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, Minnesota. He was recognized with the Atherton and Winifred W. Bean Professorship in 2001 and as a Mayo Distinguished Investigator in 2008. He formerly held the position of Dean of Development at Mayo Clinic. He holds the ranks of Professor of Medicine, Pharmacology, and Physiology at Mayo Clinic College of Medicine. He joined the staff of Mayo Clinic in 1990. His research interests include clinical enteric neurosciences, gut neurohormonal control, obesity, irritable bowel syndrome, and pharmacology/pharmacogenomics. He has published ~1300 articles (H index 104 and more than 40k citations, more than 35k without self-citation). He has received numerous awards and honors including the Joseph B. Kirsner Award and the Julius Friedenwald Medal from the American Gastroenterological Association, and the Ismar Boas Medal from the German Society of Digestive and Metabolic Disease. He has mentored more than 80 national/international postdoctoral fellows/scientists. He is Past President of the American Gastroenterological Association and the American Neurogastroenterology and Motility Society, the founding editor of Clinical Gastroenterology and Hepatology, and is currently an associate editor of Gut. C. PRAKASH GYAWALI, MD, FACG

Dr. Prakash Gyawali is currently a Professor of Medicine, Director of Neurogastroenterology and Motility, and Program Director of Gastroenterology Fellowship Training at the Division of Gastroenterology, Washington University School of Medicine, St. Louis. He went to Medical School at Calicut Medical College in South India, where he also completed his rotating house-officer training, and three years of training in general internal medicine. He continued his training in the

United Kingdom, with senior house-officer jobs culminating in Membership of the Royal College of Physicians (MRCP). Dr. Gyawali then joined internal medicine residency at Barnes Hospital and Washington University School of Medicine in St. Louis. He completed fellowship training in gastroenterology at the same center, and joined the faculty of the Division of Gastroenterology, Washington University in St. Louis in 1999, where he has remained since then. Dr. Gyawali's academic interests include esophageal motility disorders, gastroesophageal reflux disease, and other benign and functional esophageal disorders. He directs the Gastroenterology Fellowship Training Program at Washington University School of Medicine and has been involved in the training of over 120 gastroenterology fellows throughout his career. He also directs gastrointestinal motility centers affiliated with Washington University and is involved in motility testing using high-resolution manometry, esophageal ambulatory esophageal pH and impedance monitoring, wireless pH monitoring, and endoscopic functional lumen imaging probe (FLIP). He is actively involved in clinical research involving benign esophageal disorders as well as neurogastroenterology and motility, and has mentored medical students, internal medicine residents, gastroenterology fellow trainees, and early career faculty members, both at Washington University School of Medicine and at other medical centers in the U.S. and abroad. He has published over 280 original articles, as well as multiple invited reviews and book chapters. He is part of several consensus committees, including the Chicago Classification, the Lyon Consensus, the Padova Consensus, the Wingate Consensus, and the Rome 4 and 5 Esophageal committee.  ABOUT THE DISTINGUISHED MENTORSHIP AND TEACHING AWARD In 2021, the College established a new Distinguished Mentorship and Teaching Award to recognize ACG members who have provided meaningful and sustained contributions to trainees/colleagues in gastroenterology. The vision for this award is to celebrate mentorship or teaching that helps develop the mentees’ overall scientific growth and career or life planning; supports their practice of high-level clinical gastroenterology; imparts skills to perform high quality clinical research; encourages those skills necessary to present and publish results of clinical research or quality improvement; and inspires mentees’ involvement in professional society, healthcare organization or leadership development. The spirit of the award is to honor those mentors and teachers who have made contributions over a significant period of time in gastroenterology. Such contributions may be via academic affiliation as well as in private practice or an integrated (government or non-government) health system. Recognizably, each of these specific pathways has provided impactful mentorship to many individuals, hence any of these backgrounds would be suitable for this award. The decision to grant any award within a given year, as well as the selection of the award winner, is at the discretion and recommendation of the ACG Awards Committee, and upon approval of the ACG Board of Trustees. This award is not necessarily given annually.

THE AMERICAN COLLEGE OF GASTROENTEROLOGY ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 37

News from the

ACG Institute

Promoting education, supporting clinical science, and raising public awareness for the prevention and treatment of digestive disease. Learn how the ACG Institute for Clinical Research and Education supports clinical GI investigators, leadership development, and education for physicians and patients in the Institute in Focus. This booklet shares important application deadlines and opportunities for leadership training, clinical research, and educational growth for you and your colleagues.  GI.ORG/INSTITUTE23

INSTITUTE IN FOCUS An Impact Report for Members

2023-2024 1


Resident Clinical Research Award ($10,000 /

The LE&E Center addresses the contemporary need for leadership training, equitable delivery of care, and ethically based decision-making with a suite of training programs and activities to provide transformational tools and experiences to GI clinicians. The programs under the LE&E Center include:

Medical Student Research Award ($5,000 / 6-10

1-year/ travel to ACG 2023) weeks/travel to ACG 2023)

The Early Career Leadership Program includes:

Pre-course learning Friday course at ACG 2023 Participate in the ACG Governors’ Washington, DC Fly-in April 2024 Participants will be immersed in coursework covering effective leadership, impactful networking, emotional intelligence, negotiation, group dynamics, and team building. The ACG Institute is excited to welcome the sixth cohort of Early Career Leadership Scholars in 2023.

Deadline for all awards:


Course Directors: Allon Kahn, MD, and Elizabeth R. Paine, MD, FACG



NEW — The Emerging Leaders Program


The ACG Early Career Leadership Program

The program aims to provide leadership training for fellows-in-training who are U.S.-based ACG member physicians (in their 3rd or 4th year of GI fellowship training) to explore their leadership potential. This program will reach fellows-in-training to develop, build, and maintain success as future leaders. Participants are immersed in coursework covering the skills needed as they look ahead to their career post-fellowship and begin to take on more leadership roles. The program includes a mix of lectures, Q&A, breakout and role-playing exercises, and networking. Topics include:


The ACG Advanced Leadership Development Program

The ACG Clinical Research Leadership Program The ACG Health Equity Research Award The ACG Visiting Scholar in Equity, Diversity & Ethical Care

Scholarships for High School Students through the Prescriptions for Success: Careers in Medicine High School Visit  LEARN MORE: GI.ORG/LEECENTER

Communication as a Physician and


Negotiating Your First Job Contract

Gastroenterologist The ACG Institute supports a robust clinical research program in gastroenterology and hepatology. This upcoming year, the ACG Institute is funding eight different award types, supporting researchers throughout their careers from medical school to established investigators. Notably, the Established Investigator Bridge Funding Award eligibility criteria was updated to increase the number of years elapsed after funding to 3 years, allow K-awards and Career Development Awards as prior funding, and the required percentage protected time reduced to 30%. Also of note, Nurse Practitioners and Physician Assistants are now eligible to apply for the Clinical Research Award and Clinical Research Pilot Award.

& Compensation Model

Time Management Change Management Start NOW: Building a Professional Community & Network

Building Equity, Diversity, and Inclusion on Your Team

total / $150,000 per year) ($300,000 total / $150,000 per year)

ACG/ASGE Epidemiologic Award in Gastrointestinal Endoscopy ($50,000 / 1- or 2-year)

ACG Health Equity Research Award ($75,000 /50k year-one, 25k year-two based on progress)

Clinical Research Award ($50,000 / 1-year) Pilot Research Award ($15,000 / 1-year)

Broaden their leadership skills Learn how to embrace and become agents of change

Elevate colleagues and trainees through mentorship and sponsorship

Enhance their flexibility and adaptability as leaders

Understand how to influence others Develop strategic thinking skills and intentionality when leading

Course Directors: Neena S. Abraham, MD, MSc (Epid), MACG, Andrew Moon, MD, MPH, Divya Bhatt, MD, Olufemi Kassim, MD, and Josh Steinberg, MD

Recognize the importance of work-life integra-


Course Directors: David J. Hass, MD, FACG, Sunanda V. Kane, MD, MSPH, FACG, and Mark B. Pochapin, MD, FACG

Junior Faculty Development Award ($450,000 Established Investigator Bridge Funding Award

The Advanced Leadership Development Program aims to develop a cohesive group of peer leaders who will serve as problem-solving consultants for each other and the College. This program offers mid-career U.S.based ACG member physicians (10-20 years post-fellowship completion) the opportunity to develop comprehensive leadership skills. The program will enhance the ability of these individuals to:

ACG'S EARLY CAREER LEADERSHIP PROGRAM The Early Career Leadership Program develops future leaders in clinical gastroenterology by providing leadership and policy training to earlycareer U.S.-based ACG member physicians (1-5 years post-fellowship completion).

38 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

tion and the power of gratitude

Become comfortable with vulnerability


ACG'S CLINICAL RESEARCH LEADERSHIP PROGRAM The Clinical Research Leadership Program is a signature program of the ACG Institute’s Center for Leadership, Ethics & Equity. Receiving a grant award is a celebratory milestone, inherent with several new responsibilities for the awardee – as a scientific leader, financial administrator, manager, and mentor. This unique interactive program will provide funded ACG clinician investigators with the skill set to start, grow and maintain success as research leaders. Participants will learn research leadership skills to maintain a successful independent research program. The goal of the program is to provide leadership training for early to midcareer clinical investigators who are U.S.-based ACG member physicians (between 2-15 years out of fellowship training), are working in the U.S., and have active or recent ACG or Federal funding as a Principal Investigator or Co-Principal Investigator. Course Directors: Neena S. Abraham, MD, MSc (Epid), MACG, Aasma Shaukat, MD, FACG, Rena Yadlapati, MD, FACG  LEARN MORE: GI.ORG/CRLP

EDGAR ACHKAR VISITING PROFESSORSHIPS This program, which honors former ACG Institute Director Edgar Achkar, MD, MACG, enables GI fellowship programs to host highquality visiting professors to enhance the training program by providing lectures, small group discussions, and one-on-one visits with trainees and faculty. Additionally, this program allows community gastroenterologists to learn from an expert through an evening event or medical grand rounds. The ACG Visiting Scholars in Equity, Diversity, and Ethical Care help institutions create awareness around the issues and challenges of delivering equitable care, respecting diversity, and instilling ethical decision-making. These visits provided an impactful learning opportunity for fellows, faculty, leadership, and Diversity, Equity, and Inclusion (DEI) leadership, as physicians seek to improve care and communication for their diverse patient populations. Topics to date have included DEI & colorectal cancer screening; hepatology/ethical issues in the care of patients with liver diseases; LGBTQ digestive health considerations, understanding the

impact of the social determinants of health: a path to liver health equity; how implicit bias affects healthcare outcomes, health disparities in GI, and diversity in GI, with additional talks planned. The LE&E Center supported five ACG Visiting Scholars in Equity, Diversity, and Ethical Care.  LEARN MORE: GI.ORG/EAVP


The ACG Institute is publishing The ACG Monograph on Microbiome Therapeutics as a supplement to The American Journal of Gastroenterology, which will serve as an overview update on the new developments and innovations related to the Microbiome in GI. The comprehensive monograph is expected to be released in December 2023 and has an editorial team of gastroenterologists led by editors Neil Stollman MD, FACG and Colleen Kelly MD, FACG. Topics to be covered include the current status of biome science, nonprescription therapeutics, prescription therapeutics, future biome therapeutics, beyond C. difficile: LBPs for non-CDI indications, and the biome in liver disease.  READ THE ACG PREGNANCY MONOGRAPH: AMJGASTRO.COM

THE G.U.T. FUND The Fund Grows, Uplifts & Transforms Clinical GI

The G.U.T. Fund is the ongoing campaign that makes possible innovative Institute programs such as the ACG Visiting Scholar in Equity, Diversity & Ethical Care, Junior Faculty Development Awards, the Early Career Leadership Program, the Advanced Leadership Development Program, the Clinical Research Leadership Program, Scholarships for High School Students through the Prescriptions for Success High School Visit initiative, and much more. The G.U.T. Fund is supported by the ACG community, individual and legacy gifts, and industry contributions. Thousands of ACG members and supporters annually make philanthropic gifts that take the programs of the ACG Institute from GOOD to GREAT. To learn more about the ACG Institute programs or to support the work of the Institute through the GUT fund, please visit: to read the new report - Institute in Focus.


for an ACG Clinical

Research Award

Deadline: Monday, December 4, 2023

ACG Junior Faculty Development Award $150,000 a year for three years

Established Investigator Bridge Funding Award up to $150,000 a year for two years

Health Equity Research Award up to $75,000

($50k year-one, $25k year-two based on progress)

ACG/ASGE Epidemiologic Research Award in Gastrointestinal Endoscopy up to $50,000 for research utilizing the GIQuIC database

Clinical Research Award

up to $50,000 for clinical research

Clinical Research Pilot Award up to $15,000 for pilot projects

Resident Clinical Research Award up to $10,000 Medical Student Research Award up to $5,000 for 6–10 week summer project

Learn more about ACG 2024 Clinical Research Opportunities and Submit Your Application:



The ACG Clinical Research Awards are a project of the ACG Institute and are supported by charitable contributions to the ACG’s ongoing fundraising campaign - The G.U.T. Fund.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 39

THE AMERICAN COLLEGE OF GASTROENTEROLOGY 40 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News


ACG GOVERNORS AWARD WINNERS and NEW ACG GOVERNORS 2023 ACG Governor Awards JUNIOR GOVERNOR’S AWARD Christine Y. Hachem, MD, FACG Christine Y. Hachem, MD, FACG is the ACG Governor for Missouri and a teaching physician at Saint Louis University. She specializes in esophageal diseases, motility disorders, and cystic fibrosis. Dr. Hachem received her medical degree from Baylor College of Medicine and completed her residency in internal medicine at Washington University in Saint Louis. She then completed her GI fellowship at Saint Louis University. Dr. Hachem is serving as the co-director of the Endoscopy School Hands-on Workshop Center for the 2023 ACG Annual Scientific Meeting. She has been a member of several ACG Committees including Educational Affairs where she chaired the AJG Journal CME sub-committee and the Self-Assessment Test subcommittee, Practice Parameters, Training, Women in Gastroenterology, and the Patient Care Committee which she chaired from 2019-2022. As ACG Governor for Missouri, Dr. Hachem has advocated for patients and physicians at both state and national levels. She attends the annual ACG Governors' fly-ins and works closely with her local Missouri state GI society.

SENIOR GOVERNOR’S AWARD Russell D. Cohen, MD, FACG Russell D. Cohen, MD, FACG is a Professor of Medicine at the Pritzker School of Medicine in the Department of Medicine, Section of Gastroenterology at the University of Chicago. He is the Co-Director of the Digestive Diseases Center, Director of the Inflammatory Bowel Disease Center, and the Co-Director of the Advanced IBD Fellowship Program at UChicago. He currently serves as the ACG Governor for Illinois and Regional Councilor. Dr. Cohen earned his BS in biological sciences at Cornell University in Ithaca, New York, and his MD with honors at Mount Sinai School of Medicine in New York City. He completed his residency in internal medicine at Beth Israel Hospital/Harvard Medical School in Boston, and his fellowships in gastroenterology, senior fellowship in inflammatory bowel diseases, and was a Health Studies Scholar at the University of Chicago. His research interests include investigations of experimental pharmacological therapies, as well as studies analyzing quality of life and the economics involved in the diagnosis and treatment of inflammatory bowel disease. He has been principal investigator and coinvestigator for nearly 200 research projects in his field. Dr. Cohen is an editor of three medical textbooks, and has coauthored more than 200 publications and video presentations. His work is published in prestigious scientific journals such as Gastroenterology, The American Journal of Gastroenterology, and Inflammatory Bowel Diseases. He is a reviewer for multiple journals, including New England Journal of Medicine, Gastroenterology, Gut, and The American Journal of Gastroenterology, and is a former Associate Section Editor of the journal Inflammatory Bowel Diseases. Dr. Cohen is the recipient of multiple honors and awards, and is named in Best Doctors in America, America’s Top Gastroenterologists, Top Doctors in the Chicago Metro Area, and Chicago Magazine’s Top Doctor in Gastroenterology.

THE WILLIAM D. CAREY AWARD Dr. Neil Stollman, MD, FACG Dr. Neil Stollman, MD, FACG, is a member of the ACG Board of Trustees, and is currently the Chief of the Division of Gastroenterology at Alta Bates Summit Medical Center in Oakland, CA. Additionally, he is an Associate Clinical Professor of Medicine in the Division of Gastroenterology at the University of California San Francisco. He has served as the ACG Governor for Northern California for 7 years (and was honored with the Junior Governor Award in 2015.) In 2018-2020, he was Chairman of the Board of Governors. During his tenure, he contributed to various committees, including the Patient Care, Practice Parameters, Credentials, and Educational Affairs, as well as the Legislative and Public Policy Council. Dr. Stollman received his medical degree from the New York University School of Medicine and completed his residency and chief residency in internal medicine at the College of Physicians and Surgeons of Columbia University in New York. He also completed fellowships in gastroenterology and advanced therapeutic endoscopy at Jackson Memorial Hospital, University of Miami School of Medicine. He has an academic and research interest in several areas, including fecal microbiota transplant (FMT) for C. difficile infection, diverticular disease, and eosinophilic esophagitis. His significant contributions to these topics have played a pivotal role in shaping recent national practice guidelines.

2023 New ACG Governors ALASKA Jeffrey W. Molloy, MD, FACG

GEORGIA Hetal A. Karsan, MD, FACG

INDIA Seshadri Chandrasekar, MD, FACG

MONTANA Andrew B. Gentry, MD, FACG

OKLAHOMA Pooja Singhal, MD, FACG


HAWAII Shilpa Jain, MD, FACG


NEVADA Amy N. Stratton, DO, FACG



ILLINOIS Darren M. Brenner, MD, FACG




ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 41

Meet the 2023–2024


ACGCRJ is a fully open access journal. View all published case reports for free.





An Online Journal of Case Gastroentero logy & Hepat Reports edited by ology Fellow s

Thanks to outgoing ACGCRJ Editorial Board members! We thank the outgoing members of the Editorial Board for their outstanding service to the Journal and wish them continued success in their careers. Vibhu Chittajallu, MD Editor-in-Chief University Hospitals, Cleveland Medical Center Cleveland, OH

Khushboo Gala, MBBS Editor-in-Chief Mayo Clinic Rochester, MN

Vaishnavi Boppana, MD Associate Editor University of New Mexico Albuquerque, NM

Nicholas McDonald, MD Tomoki Sempokuya, MD Yvette Achuo-Egbe MD, MPH, MS Michael Beattie, DO Divya Chalikonda, MD

Smit Deliwala, MD Associate Editor Emory University Atlanta, GA

Erik Holzwanger, MD Anand Kumar, MBBS, MD Jennifer Onwochei MD, MPH, MS Eric Swei, MD

Banreet Dhindsa, MD Associate Editor New York University Langone Health New York, NY

Yue-Sai Jao, MD Associate Editor University of Puerto Rico San Juan, PR

Robert J. Pattison, MD, MPH Associate Editor HCA Healthcare Las Vegas, NV

Nicholas Placone, MD Associate Editor University of Southern California Los Angeles, CA

Shazia Rashid, MD Associate Editor Louisiana State University Health Sciences Center Shreveport, LA

Achintya Singh, MD Associate Editor Metrohealth Medical Center, Case Western Reserve University Cleveland, OH

Gianna Stoleru, MD Associate Editor University of Virginia Medical Center Charlottesville, VA

Muhammad Nadeem Yousaf, MD Associate Editor University of Missouri School of Medicine Columbia, MO

42 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Global Researcher, Addressing Cancer Epidemiology and Prevention in Latin America and the U.S.:

Douglas R. Morgan, MD, MPH, FACG

Earns the International Leadership Award

For his work researching and improving health outcomes in Hispanic-Latino communities, Dr. Morgan is the recipient of the 2023 International Leadership Award. Douglas R. Morgan, MD, MPH, FACG, is Professor of Medicine and Epidemiology and Division Director of Gastroenterology and Hepatology at the University of Alabama, Birmingham (UAB). He has developed an extensive portfolio in research, education, and clinical service in gastroenterology, epidemiology, and global health. His central research interest is cancer epidemiology and prevention in Hispanic-Latino populations in Latin America and the U.S. His specific focus is gastric adenocarcinoma research in low/middle income countries (LMICs) of northern Central America, a geopolitical region named the Central America Four (CA-4: Honduras, Nicaragua, Guatemala, and El Salvador). The CA-4 is the largest LMIC region in the western hemisphere, at the intersection of Latino/a, immigrant, and LMIC global health. He has been funded by NIH/NCI, NCI Global Health, the Gates Foundation, Rome Foundation, and mentor grants (Fogarty, T35). An important achievement has been the advancement of cancer control initiatives and cancer registries in Central America through advocacy and training. He was Director of the first-ever CA-4 Cancer Informatics Congress, which was the foundation for the NCI Cancer Control Leadership Forum for Central America. Dr. Morgan is a staunch supporter of the ACG and served as chair of the International Relations Committee from 2016 to 2019. One important achievement was the reduction of annual fees for international members from LMICs. Dr. Morgan has been invited to serve as ACG delegate for multiple international Congresses in Latin America since 2011. He currently is a member of the Practice Parameters Committee.

Dr. Morgan served as a Peace Corps engineer in Honduras, an experience that inspired a medical career. As a trainee, he implemented an AIDS education initiative in Honduras with the underground female sex worker and gay communities and rotated in the Rio Grande Valley primary care clinics for immigrants and migrant farm workers. As faculty, he ‘reconnected’ with Central America as a volunteer physician in Honduras and Nicaragua following Hurricane Mitch, which opened the door for a career focus on cancer prevention in the region. The gastroenterology and global health platforms have served as the foundation for robust education and service initiatives. Dr. Morgan was the founding Co-Director of the UNC SOM International Office and founding Director of the UNC-Nicaragua Program. He was Director of Latin America sites for the Vanderbilt Institute for Global Health. In 2016, Dr. Morgan was awarded Honorary Professor of Medicine by the National University of Nicaragua. He has supported numerous U.S. trainees (medicine, nursing, and public health) who have participated in clinical and research rotations. In addition, many Central America trainees have been part of the research teams, and a select group have entered competitive U.S. residency/fellowship programs and are now on faculty at top tier U.S. AMCs. Dr. Morgan has been able to leverage the natural synergy between Central America and the U.S. Latino populations. He was the founding PIDirector of the grant-funded UNC Center for Latino Health (CELAH). This unique clinical and educational infrastructure serves Latino populations, primarily recent immigrants from

Mesoamerica. In recognition, Dr. Morgan received the North Carolina Diamante Award in Science and Health in 2010, and the Ohtli Award in 2011, the highest award for foreign nationals, from the government of Mexico. Dr. Morgan received his medical degree from Case Western Reserve University (AOA). He completed his postgraduate training in internal medicine and gastroenterology at UCSF, and earned an MPH in Epidemiology at UC Berkeley. He has held faculty appointments at the University of North Carolina and Vanderbilt University and was recruited to UAB in 2018. He is indebted with enduring gratitude to his family (Lynne, Bryn, and Camille), outstanding mentors, and the deep friendships with colleagues and their families in Central and Latin America.

 ABOUT INTERNATIONAL LEADERSHIP AWARD The International Leadership Award is given to a Fellow or Master of the ACG in recognition of outstanding and substantial contributions to gastroenterology, to the College, and to the international gastroenterology community. Substantial contributions internationally may include, but are not limited to the following: The training of individuals from other countries who have gone on to become leaders in gastroenterology in their community; leadership in international organizations that has resulted in improvement in the care of patients; and participation in humanitarian efforts.


NEW in 2024! Monograph ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 43


2023 Berk/Fise Clinical Achievement Awardee For her numerous significant clinical and research accomplishments and the advances that she has made in the field of colorectal cancer as an international expert in hereditary colorectal cancer and polyposis syndromes, ACG Past President Carol Ann Burke, MD, FACG, is this year’s Berk/Fise Clinical Achievement Awardee. Dr. Burke’s CV is a testament of distinguished contributions to clinical gastroenterology over a 30-year career making seminal contributions to the clinical practice of gastroenterology, contributions in patient care, clinical science, clinical education, technological innovation, and public service. In addition to her long track record of dedicated service to the American College of Gastroenterology including her time as ACG President from 2016 to 2017, she has an important clinical and research career. Currently Director of the Section of Polyposis in the Sanford R. Weiss, MD Center for Hereditary Colorectal Neoplasia (The Weiss Center) at the Cleveland Clinic, Dr. Burke will be the inaugural Program Director for the newly incepted “Carol A. Burke, MDSheetz Family Fellowship in Hereditary Gastrointestinal Cancer” in The Weiss Center. Formerly, she served as Vice Chair of the Department of Gastroenterology, Hepatology and Nutrition at the Cleveland Clinic. She holds joint appointments in the Taussig Cancer Center and the Department of Colorectal Surgery there. Her research in the field of hereditary colorectal cancer and focusing on familial adenomatous polyposis (FAP) has been extensive, as has her clinical care of these patients. Dr. Burke has had a tremendous clinical research career with 28 years of continual external research funding through NCI, NIH, DOD, and the American College of Gastroenterology. Her research focuses on chemoprevention of colorectal neoplasia in both hereditary GI cancer syndrome and sporadic adenoma patients. She has done multiple studies of chemoprevention of polyps, diagnosis of small bowel polyps, promotion of screening in high-risk individuals, and looking at chromatography in FAP. Currently, she has research grants on topics including chemoprevention as well as multiomic blood testing to detect colon cancer. Dr. Burke has published over 250 peer-reviewed publications including

numerous guidelines. One of her nominators noted that her “publication velocity is impressive, with 23 papers accepted in 2022 and 2023 thus far.” Her impact on the field has been recognized on national and international levels. Dr. Burke was President of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA) from 2011 to 2012, and in 2020 received the CGA Lifetime Achievement Award. She has been a member of the World Gastroenterology Organisation's Scientific Programs Committee since 2021. Since 2019, she has served as a guideline panel member for the National Comprehensive Cancer Network (NCCN) task force on Familial/Genetic High-Risk Assessment. From 2018 to 2021, she represented ACG on the U.S. Multi-Society Task Force on Colorectal Cancer. Since 2021, she has served on the Clinical Operations Committee, National Cancer Institute, ClinCap Consortium. In addition, she has served on the Colonoscopy Subcommittee of the GI Quality Improvement Consortium (GIQuIC). In 2023, she was presented with the George W. Crile Founders Professional Staff Award for Research which recognizes a professional staff member who demonstrates outstanding dedication to research throughout their career at Cleveland Clinic and recognizes an individual’s body of work based on human subject research. This award is named for Cleveland Clinic co-founder George W. Crile, a renowned surgeon who achieved numerous distinctions over his storied career, including the world’s first successful human-to-human blood transfusion and as a founding member of the American College of Surgeons. Dr. Burke also was awarded the Research Mentor of the Year for the Internal Medicine Residency Program in 2022. According to one of her nominators, “Carol’s most significant contribution is being a trailblazer and inspiration for women in gastroenterology…Her contributions to the field and service to the College are especially meaningful as she navigated a male-dominated field with poise and confidence and set examples for how to be effective and graceful. She has promoted women in the College and remains active in the cause to make the field diverse and richer through her work.” Dr. Burke’s work has advanced the field of hereditary colon cancer as a world expert making major contributions in terms of diagnosis, screening, prevention, and management. She is an outstanding

clinician and educator who is dedicated to public education and community service. Above and beyond her many leadership contributions to the College, Dr. Burke has distinguished herself for seminal contributions to the clinical practice of gastroenterology, contributions to patient care, clinical science, clinical education, technological innovation, and public service. Dr. Burke fulfills the qualifications and embodies the spirit of the Berk/Fise Clinical Achievement Award. ABOUT DR. BURKE Carol A. Burke, MD, FACG, is staff gastroenterologist in the Department of Gastroenterology, Hepatology and Nutrition with joint appointments in the Department of Colorectal Surgery and the Taussig Cancer Institute at the Cleveland Clinic in Cleveland, Ohio. She forged a 30-year career in the care of patients and families with a hereditary predisposition to gastrointestinal cancer. Her professional time is balanced between endoscopy, cancer prevention research, patient management, and patient and physician education. She has international recognition in her areas of expertise and is a frequently invited as a visiting professor. Dr. Burke has benefited from continual external research funding since 1995 through the National Cancer Institute, National Institutes of Health, Department of Defense, and the American College of Gastroenterology to perform clinical research, the majority of which focuses on prevention, particularly chemoprevention, of colorectal neoplasia in both patients with the hereditary gastrointestinal cancer syndromes, as well as sporadic adenoma and colorectal risk. In 2023, she was awarded the Cleveland Clinic’s George Crile Founders award in research, notably being only the fourth female clinical researcher at Cleveland Clinic to receive this honor over the past 23 years. Other areas of investigative interest include burnout, microaggression and impostor phenomenon mitigation, gender parity in medicine, ergonomics, early onset colorectal neoplasia, and colorectal cancer screening. She has authored over 250 peer-reviewed publications, hundreds of abstracts, numerous guidelines, and mentored tens of medical trainees and junior staff. In 2022, she was awarded the Cleveland Clinic Internal Medicine Residency Program Research Mentor of the Year. Dr. Burke was previously associate editor for the The American Journal of Gastroenterology and is a current reviewer

for GUT, Gastroenterology, Gastrointestinal Endoscopy, Clinical Gastroenterology and Hepatology, BMJ, NEJM, Endoscopy, and PlosOne, to name a few. Dr. Burke is the Director of the section of polyposis and Program Director for the newly incepted “Carol A. Burke, MDSheetz Family Endowed Fellowship in Hereditary Gastrointestinal Cancer” in the Weiss Center for Hereditary Colorectal Neoplasia at the Cleveland Clinic. She is a founding member of the Digestive Disease Institute Women’s Leadership Coalition. Her past leadership roles included Vice Chair for Research and Education and Chair of the GI Fellowship Clinical Competency Committee in the Department of Gastroenterology, Hepatology and Nutrition. Dr. Burke joined the ACG Board of Trustees in 2005 and was the third woman President of the College from 2016 to 2017. She was past president of the Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA) and received the CGA Lifetime Achievement Award for her work in hereditary GI cancer in 2020. She currently is a member of the National Comprehensive Cancer Network (NCCN) Guideline on Genetic/Familial HighRisk Assessment: Colorectal; the Clinical Operations Committee for the National Cancer Institute ClinCap Consortium; the World Gastroenterology Organisation Scientific Programs Committee; GIQuIC Registry colonoscopy subcommittee; and ACG representative to the United States Multi-Society Task Force on Colorectal Cancer. She enjoys traveling, biking, hiking, gardening, yoga, and visiting her identical twin daughters Rana and Rima in Pittsburgh and Columbus, respectively, with her husband Dr. George Jurjus.  ABOUT THE BERK/FISE CLINICAL ACHIEVEMENT AWARD The Berk/Fise Clinical Achievement Award, formerly the ACG Clinical Achievement Award, is presented to no more than one member/ Fellow of the College in any year, and is made in recognition of distinguished contributions to clinical gastroenterology over a significant period of time. In addition to a career of distinguished clinical practice of gastroenterology, specific criteria include contributions in patient care, clinical science, clinical education, technological innovation, and public and community service.

ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 45


a New Book Series

PURCHASE AT THE ACG STORE! (located in the Ballroom Foyer)




MEET THE AUTHORS AT THE ACG STORE! Friday, October 20 4:00 pm - 5:00 pm Saturday, October 21 12:00 pm - 2:00 pm 4:30 pm - 5:00 pm Sunday, October 22 1:00 pm - 3:00 pm 6:15 pm - 7:00 pm** **at the ACG booth during the Welcome Reception

Monday, October 23 10:30 am - 11:30 am 12:45 pm – 2:15 pm

Online Purchase Brennan Spiegel, MD, MSHS, FACG

Hetal A. Karsan, MD, FACG ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News | 47












Collaborative Patient-Centered Care

g Out:

n Inclusiolenges l and ChLaGBTQ+ for ology in Gastr


TELLING STORIES THAT MATTER TO YOU. Submit your ideas today: ACGMAG@GI.ORG 48 | ACG 2023 Annual Scientific Meeting & Postgraduate Course Meeting News

Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.